<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">93246</article-id><article-id pub-id-type="doi">10.7554/eLife.93246</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.93246.3</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>A latent clinical-anatomical dimension relating metabolic syndrome to brain structure and cognition</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-285748"><name><surname>Petersen</surname><given-names>Marvin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6426-7167</contrib-id><email>mar.petersen@uke.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-126296"><name><surname>Hoffstaedter</surname><given-names>Felix</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7163-3110</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-325253"><name><surname>Nägele</surname><given-names>Felix L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-325252"><name><surname>Mayer</surname><given-names>Carola</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8065-8683</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-325254"><name><surname>Schell</surname><given-names>Maximilian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-325257"><name><surname>Rimmele</surname><given-names>D Leander</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-325264"><name><surname>Zyriax</surname><given-names>Birgit-Christiane</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-267736"><name><surname>Zeller</surname><given-names>Tanja</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-325255"><name><surname>Kühn</surname><given-names>Simone</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-128124"><name><surname>Gallinat</surname><given-names>Jürgen</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-338387"><name><surname>Fiehler</surname><given-names>Jens</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-338388"><name><surname>Twerenbold</surname><given-names>Raphael</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3814-6542</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-310426"><name><surname>Omidvarnia</surname><given-names>Amir</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4744-8721</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283723"><name><surname>Patil</surname><given-names>Kaustubh R</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167624"><name><surname>Eickhoff</surname><given-names>Simon B</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-314595"><name><surname>Thomalla</surname><given-names>Goetz</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-244229"><name><surname>Cheng</surname><given-names>Bastian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01zgy1s35</institution-id><institution>Department of Neurology, University Medical Center Hamburg-Eppendorf</institution></institution-wrap><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/024z2rq82</institution-id><institution>Institute for Systems Neuroscience, Medical Faculty, Heinrich-Heine University Düsseldorf</institution></institution-wrap><addr-line><named-content content-type="city">Düsseldorf</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02nv7yv05</institution-id><institution>Institute of Neuroscience and Medicine, Brain and Behaviour (INM-7), Research Center Jülich</institution></institution-wrap><addr-line><named-content content-type="city">Jülich</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01zgy1s35</institution-id><institution>Midwifery Science-Health Services Research and Prevention, Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf</institution></institution-wrap><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01zgy1s35</institution-id><institution>Department of Cardiology, University Heart and Vascular Center</institution></institution-wrap><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/031t5w623</institution-id><institution>German Center for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Luebeck</institution></institution-wrap><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01zgy1s35</institution-id><institution>University Center of Cardiovascular Science, University Heart and Vascular Center</institution></institution-wrap><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01zgy1s35</institution-id><institution>Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf</institution></institution-wrap><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01zgy1s35</institution-id><institution>Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf</institution></institution-wrap><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01zgy1s35</institution-id><institution>Epidemiological Study Center, University Medical Center Hamburg-Eppendorf</institution></institution-wrap><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Lerch</surname><given-names>Jason P</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>University of Oxford</institution></institution-wrap><country>United Kingdom</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Roiser</surname><given-names>Jonathan</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>University College London</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>21</day><month>03</month><year>2024</year></pub-date><volume>12</volume><elocation-id>RP93246</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-10-12"><day>12</day><month>10</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-10-12"><day>12</day><month>10</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.02.22.529531"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-12-07"><day>07</day><month>12</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.93246.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-02-28"><day>28</day><month>02</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.93246.2"/></event></pub-history><permissions><copyright-statement>© 2023, Petersen et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Petersen et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-93246-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-93246-figures-v1.pdf"/><abstract><p>The link between metabolic syndrome (MetS) and neurodegenerative as well as cerebrovascular conditions holds substantial implications for brain health in at-risk populations. This study elucidates the complex relationship between MetS and brain health by conducting a comprehensive examination of cardiometabolic risk factors, brain morphology, and cognitive function in 40,087 individuals. Multivariate, data-driven statistics identified a latent dimension linking more severe MetS to widespread brain morphological abnormalities, accounting for up to 71% of shared variance in the data. This dimension was replicable across sub-samples. In a mediation analysis, we could demonstrate that MetS-related brain morphological abnormalities mediated the link between MetS severity and cognitive performance in multiple domains. Employing imaging transcriptomics and connectomics, our results also suggest that MetS-related morphological abnormalities are linked to the regional cellular composition and macroscopic brain network organization. By leveraging extensive, multi-domain data combined with a dimensional stratification approach, our analysis provides profound insights into the association of MetS and brain health. These findings can inform effective therapeutic and risk mitigation strategies aimed at maintaining brain integrity.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>metabolic syndrome</kwd><kwd>magnetic resonance imaging</kwd><kwd>brain morphology</kwd><kwd>cognitive function</kwd><kwd>imaging transcriptomics</kwd><kwd>connectomics</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>German Research Foundation</institution></institution-wrap></funding-source><award-id>454012190</award-id><principal-award-recipient><name><surname>Eickhoff</surname><given-names>Simon B</given-names></name><name><surname>Thomalla</surname><given-names>Goetz</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>German Research Foundation</institution></institution-wrap></funding-source><award-id>178316478</award-id><principal-award-recipient><name><surname>Cheng</surname><given-names>Bastian</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>MH074457</award-id><principal-award-recipient><name><surname>Eickhoff</surname><given-names>Simon B</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007601</institution-id><institution>Horizon 2020 - Research and Innovation Framework Programme</institution></institution-wrap></funding-source><award-id>945539</award-id><principal-award-recipient><name><surname>Eickhoff</surname><given-names>Simon B</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007601</institution-id><institution>Horizon 2020 - Research and Innovation Framework Programme</institution></institution-wrap></funding-source><award-id>826421</award-id><principal-award-recipient><name><surname>Eickhoff</surname><given-names>Simon B</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Structural neuroimaging of 40,087 individuals identifies a distinct brain morphological profile associated with metabolic syndrome, linking cardiometabolic risk to cognitive performance, microscale tissue composition, and macroscale brain network architecture.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Metabolic syndrome (MetS) represents a cluster of cardiometabolic risk factors, including abdominal obesity, arterial hypertension, dyslipidemia, and insulin resistance (<xref ref-type="bibr" rid="bib2">Alberti et al., 2006</xref>). With a prevalence of 23–35% in Western societies, it poses a considerable health challenge, promoting neurodegenerative, and cerebrovascular diseases such as cognitive decline, dementia, and stroke (<xref ref-type="bibr" rid="bib1">Aguilar et al., 2015</xref>; <xref ref-type="bibr" rid="bib71">Scuteri et al., 2015</xref>; <xref ref-type="bibr" rid="bib5">Beltrán-Sánchez et al., 2013</xref>; <xref ref-type="bibr" rid="bib8">Boden-Albala et al., 2008</xref>; <xref ref-type="bibr" rid="bib4">Atti et al., 2019</xref>). As lifestyle and pharmacological interventions can modify the trajectory of MetS, advancing our understanding of its pathophysiological effects on brain structure and function as potential mediators of MetS-related neurological diseases is crucial to inform and motivate risk reduction strategies (<xref ref-type="bibr" rid="bib17">Eckel et al., 2005</xref>).</p><p>Magnetic resonance imaging (MRI) is a powerful non-invasive tool for examining the intricacies of neurological conditions in vivo. Among studies exploring MetS and brain structure, one of the most consistent findings has been alterations in cortical gray matter morphology (<xref ref-type="bibr" rid="bib91">Yates et al., 2012</xref>). Still, our understanding of the relationship between MetS and brain structure is constrained by several factors. To date, there have been only a few studies on MetS effects on gray matter integrity that are well-powered (<xref ref-type="bibr" rid="bib6">Beyer et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Lu et al., 2021</xref>; <xref ref-type="bibr" rid="bib90">Wolf et al., 2016</xref>; <xref ref-type="bibr" rid="bib81">Tiehuis et al., 2014</xref>). The majority of analyses are based on small sample sizes and report effects only on global measures of brain morphology or a priori-defined regions of interest, limiting their scope (<xref ref-type="bibr" rid="bib81">Tiehuis et al., 2014</xref>; <xref ref-type="bibr" rid="bib52">McIntosh et al., 2017</xref>; <xref ref-type="bibr" rid="bib67">Sala et al., 2014</xref>). As a result, reported effects are heterogeneous and most likely difficult to reproduce (<xref ref-type="bibr" rid="bib46">Marek et al., 2022</xref>). Existing large-scale analyses on the isolated effects of individual risk factors (such as hypertension or obesity) do not account for the high covariance of MetS components driven by interacting pathophysiological effects, which may prevent them from capturing the whole picture of MetS as a risk factor composite (<xref ref-type="bibr" rid="bib26">Hamer and Batty, 2019</xref>; <xref ref-type="bibr" rid="bib57">Opel et al., 2021</xref>; <xref ref-type="bibr" rid="bib69">Schaare et al., 2019</xref>; <xref ref-type="bibr" rid="bib9">Borshchev et al., 2019</xref>). In addition, analyses addressing the complex interrelationship of MetS, brain structure, and cognitive functioning by investigating them in conjunction are scarce (<xref ref-type="bibr" rid="bib91">Yates et al., 2012</xref>). Lastly, while previous studies adopted a case-control design treating MetS as a broad diagnostic category (<xref ref-type="bibr" rid="bib45">Lu et al., 2021</xref>; <xref ref-type="bibr" rid="bib90">Wolf et al., 2016</xref>; <xref ref-type="bibr" rid="bib81">Tiehuis et al., 2014</xref>), a dimensional approach viewing MetS as a continuum could offer a more nuanced representation of the multivariate, continuous nature of the risk factor composite.</p><p>Despite reports on MetS effects on brain structure, the determinants and spatial effect patterns remain unclear. A growing body of evidence shows that spatial patterns of brain pathology are shaped by multi-scale neurobiological processes, ranging from the cellular level to regional dynamics to large-scale brain networks (<xref ref-type="bibr" rid="bib19">Fornito et al., 2015</xref>). Accordingly, disease effects can not only be driven by local properties, when local patterns of tissue composition predispose individual regions to pathology, but also by topological properties of structural and functional brain networks (<xref ref-type="bibr" rid="bib19">Fornito et al., 2015</xref>; <xref ref-type="bibr" rid="bib73">Seidlitz et al., 2020</xref>). Guided by these concepts, multi-modal and multi-scale analysis approaches could advance our understanding of the mechanisms influencing MetS effects on brain morphology.</p><p>We argue that further research leveraging extensive clinical and brain imaging data is required to explore MetS effects on brain morphology. These examinations should integrate (1) a research methodology that strikes a balance between resolving the multivariate connection of MetS and brain structure while accounting for the high covariance of MetS components; (2) the recognition of impaired cognitive function as a pertinent consequence of MetS; and (3) the analysis of the spatial effect pattern of MetS and its possible determinants.</p><p>To meet these research needs, we investigated cortical thickness and subcortical volumetric measurements in a pooled sample of two large-scale population-based cohorts from the UK Biobank (UKB) and Hamburg City Health Study (HCHS) comprising in total 40,087 participants. Partial least squares correlation analysis (PLS) was employed to characterize MetS effects on regional brain morphology. PLS is especially suitable for this research task as it identifies overarching latent relationships by establishing a data-driven multivariate mapping between MetS components and brain morphometric indices. Furthermore, capitalizing on the cognitive phenotyping of both investigated cohorts, we examined the interrelation between MetS, cognitive function, and brain structure in a mediation analysis. Finally, to uncover factors associated with brain region-specific MetS effects, we mapped local cellular as well as network topological attributes to observed MetS-associated cortical abnormalities. With this work, we aimed to advance the understanding of the fundamental principles underlying the neurobiology of MetS.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Sample characteristics</title><p>Application of exclusion criteria and quality assessment ruled out 2188 UKB subjects and 30 HCHS subjects resulting in a final analysis sample of 40,087 individuals. For a flowchart providing details on the sample selection procedure please refer to <xref ref-type="fig" rid="app1fig1">Appendix 1—figure 1</xref>. Descriptive statistics are listed in <xref ref-type="table" rid="table1">Table 1</xref>. To sensitivity analyze our results, as well as to facilitate the comparison with previous reports which primarily rely on a case-control design, we supplemented group statistics comparing individuals with clinically defined MetS and matched controls, where applicable. Corresponding group analysis results are described in more detail in <italic>appendix 2</italic>.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Descriptive statistics UKB and HCHS.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Metric</th><th align="left" valign="top">Stat<xref ref-type="table-fn" rid="table1fn1">*</xref></th></tr></thead><tbody><tr><td align="left" valign="bottom">Age (years)</td><td align="char" char="plusmn" valign="bottom">63.55±7.59 (40087)</td></tr><tr><td align="left" valign="bottom">Sex (% female)</td><td align="char" char="." valign="bottom">46.47 (40087)</td></tr><tr><td align="left" valign="bottom">Education (ISCED)</td><td align="char" char="plusmn" valign="bottom">2.62±0.73 (39944)</td></tr><tr><td align="left" valign="bottom" colspan="2"/></tr><tr><td align="left" valign="bottom" colspan="2"><underline>Metabolic syndrome components</underline></td></tr><tr><td align="left" valign="bottom">Waist circumference (cm)</td><td align="char" char="plusmn" valign="bottom">88.47±12.71 (38800)</td></tr><tr><td align="left" valign="bottom">Hip circumference (cm)</td><td align="char" char="plusmn" valign="bottom">100.90±8.79 (38801)</td></tr><tr><td align="left" valign="bottom">Waist-hip ratio</td><td align="char" char="plusmn" valign="bottom">0.88±0.09 (38800)</td></tr><tr><td align="left" valign="bottom">Body mass index</td><td align="char" char="plusmn" valign="bottom">26.47±4.37 (38701)</td></tr><tr><td align="left" valign="bottom">RR<sub>systolic</sub> (mmHg)</td><td align="char" char="plusmn" valign="bottom">138.30±18.57 (31234)</td></tr><tr><td align="left" valign="bottom">RR<sub>diastolic</sub> (mmHg)</td><td align="char" char="plusmn" valign="bottom">78.88±10.09 (31238)</td></tr><tr><td align="left" valign="bottom">Antihypertensive therapy (%)</td><td align="char" char="." valign="bottom">6.96 (39976)</td></tr><tr><td align="left" valign="bottom">HDL (mg/dL)</td><td align="char" char="plusmn" valign="bottom">61.76±23.69 (34468)</td></tr><tr><td align="left" valign="bottom">LDL (mg/dL)</td><td align="char" char="plusmn" valign="bottom">137.38±36.29 (37456)</td></tr><tr><td align="left" valign="bottom">Cholesterol (mg/dL)</td><td align="char" char="plusmn" valign="bottom">211.29±56.42 (37531)</td></tr><tr><td align="left" valign="bottom">Triglycerides (mg/dL)</td><td align="char" char="plusmn" valign="bottom">148.90±83.84 (37510)</td></tr><tr><td align="left" valign="bottom">Lipid lowering therapy (%)</td><td align="char" char="." valign="bottom">14.44 (39976)</td></tr><tr><td align="left" valign="bottom">HbA1c (%)</td><td align="char" char="plusmn" valign="bottom">5.37±0.48 (37284)</td></tr><tr><td align="left" valign="bottom">Blood glucose (mg/dL)</td><td align="char" char="plusmn" valign="bottom">90.29±17.58 (34432)</td></tr><tr><td align="left" valign="bottom">Antidiabetic therapy (%)</td><td align="char" char="." valign="bottom">0.45 (39976)</td></tr><tr><td align="left" valign="bottom" colspan="2"/></tr><tr><td align="left" valign="bottom" colspan="2"><underline>Imaging</underline></td></tr><tr><td align="left" valign="bottom">Mean cortical thickness (mm)</td><td align="char" char="plusmn" valign="bottom">2.40±0.09 (40087)</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><underline>Cognitive variables of the UK Biobank</underline></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Fluid Intelligence</td><td align="char" char="plusmn" valign="bottom">6.63±2.06 (36510)</td></tr><tr><td align="left" valign="bottom">Matrix Pattern Completion</td><td align="char" char="plusmn" valign="bottom">7.99±2.13 (25771)</td></tr><tr><td align="left" valign="bottom">Numeric Memory Test</td><td align="char" char="plusmn" valign="bottom">6.69±1.52 (26780)</td></tr><tr><td align="left" valign="bottom">Paired Associate Learning</td><td align="char" char="plusmn" valign="bottom">6.92±2.63 (26048)</td></tr><tr><td align="left" valign="bottom">Prospective Memory</td><td align="char" char="plusmn" valign="bottom">1.07±0.39 (37192)</td></tr><tr><td align="left" valign="bottom">Reaction Time (sec)</td><td align="char" char="plusmn" valign="bottom">594.16±109.08 (37015)</td></tr><tr><td align="left" valign="bottom">Symbol Digit Substitution</td><td align="char" char="plusmn" valign="bottom">18.96±5.25 (25810)</td></tr><tr><td align="left" valign="bottom">Tower Rearranging Test</td><td align="char" char="plusmn" valign="bottom">9.91±3.23 (25555)</td></tr><tr><td align="left" valign="bottom">Trail Making Test A (sec)</td><td align="char" char="plusmn" valign="bottom">223.03±86.51 (26048)</td></tr><tr><td align="left" valign="bottom">Trail Making Test B (sec)</td><td align="char" char="plusmn" valign="bottom">550.01±270.09 (26048)</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><underline>Cognitive variables of the Hamburg City Health Study</underline></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Animal Naming Test</td><td align="char" char="plusmn" valign="bottom">24.78±6.92 (2416)</td></tr><tr><td align="left" valign="bottom">Clock Drawing Test</td><td align="char" char="plusmn" valign="bottom">6.43±1.12 (2479)</td></tr><tr><td align="left" valign="bottom">Trail Making Test A (sec)</td><td align="char" char="plusmn" valign="bottom">40.09±14.33 (2290)</td></tr><tr><td align="left" valign="bottom">Trail Making Test B (sec)</td><td align="char" char="plusmn" valign="bottom">90.05±37.30 (2264)</td></tr><tr><td align="left" valign="bottom">Multiple-Choice Vocabulary Intelligence Test</td><td align="char" char="plusmn" valign="bottom">31.27±3.58 (2026)</td></tr><tr><td align="left" valign="bottom">Word List Recall</td><td align="char" char="plusmn" valign="bottom">7.75±1.84 (2342)</td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><label>*</label><p>Presented as mean ± SD (N).</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-2"><title>Partial least squares correlation analysis</title><p>We investigated the relationship between brain morphological and clinical measures of MetS (abdominal obesity, arterial hypertension, dyslipidemia, insulin resistance) in a PLS considering all individuals from both studies (n=40,087) (<xref ref-type="fig" rid="fig1">Figure 1</xref>). By this, we aimed to detect the continuous effect of any MetS component independent from a formal binary classification of MetS (present/not present). A correlation matrix relating all considered MetS component measures is displayed in <xref ref-type="fig" rid="app1fig2">Appendix 1—figure 2</xref>. Before conducting the PLS, brain morphological and clinical data were deconfounded for age, sex, education, and cohort effects.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Methodology.</title><p>(<bold>a</bold>) Illustration of the partial least squares correlation analysis. Starting from two input matrices containing per-subject information of regional morphological measures as well as clinical data (demographic and metabolic syndrome (MetS)-related risk factors) a correlation matrix is computed. This matrix is subsequently subjected to singular value decomposition resulting in a set of mutually orthogonal latent variables. Latent variables each consist of a left singular vector (here, clinical covariance profile), singular value, and right singular vector (here, imaging covariance profile). In addition, subject-specific clinical and imaging scores are computed. (<bold>b</bold>) The interplay between MetS, brain structure, and cognition was investigated in a post-hoc mediation analysis. We tested whether the relationship between the clinical score, representing MetS severity, and different cognitive test performances was statistically mediated by the imaging score. (<bold>c</bold>) Contextualization analysis. Upper row: based on microarray gene expression data, the densities of different cell populations across the cortex were quantified. Middle and lower row: based on functional and structural group-consensus connectomes based on data from the Human Connectome Project, metrics of functional and structural brain network topology were derived. Cell density as well as connectomic measures were related to the bootstrap ratio via spatial correlations. Modified from <xref ref-type="bibr" rid="bib60">Petersen et al., 2022b</xref>; <xref ref-type="bibr" rid="bib92">Zeighami et al., 2019</xref>. Abbreviations: Astro – astrocytes; DWI – diffusion-weighted magnetic resonance imaging; Endo – endothelial cells; Ex – excitatory neuron populations (Ex1-8); In – inhibitory neuron populations (In1-8); Micro – microglia; Oligo – oligodendrocytes; rs-fMRI – resting-state functional magnetic resonance imaging; SVD – singular value decomposition.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-fig1-v1.tif"/></fig><p>PLS identified eight significant latent variables which represent clinical-anatomical dimensions relating MetS components to brain morphology (<xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>). The first latent variable explained 71.20% of the shared variance and was thus further investigated (<xref ref-type="fig" rid="fig2">Figure 2a</xref>). Specifically, the first latent variable corresponded with a covariance profile of lower severity of MetS (<xref ref-type="fig" rid="fig2">Figure 2c</xref>; loadings [95% confidence interval]; waist circumference: –0.230 [–0.239, –0.221], hip circumference: –0.187 [–0.195, –0.178], waist-hip ratio: –0.167 [–0.176, –0.158], body mass index: –0.234 [–0.243, –0.226], systolic blood pressure: –0.089 [–0.098, –0.080], diastolic blood pressure: –0.116 [–0.125, –0.107], high-density lipoprotein: 0.099 [0.090, 0.108], low-density lipoprotein: –0.013 [–0.022, –0.004], total cholesterol: 0.003 [–0.006, 0.012], triglycerides: –0.102 [–0.111, –0.092], HbA1c: –0.064 [–0.073, –0.54], glucose: –0.049 [–0.058, –0.039]). Notably, the obesity-related measures showed the strongest contribution to the covariance profile as indicated by the highest loading to the latent variable. Age (&lt;0.001 [–0.009, 0.009]), sex (&lt;0.001 [–0.009, 0.009]), education (&lt;0.001 [–0.009, 0.009]), and cohort (&lt;–0.001 [–0.008, 0.007]) did not significantly contribute to the latent variable, which is compatible with sufficient effects of deconfounding. Details on the second latent variable which explained 22.33% of shared variance are provided in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>. In brief, it predominantly related lower HbA1c and blood glucose to higher thickness and volume in lateral frontal, posterior temporal, parietal, and occipital regions and vice versa.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Partial least squares correlation analysis (PLS).</title><p>(<bold>a</bold>) Explained variance and p-values of latent variables. (<bold>b</bold>) Scatter plot relating subject-specific clinical and imaging PLS scores. Higher scores indicate higher adherence to the respective covariance profile. (<bold>c</bold>) Clinical covariance profile. 95% confidence intervals were calculated via bootstrap resampling. Note that confound removal for age, sex, education, and cohort was performed prior to the PLS. (<bold>d</bold>) Imaging covariance profile represented by bootstrap ratio. A high positive or negative bootstrap ratio indicates high contribution of a brain region to the overall covariance profile. Regions with a significant bootstrap ratio (&gt;1.96 or &lt;–1.96) are highlighted by colors. Abbreviations: BMI – Body mass index, HDL – high-density lipoprotein, LDL – low-density lipoprotein, <inline-formula><mml:math id="inf1"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> - Spearman correlation coefficient.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Partial least squares correlation analysis – Latent variable 2.</title><p>The figure presents the results of latent variable 2 of the partial least squares correlation analysis. (<bold>a</bold>) Scatter plot relating subject-specific clinical and imaging PLS scores. (<bold>b</bold>) Clinical covariance profile. (<bold>c</bold>) Imaging covariance profile represented by bootstrap ratio. A high positive or negative bootstrap ratio indicates high contribution of a brain region to the overall covariance profile. Regions with a significant bootstrap ratio (&gt;1.96 or &lt;–1.96) are highlighted by colors. Abbreviations: BMI – Body mass index, HDL – high-density lipoprotein, LDL – low-density lipoprotein, <inline-formula><mml:math id="inf2"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> - Spearman correlation coefficient.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Partial least squares correlation analysis – UK Biobank (including cognitive test results).</title><p>Partial least squares correlation analysis of the UK Biobank subsample including cognitive test results. (<bold>a</bold>) Explained variance and p-values of latent variables. (<bold>b</bold>) Scatter plot relating subject-specific clinical and imaging scores. Higher scores indicate higher adherence to the respective covariance profile. (<bold>c</bold>) Clinical covariance profile. 95% confidence intervals were calculated via bootstrap resampling. Note that confound removal for age, sex, and education was performed prior to the PLS. (<bold>d</bold>) Bootstrap ratio representing the covarying brain morphology pattern. A high positive or negative bootstrap ratio indicates high contribution of a brain region to the overall covariance profile. Regions with a significant bootstrap ratio (&gt;1.96 or &lt;–1.96) are highlighted by colors. Abbreviations: BMI – Body mass index, HDL – high-density lipoprotein, LDL – low-density lipoprotein, <inline-formula><mml:math id="inf3"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> – Spearman correlation coefficient; p – p-value; TMT-A – Trail Making Test A; TMT-B – Trail Making Test B.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Partial least squares correlation analysis – Hamburg City Health Study (HCHS) (including cognitive test results).</title><p>Partial least squares correlation analysis of the HCHS subsample including cognitive test results. (<bold>a</bold>) Explained variance and p-values of latent variables. (<bold>b</bold>) Scatter plot relating subject-specific clinical and imaging scores. Higher scores indicate higher adherence to the respective covariance profile. (<bold>c</bold>) Clinical covariance profile. 95% confidence intervals were calculated via bootstrap resampling. Note that confound removal for age, sex, and education was performed prior to the PLS. (<bold>d</bold>) Bootstrap ratio representing the covarying brain morphology pattern. A high positive or negative bootstrap ratio indicates high contribution of a brain region to the overall covariance profile. Regions with a significant bootstrap ratio (&gt;1.96 or &lt;–1.96) are highlighted by colors. Abbreviations: BMI – Body mass index, HDL – high-density lipoprotein, LDL – low-density lipoprotein, <inline-formula><mml:math id="inf4"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> – Spearman correlation coefficient; p – p-value; TMT-A – Trail Making Test A; TMT-B – Trail Making Test B.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-fig2-figsupp3-v1.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>Spatial correlation of effect size maps.</title><p>Spatial correlation matrix of all Schaefer 400-parcellated metabolic syndrome effect maps (bootstrap ratio and t-statistic). The upper triangle of the matrix displays Spearman correlations with dot size and color representing the magnitude of the coefficients. Asterisks highlight significant correlations after spin permutation testing and false discovery rate correction. The diagonal shows kernel density plots. The lower triangle illustrates the variables’ linear relationships via regression plots. Abbreviations: HCHS – Hamburg City Health Study, PLS – Partial least squares correlation analysis; <inline-formula><mml:math id="inf5"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> - Spearman correlation coefficient; <inline-formula><mml:math id="inf6"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> – false discovery rate-corrected p-value derived from spin permutations; UKB – UK Biobank.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-fig2-figsupp4-v1.tif"/></fig></fig-group><p>Bootstrap ratios (<inline-formula><mml:math id="inf7"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mi>u</mml:mi><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>p</mml:mi><mml:mo>−</mml:mo><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>d</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></inline-formula>) were computed to identify brain regions with a significant contribution to the covariance profile (see Methods). Cortical thickness in orbitofrontal, lateral prefrontal, insular, anterior cingulate, and temporal areas as well as volumes of all investigated subcortical regions contributed positively to the covariance profile as indicated by a positive bootstrap ratio (<xref ref-type="fig" rid="fig2">Figure 2d</xref>). Thus, a higher cortical thickness and subcortical volume in these areas corresponded with less obesity, hypertension, dyslipidemia, and insulin resistance and vice versa, i.e., lower cortical thickness and subcortical volumes with increased severity of MetS. A negative bootstrap ratio was found in superior frontal, parietal, and occipital regions indicating that a higher cortical thickness in these regions corresponded with more severe MetS. This overall pattern was confirmed via conventional, vertex-wise group comparisons of cortical thickness measurements based on the binary classification of individuals with MetS and matched controls (<xref ref-type="fig" rid="app2fig4">Appendix 2—figure 4</xref>) as well as subsample analyses considering the UKB and HCHS participants independently (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplements 2</xref> and <xref ref-type="fig" rid="fig2s3">3</xref>). The correlation matrix of all spatial effect maps investigated in this study (bootstrap ratio and Schaefer 400-parcellated t-statistic from group comparisons) is visualized in <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>. All derived effect size maps were significantly correlated (<inline-formula><mml:math id="inf8"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> =0.67−0.99, <inline-formula><mml:math id="inf9"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt; 0.05) (<xref ref-type="bibr" rid="bib70">Schaefer et al., 2018</xref>).</p><p>Subject-specific imaging and clinical scores for the first latent variable were computed. These scores indicate to which degree an individual expresses the corresponding covariance profiles. By definition, the scores are correlated (<inline-formula><mml:math id="inf10"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.201, p&lt;0.005, <xref ref-type="fig" rid="fig2">Figure 2b</xref>) indicating that individuals exhibiting the clinical covariance profile (severity of MetS components) also express the brain morphological pattern. This relationship was robust across a 10-fold cross-validation (avg. <inline-formula><mml:math id="inf11"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.19, <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref>).</p><p>These results were consistent in separate PLS analyses for both the UKB and HCHS samples, as displayed in <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplements 2</xref> and <xref ref-type="fig" rid="fig2s3">3</xref>. In these subset-specific analyses, cognitive test performances significantly contributed to the first latent variable when included in the PLS. Consequently, the first latent variable associated more severe MetS with both brain morphological abnormalities and poorer cognitive performance.</p></sec><sec id="s2-3"><title>Mediation analysis of cognitive outcomes</title><p>To gain a better understanding of the link between MetS, brain morphology, and cognitive function, we performed a mediation analysis on cognitive test results and subject-specific PLS scores. Therefore, we investigated whether the imaging PLS score (representing MetS-related brain structural abnormalities) acts as a mediator in the relationship between the clinical PLS score (representing MetS severity) and cognitive test performances. Importantly, scores of the main PLS analysis, which did not include cognitive measures, were considered. The corresponding path plots are shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>. The imaging score was found to fully mediate the relationship of the clinical score and results of the Trail Making Test B (ab = –0.011, <italic>P<sub>FDR</sub></italic> &lt;0.001; c’=–0.012, <italic>P<sub>FDR</sub></italic> = 0.072; c=–0.023, <italic>P<sub>FDR</sub></italic> &lt;0.001), Fluid Intelligence Test (ab = 0.017, <italic>P<sub>FDR</sub></italic> &lt;0.001; c’=0.011, <italic>P<sub>FDR</sub></italic> = 0.072; c=0.028, <italic>P<sub>FDR</sub></italic> &lt;0.001) as well as Matrix Pattern Completion Test (ab = 0.015, <italic>P<sub>FDR</sub></italic> &lt;0.001; c’=0.010, <italic>P<sub>FDR</sub></italic> = 0.172; c=0.025, <italic>P<sub>FDR</sub></italic> &lt;0.001). Further, the imaging score partially mediated the relationship of the clinical score and results of the Symbol Digit Substitution Test (ab = 0.010, <italic>P<sub>FDR</sub></italic> &lt;0.001; c’=0.036, <italic>P<sub>FDR</sub></italic> &lt;0.001; c=0.046, <italic>P<sub>FDR</sub></italic> &lt;0.001), Numeric Memory Test (ab = 0.014, <italic>P<sub>FDR</sub></italic> &lt;0.001; c’=0.044, <italic>P<sub>FDR</sub></italic> &lt;0.001; c=0.058, <italic>P<sub>FDR</sub></italic> &lt;0.001) and Paired Associate Learning Test (ab = 0.015, <italic>P<sub>FDR</sub></italic> &lt;0.001; c’=0.044, <italic>P<sub>FDR</sub></italic> &lt;0.001; c=0.059, <italic>P<sub>FDR</sub></italic> &lt;0.001). For the remaining cognitive tests, no significant mediation was found.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Mediation analysis results.</title><p>Mediation effects of subject-specific imaging PLS scores on the relationship between metabolic syndrome (MetS) represented by the clinical PLS score and cognitive test performances. Path plots display standardized effects and p-values: (<bold>a</bold>) clinical score to imaging score, (<bold>b</bold>) imaging score to cognitive score, (ab) indirect effect (<bold>c’</bold>) direct effect, and (<bold>c</bold>) total effect. Significant paths are highlighted in blue; non-significant in light gray. If the indirect effect ab was significant, the text for ab is highlighted in blue. A blue dot in the path plot indicates if a relationship is significantly mediated, i.e., the indirect effect ab was significant and the direct effect c’ was reduced or non-significant compared to the total effect c. An empty dot indicates a partial mediation, and a full dot indicates a full mediation. Abbreviations:<inline-formula><mml:math id="inf12"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> - false discovery rate-corrected p-values; PLS – partial least squares correlation; TMT-A – Trail Making Test A; TMT-B – Trail Making Test B.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-fig3-v1.tif"/></fig></sec><sec id="s2-4"><title>Contextualization of MetS-associated brain morphological abnormalities</title><p>We investigated whether the pattern of MetS effects on cortical structure is linked to the regional density of specific cell populations and global brain network topology in a surface-based contextualization analysis (see Methods).</p><p>Therefore, we first used a virtual histology approach to relate the bootstrap ratio from PLS to the differential expression of cell-type specific genes based on microarray data from the Allen Human Brain Atlas (<xref ref-type="bibr" rid="bib27">Hawrylycz et al., 2012</xref>). The results are illustrated in <xref ref-type="fig" rid="fig4">Figure 4</xref>. The bootstrap ratio was significantly positively correlated with the density of endothelial cells (<inline-formula><mml:math id="inf13"><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></inline-formula> = 0.190, <inline-formula><mml:math id="inf14"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.016), microglia (<inline-formula><mml:math id="inf15"><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></inline-formula> = 0.271, <inline-formula><mml:math id="inf16"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.016), excitatory neurons type 8 (<inline-formula><mml:math id="inf17"><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></inline-formula> = 0.165, <inline-formula><mml:math id="inf18"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.016), inhibitory neurons type 1 (<inline-formula><mml:math id="inf19"><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></inline-formula> = 0.363, <inline-formula><mml:math id="inf20"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.036) and excitatory neurons type 6 (<inline-formula><mml:math id="inf21"><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></inline-formula> = 0.146, <inline-formula><mml:math id="inf22"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.034) indicating that MetS-related brain morphological abnormalities are strongest in regions of the highest density of these cell types. No significant associations were found regarding the remaining excitatory neuron types (Ex1-Ex5, Ex7), inhibitory neurons (In2-In8), astrocytes, and oligodendrocytes (<xref ref-type="table" rid="app1table3">Appendix 1—table 3</xref>). Virtual histology analysis results for bootstrap ratios corresponding with latent variables 2 and 3 are shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>. As a sensitivity analysis, we contextualized the t-statistic map derived from group statistics. The results remained stable except for excitatory neurons type 6 (<inline-formula><mml:math id="inf23"><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></inline-formula> = 0.145, <inline-formula><mml:math id="inf24"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.123) and inhibitory neurons type 1 (<inline-formula><mml:math id="inf25"><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></inline-formula> = 0.432, <inline-formula><mml:math id="inf26"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.108), which no longer showed a significant association (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>, <xref ref-type="table" rid="app1table4">Appendix 1—table 4</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Virtual histology analysis.</title><p>The regional correspondence between metabolic syndrome (MetS) effects (bootstrap ratio) and cell type-specific gene expression profiles was examined via an ensemble-based gene category enrichment analysis. (<bold>a</bold>) Barplot displaying spatial correlation results. The bar height displays the significance level. Colors encode the aggregate z-transformed Spearman correlation coefficient relating the Schaefer100-parcellated bootstrap ratio and respective cell population densities. Asterisks indicate statistical significance. The significance threshold of <inline-formula><mml:math id="inf27"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt;0.05 is highlighted by a vertical dashed line. (<bold>b</bold>) Scatter plots illustrating spatial correlations between MetS effects and exemplary cortical gene expression profiles per cell population significantly associated across analyses – i.e., endothelium, microglia, and excitatory neurons type 8. Top 5 genes most strongly correlating with the bootstrap ratio map were visualized for each of these cell populations. Icons in the bottom right of each scatter plot indicate the corresponding cell type. A legend explaining the icons is provided at the bottom. First row: endothelium; second row: microglia; third row: excitatory neurons type 8. Virtual histology analysis results for the bootstrap ratios of latent variables 2 and 3 are shown in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>. A corresponding plot illustrating the contextualization of the t-statistic derived from group statistics is shown in <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>. Abbreviations: <inline-formula><mml:math id="inf28"><mml:mo>-</mml:mo><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>g</mml:mi><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></inline-formula> – negative logarithm of the false discovery rate-corrected p-value derived from spatial lag models (<xref ref-type="bibr" rid="bib16">Dukart et al., 2021</xref>; <xref ref-type="bibr" rid="bib10">Burt et al., 2018</xref>); <inline-formula><mml:math id="inf29"><mml:mi>r</mml:mi></mml:math></inline-formula> – Spearman correlation coeffient. <inline-formula><mml:math id="inf30"><mml:mi>Z</mml:mi><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></inline-formula> – aggregate z-transformed Spearman correlation coefficient.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Virtual histology analysis of latent variables 2 and 3.</title><p>Virtual histology analysis of the bootstrap ratio maps of latent variables 2 and 3 from the partial least squares (PLS) main analysis. Barplots display spatial correlation results of the bootstrap ratio of latent variables 2 and 3 and respective cell population densities computed via ensemble-based gene category enrichment analysis. (<bold>a</bold>) Results corresponding with the bootstrap ratio of latent variable 2. (<bold>b</bold>) Results corresponding with the bootstrap ratio of latent variable 3. Abbreviations: <inline-formula><mml:math id="inf31"><mml:mo>-</mml:mo><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>g</mml:mi><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></inline-formula> – negative logarithm of the false discovery rate-corrected p-value derived from spatial lag models; <inline-formula><mml:math id="inf32"><mml:mi>r</mml:mi></mml:math></inline-formula> – Spearman correlation coefficient. <inline-formula><mml:math id="inf33"><mml:mi>Z</mml:mi><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></inline-formula> – aggregate z-transformed Spearman correlation coefficient.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Sensitivity virtual histology analysis based on t-statistic map from group comparison.</title><p>Virtual histology analysis of the t-statistic map derived from group comparison between individuals with metabolic syndrome and controls. (<bold>a</bold>) Barplot displaying spatial correlation results of the bootstrap ratio and respective cell population densities computed via ensemble-based gene category enrichment analysis. (<bold>b</bold>) Scatter plots illustrating per significantly associated cell population exemplary genes with top 5-highest correlation coefficients with the t-statistic map per significantly associated cell population across analyses (i.e. endothelium, microglia, excitatory neurons 8). Icons in the bottom right of each scatter plot indicate the corresponding cell type. First row: endothelium; second row: microglia; third row: excitatory neurons type 8. Abbreviations: <inline-formula><mml:math id="inf34"><mml:mo>-</mml:mo><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>g</mml:mi><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></inline-formula> – negative logarithm of the false discovery rate-corrected p-value derived from spatial lag models; <inline-formula><mml:math id="inf35"><mml:mi>r</mml:mi></mml:math></inline-formula> – Spearman correlation coefficient. <inline-formula><mml:math id="inf36"><mml:mi>Z</mml:mi><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></inline-formula> – aggregate z-transformed Spearman correlation coefficient.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-fig4-figsupp2-v1.tif"/></fig></fig-group><p>Second, we associated the bootstrap ratio with three pre-selected measures of brain network topology derived from group consensus functional and structural connectomes of the Human Connectome Project (HCP) (<xref ref-type="fig" rid="fig5">Figure 5</xref>): weighted degree centrality (marking brain network hubs), neighborhood abnormality, and macroscale functional connectivity gradients (<xref ref-type="bibr" rid="bib60">Petersen et al., 2022b</xref>). The bootstrap ratio showed a medium positive correlation with the functional neighborhood abnormality (<inline-formula><mml:math id="inf37"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.464, <inline-formula><mml:math id="inf38"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt; 0.001, <inline-formula><mml:math id="inf39"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt; 0.001, <inline-formula><mml:math id="inf40"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt; 0.001) and a strong positive correlation with the structural neighborhood abnormality (<inline-formula><mml:math id="inf41"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.764, <inline-formula><mml:math id="inf42"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = &lt;0.001, <inline-formula><mml:math id="inf43"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt; 0.001, <inline-formula><mml:math id="inf44"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt; 0.001) indicating functional and structural interconnectedness of areas exhibiting similar MetS effects. These results remained significant when the t-statistic map was contextualized instead of the bootstrap ratio as well as when neighborhood abnormality measures were derived from consensus connectomes of the HCHS instead of the HCP (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplements 1</xref> and <xref ref-type="fig" rid="fig5s2">2</xref>). We found no significant associations for the remaining indices of network topology, i.e., functional degree centrality (<inline-formula><mml:math id="inf45"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.163, <inline-formula><mml:math id="inf46"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0 .365, <inline-formula><mml:math id="inf47"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.406, <inline-formula><mml:math id="inf48"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.870), structural degree centrality (<inline-formula><mml:math id="inf49"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.029, <inline-formula><mml:math id="inf50"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.423, <inline-formula><mml:math id="inf51"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.814, <inline-formula><mml:math id="inf52"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.103) as well as functional cortical gradient 1 (<inline-formula><mml:math id="inf53"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.152, <inline-formula><mml:math id="inf54"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.313, <inline-formula><mml:math id="inf55"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.406, <inline-formula><mml:math id="inf56"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.030) and gradient 2 (<inline-formula><mml:math id="inf57"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = –0.177, <inline-formula><mml:math id="inf58"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.313, <inline-formula><mml:math id="inf59"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.406, <inline-formula><mml:math id="inf60"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt; 0.001).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Brain network contextualization.</title><p>Spatial correlation results derived from relating Schaefer 400×7-parcellated maps of metabolic syndrome (MetS) effects (bootstrap ratio) to network topological indices (red: functional connectivity, blue: structural connectivity). Scatter plots that illustrate the spatial relationship are supplemented by surface plots for anatomical localization. The color coding of cortical regions and associated dots corresponds. (<bold>a and b</bold>) Functional and structural degree centrality rank. (<bold>c and d</bold>) Functional and structural neighborhood abnormality. (<bold>e and f</bold>) Intrinsic functional network hierarchy represented by functional connectivity gradients 1 and 2. Complementary results concerning t-statistic maps derived from group comparisons between MetS subjects and controls are presented in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>. Corresponding results after reperforming the analysis with HCHS-derived group-consensus connectomes are presented in <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>. Abbreviations: HCHS – Hamburg City Health Study; <inline-formula><mml:math id="inf61"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> - p-value derived from network rewiring (<xref ref-type="bibr" rid="bib50">Maslov et al., 2004</xref>); <inline-formula><mml:math id="inf62"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> - p-value derived from brainSMASH surrogates (<xref ref-type="bibr" rid="bib11">Burt et al., 2020</xref>); <inline-formula><mml:math id="inf63"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> - p-value derived from spin permutation results (<xref ref-type="bibr" rid="bib3">Alexander-Bloch et al., 2018</xref>); <inline-formula><mml:math id="inf64"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> - Spearman correlation coefficient.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Sensitivity network contextualization analysis based on t-statistic map derived from group comparison.</title><p>Brain network contextualization analysis of group statistics results. Results are presented for t-statistics maps derived from group statistics considering the pooled sample of UK Biobank subjects and Hamburg City Health Study (HCHS) subjects. The upper row barplot summarizes the analysis results displaying the Spearman correlation with regard to each investigated index. Asterisks indicate statistical significance with respect to spin, brainSMASH, and network rewiring null models. The middle and lower rows display scatter plots of the significant association of the t-statistics map and the functional and structural neighborhood abnormality, respectively. The scatter plots are supplemented by surface plots for anatomical localization. Abbreviations: <inline-formula><mml:math id="inf65"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> - p-value derived from network rewiring (<xref ref-type="bibr" rid="bib50">Maslov et al., 2004</xref>); <inline-formula><mml:math id="inf66"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> - p-value derived from brainSMASH surrogates (<xref ref-type="bibr" rid="bib11">Burt et al., 2020</xref>); <inline-formula><mml:math id="inf67"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> - p-value derived from spin permutation results (<xref ref-type="bibr" rid="bib3">Alexander-Bloch et al., 2018</xref>); <inline-formula><mml:math id="inf68"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> - Spearman correlation coefficient.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Sensitivity network contextualization analysis based on group-consensus connectomes from the Hamburg City Health Study.</title><p>Brain network contextualization analysis of partial least squares correlation results (bootstrap ratio) based on group-consensus connectomes from the Hamburg City Health Study. Results are presented for bootstrap ratio maps derived from partial least squares correlation analysis considering the pooled sample. The upper row bar plot summarizes the analysis results displaying the Spearman correlation with regard to each investigated index. Asterisks indicate statistical significance with respect to spin, brainSMASH, and network rewiring null models. Scatter plots that illustrate the significant spatial relationships are presented below. The middle row displays the relationship of the bootstrap ratio map and the ranked functional and structural degree centrality. The lower row illustrates the association of the bootstrap ratio map and the functional and structural neighborhood abnormality. Abbreviations: <inline-formula><mml:math id="inf69"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> - p-value derived from network rewiring (<xref ref-type="bibr" rid="bib50">Maslov et al., 2004</xref>); <inline-formula><mml:math id="inf70"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> - p-value derived from brainSMASH surrogates (<xref ref-type="bibr" rid="bib11">Burt et al., 2020</xref>); <inline-formula><mml:math id="inf71"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> - p-value derived from spin permutation results (<xref ref-type="bibr" rid="bib3">Alexander-Bloch et al., 2018</xref>); <inline-formula><mml:math id="inf72"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> - Spearman correlation coefficient.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-fig5-figsupp2-v1.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We investigated the impact of MetS on brain morphology and cognitive function in a large sample of individuals from two population-based neuroimaging studies. We report three main findings: (1) multivariate, data-driven statistics revealed a latent variable relating MetS and brain health: participants were distributed along a clinical-anatomical dimension of interindividual variability, linking more severe MetS to widespread brain morphological abnormalities. Negative MetS-related brain morphological abnormalities were strongest in orbitofrontal, lateral prefrontal, insular, cingulate, and temporal cortices as well as subcortical areas. Positive MetS-related brain morphological abnormalities were strongest in superior frontal, parietal, and occipital regions. (2) The severity of MetS was associated with executive function and processing speed, memory, and reasoning test performances, and was found to be statistically mediated by MetS-related brain morphological abnormalities. (3) The pattern of MetS-related brain morphological abnormalities appeared to be linked to regional cell composition as well as functional and structural connectivity. These findings were robust across sensitivity analyses. In sum, our study provides an in-depth examination of the intricate relationship between MetS, brain morphology, and cognition. A graphical abstract summarizing the results is included as <xref ref-type="fig" rid="fig6">Figure 6</xref>.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Graphical abstract.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-fig6-v1.tif"/></fig><sec id="s3-1"><title>PLS reveals a latent clinical-anatomical dimension relating MetS and brain health</title><p>MetS adversely impacts brain health through complex, interacting effects on the cerebral vasculature and parenchyma as shown by histopathological and imaging studies (<xref ref-type="bibr" rid="bib9">Borshchev et al., 2019</xref>). The pathophysiology of MetS involves atherosclerosis, which affects blood supply and triggers inflammation (<xref ref-type="bibr" rid="bib41">Libby et al., 2002</xref>; <xref ref-type="bibr" rid="bib7">Birdsill et al., 2013</xref>); endothelial dysfunction reducing cerebral vasoreactivity <xref ref-type="bibr" rid="bib42">Lind, 2008</xref>; breakdown of the blood-brain barrier inciting an inflammatory response <xref ref-type="bibr" rid="bib28">Hussain et al., 2021</xref>; oxidative stress causing neuronal and mitochondrial dysfunction <xref ref-type="bibr" rid="bib56">Mullins et al., 2020</xref>; and small vessel injury leading to various pathologies including white matter damage, microinfarcts, and cerebral microbleeds (<xref ref-type="bibr" rid="bib20">Frey et al., 2019</xref>).</p><p>To address these interacting effects, we harnessed multivariate, data-driven statistics in the form of a PLS in two large-scale population-based studies to probe for covariance profiles relating the full range of MetS components (such as obesity or arterial hypertension) to regional brain morphological information in a single analysis. PLS identified eight significant latent variables with the first variable explaining the majority (71.20%) of shared variance within the imaging and clinical data (<xref ref-type="fig" rid="fig2">Figure 2a</xref>). This finding indicates a relatively uniform connection between MetS and brain morphology, implying that the associative effects of various MetS components on brain structure are comparatively similar, despite the distinct pathomechanisms each component entails.</p><p>PLS revealed that all MetS components were contributing to this latent signature. However, waist circumference, hip circumference, waist-hip ratio, and body mass index consistently contributed higher than the remaining variables across conducted analyses which highlights obesity as the strongest driver of MetS-related brain morphological abnormalities.</p><p>We interpret these findings as evidence that MetS-associated conditions jointly contribute to the harmful effects on brain structure rather than affecting it in a strictly individual manner. This notion is supported by previous work in the UKB demonstrating overlapping effects of individual risk factors on brain morphology (<xref ref-type="bibr" rid="bib13">Cox et al., 2019</xref>). Specifically, the first latent variable related to increased severity of obesity, dyslipidemia, arterial hypertension, and insulin resistance with lower thickness in orbitofrontal, lateral prefrontal, insular, cingulate, and temporal cortices as well as lower volume across subcortical regions (<xref ref-type="fig" rid="fig2">Figure 2c and d</xref>). This profile was consistent in separate PLS analyses of UKB and HCHS participants as well as group comparisons (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>). Previous research aligns with our detection of a MetS-associated frontotemporal morphometric abnormality pattern (<xref ref-type="bibr" rid="bib6">Beyer et al., 2019</xref>; <xref ref-type="bibr" rid="bib52">McIntosh et al., 2017</xref>; <xref ref-type="bibr" rid="bib31">Kotkowski et al., 2019</xref>). As a speculative causative pathway, human and animal studies have related the orbitofrontal, insular, and anterior cingulate cortex to food-related reward processing, taste, and impulse regulation (<xref ref-type="bibr" rid="bib83">Tuulari et al., 2015</xref>; <xref ref-type="bibr" rid="bib64">Rolls, 2016</xref>). Conceivably, structural alterations of these brain regions are linked to brain functions and behaviors that exacerbate the risk profile leading to MetS (<xref ref-type="bibr" rid="bib65">Rolls, 2023</xref>; <xref ref-type="bibr" rid="bib62">Price et al., 2019</xref>). We also noted a positive MetS-cortical thickness association in superior frontal, parietal, and occipital lobes, a less intuitive finding that has been previously reported (<xref ref-type="bibr" rid="bib32">Krishnadas et al., 2013</xref>; <xref ref-type="bibr" rid="bib40">Leritz et al., 2011</xref>). Although speculative, the positive effects might be due to MetS compensating cholesterol disruptions associated with neurodegenerative processes (<xref ref-type="bibr" rid="bib63">Qin et al., 2021</xref>).</p><p>The second latent variable accounted for 22.33% of the shared variance and linked higher markers of insulin resistance and lower dyslipidemia to lower thickness and volume in lateral frontal, posterior temporal, parietal, and occipital regions. The distinct covariance profile of this latent variable, compared to the first, likely indicates a separate pathomechanistic connection between MetS components and brain morphology. Given that HbA1c and blood glucose were the most significant contributors to this variable, insulin resistance might drive the observed clinical-anatomical relationship.</p></sec><sec id="s3-2"><title>Brain morphological abnormalities mediate the relationship between MetS and cognitive deficits</title><p>Cognitive performance has been consistently linked to cardiometabolic risk factors in health and disease (<xref ref-type="bibr" rid="bib25">Genon et al., 2022</xref>). Yet, the pathomechanistic correlates of this relationship remain to be understood. Our mediation analysis revealed that increased MetS severity correlates with worse performance in executive function and processing speed (Symbol Digit Substitution Test, Trail Making Test B), memory (Numeric Memory Test, Paired Associate Learning Test), and reasoning (Fluid intelligence, Matrix Pattern Completion Test), with brain morphological abnormalities statistically mediating these relationships. Additionally, group comparisons indicated poorer cognitive performance in MetS subjects (<xref ref-type="table" rid="app2table1 app2table2">Appendix 2—tables 1 and 2</xref>) and including cognitive outcomes in the PLS as clinical variables revealed a significant contribution to the first latent variable (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplements 2</xref> and <xref ref-type="fig" rid="fig2s3">3</xref>). These results suggest that MetS is significantly associated with cognitive deficits across various domains, and brain morphological abnormalities are a crucial pathomechanistic link in this relationship. In support of this, previous studies have shown that brain structure mediates the relationship between MetS and cognitive performance in a pediatric sample and elderly patients with vascular cognitive impairment (<xref ref-type="bibr" rid="bib38">Laurent et al., 2020</xref>; <xref ref-type="bibr" rid="bib74">Seo et al., 2010</xref>; <xref ref-type="bibr" rid="bib30">Kim et al., 2014</xref>). The detected latent variable might represent a continuous disease spectrum spanning from minor cognitive deficits due to a cardiometabolic risk profile to severe cognitive deficits due to dementia. In support of this hypothesis, the determined brain morphological abnormality pattern is consistent with the atrophy pattern found in vascular mild cognitive impairment, vascular dementia, and Alzheimer’s dementia (<xref ref-type="bibr" rid="bib74">Seo et al., 2010</xref>; <xref ref-type="bibr" rid="bib30">Kim et al., 2014</xref>; <xref ref-type="bibr" rid="bib55">Morys et al., 2023</xref>).</p><p>Collectively, these findings highlight the role of MetS in cognitive impairment and underscore the potential impact of therapies targeting cardiometabolic risk factors. Although the definitive role of such therapies in preventing cognitive decline is not yet fully established, emerging evidence suggests that these interventions can mitigate the adverse cognitive effects of MetS (<xref ref-type="bibr" rid="bib85">Veronese et al., 2017</xref>; <xref ref-type="bibr" rid="bib39">Lennon et al., 2023</xref>; <xref ref-type="bibr" rid="bib23">Gelber et al., 2013</xref>). As our results highlight obesity as a key factor in the observed clinical-anatomical relationship, we think that future studies should further investigate weight-reducing interventions to examine their effects on cognitive outcomes. Advanced neuroimaging techniques promise to refine these therapeutic approaches by enabling to identify MetS patients at risk of cognitive decline that would benefit the most from targeted interventions for cognitive health protection.</p></sec><sec id="s3-3"><title>MetS-related brain morphological abnormalities link to cellular tissue composition and network topology</title><p>To better understand the emergence of the spatial pattern of MetS-related brain morphological abnormalities, we conducted two contextualization analyses leveraging reference datasets of local gene expression data as well as properties of brain network topology.</p><p>Using a virtual histology approach based on regional gene expression data, we investigated MetS effects in relation to cell population densities (<xref ref-type="fig" rid="fig4">Figure 4</xref>). As the main finding, we report that higher MetS-related brain morphological abnormalities coincide with a higher regional density of endothelial cells. This aligns with the known role of endothelial dysfunction in MetS compromising tissues via chronic vascular inflammation, increased thrombosis risk, and hypoperfusion due to altered vasoreactivity and vascular remodeling (<xref ref-type="bibr" rid="bib42">Lind, 2008</xref>). As endothelial density also indicates the degree of general tissue vascularization, well-vascularized regions are also likely more exposed to cardiometabolic risk factor effects in general (<xref ref-type="bibr" rid="bib41">Libby et al., 2002</xref>). Our results furthermore indicate that microglial density determines a brain region’s susceptibility to MetS effects. Microglia are resident macrophages of the central nervous system that sustain neuronal integrity by maintaining a healthy microenvironment. Animal studies have linked microglial activation mediated by blood-brain barrier leakage and systemic inflammation to cardiometabolic risk (<xref ref-type="bibr" rid="bib14">Denes et al., 2012</xref>; <xref ref-type="bibr" rid="bib82">Tucsek et al., 2014</xref>). Activated microglia can harm the brain structure by releasing reactive oxygen species, proinflammatory cytokines, and proteinases (<xref ref-type="bibr" rid="bib15">Dheen et al., 2007</xref>). Lastly, we found an association with the density of excitatory neurons of subtype 8. These neurons reside in cortical layer 6 and their axons mainly entertain long-range cortico-cortical and cortico-thalamic connections (<xref ref-type="bibr" rid="bib34">Lake et al., 2016</xref>; <xref ref-type="bibr" rid="bib79">Thomson, 2010</xref>). Consequently, layer 6 neurons might be particularly susceptible to MetS effects due to their exposition to MetS-related white matter disease (<xref ref-type="bibr" rid="bib59">Petersen et al., 2022a</xref>; <xref ref-type="bibr" rid="bib58">Petersen et al., 2020</xref>). Taken together, the virtual histology analysis indicates that MetS-related brain morphological abnormalities are associated with local cellular fingerprints. Our findings emphasize the involvement of endothelial cells and microglia in brain structural abnormalities due to cardiometabolic risk, marking them as potential targets for therapies aimed at mitigating MetS effects on brain health.</p><p>For the second approach, we contextualized MetS-related brain morphological abnormalities using principal topological properties of functional and structural brain networks. We found that regional MetS effects and those of functionally and structurally connected neighbors were correlated (<xref ref-type="fig" rid="fig5">Figure 5c and d</xref>) – i.e., areas with similar MetS effects tended to be disproportionately interconnected. Put differently, MetS effects coincided within functional and structural brain networks. Therefore, our findings can be interpreted as evidence that a region’s functional and structural network embedding – i.e., its individual profile of functional interactions as well as white matter fiber tract connections – are associated with its susceptibility to morphological MetS effects. Multiple mechanisms might explain how connectivity might be associated with MetS-related morphological alterations. For example, microvascular pathology might impair white matter fiber tracts leading to joint degeneration in interconnected cortical brain areas: that is, the occurrence of shared MetS effects within functionally and structurally connected neighborhoods is explained by their shared (dis-)connectivity profile (<xref ref-type="bibr" rid="bib51">Mayer et al., 2021</xref>). In support of this, previous work using diffusion tensor imaging suggests that MetS-related microstructural white matter alterations preferentially occur in the frontal and temporal lobe, which spatially matches the frontotemporal morphometric differences observed in our work (<xref ref-type="bibr" rid="bib72">Segura et al., 2009</xref>). Furthermore, we speculate on an interplay between local and network-topological susceptibility in MetS: functional and structural connectivity may provide a scaffold for propagating MetS-related perturbation across the network in the sense of a spreading phenomenon – i.e., a region might be influenced by network-driven exposure to regions with higher local susceptibility. Observed degeneration of a region might be aggravated by malfunctional communication to other vulnerable regions including mechanisms of excitotoxicity, diminished excitation and metabolic stress (<xref ref-type="bibr" rid="bib68">Saxena and Caroni, 2011</xref>). These findings underscore the relevance of brain network organization in understanding the pathomechanistic link of MetS and brain morphology.</p><p>While this work’s strengths lie in a large sample size, high-quality MRI and clinical data, robust image processing, and a comprehensive methodology for examining the link of MetS and brain health, it also has limitations. First, the virtual histology analysis relies on post-mortem brain samples, potentially different from in-vivo profiles. In addition, the predominance of UKB subjects may bias the results, and potential reliability issues of the cognitive assessment in the UKB need to be acknowledged (<xref ref-type="bibr" rid="bib24">Gell et al., 2023</xref>). Lastly, the cross-sectional design restricts the ability for demonstrating causative effects. Longitudinal assessment of the surveyed relationships would provide more robust evidence and therefore, future studies should move in this direction.</p></sec><sec id="s3-4"><title>Conclusion</title><p>Our analysis revealed associative effects of MetS, structural brain integrity, and cognition, complementing existing efforts to motivate and inform strategies for cardiometabolic risk reduction. In conjunction, a characteristic and reproducible structural imaging fingerprint associated with MetS was identified. This pattern of MetS-related brain morphological abnormalities was linked to local histological as well as global network topological features. Collectively, our results highlight how an integrative, multi-modal, and multi-scale analysis approach can lead to a more holistic understanding of the neural underpinnings of MetS and its risk components. As research in this field advances, leveraging neuroimaging may improve personalized cardiometabolic risk mitigation approaches.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Study population – the UK Biobank and Hamburg City Health Study</title><p>Here, we investigated cross-sectional clinical and imaging data from two large-scale population-based cohort studies: (1) the UK Biobank (UKB, n=39,668, age 45–80 years; application number 41655) and (2) the Hamburg City Health Study (HCHS, n=2637, age 45–74 years) (<xref ref-type="bibr" rid="bib53">Miller et al., 2016</xref>; <xref ref-type="bibr" rid="bib29">Jagodzinski et al., 2020</xref>). Both studies recruit large study samples with neuroimaging data alongside a detailed demographic and clinical assessment. Respectively, data for the first visit including a neuroimaging assessment were included. Individuals were excluded if they had a history or a current diagnosis of neurological or psychiatric disease. Field IDs of the used UKB variables are presented in <xref ref-type="table" rid="app1table5">Appendix 1—table 5</xref>. UKB individuals were excluded based on the non-cancer illnesses codes (<ext-link ext-link-type="uri" xlink:href="http://biobank.ndph.ox.ac.uk/showcase/coding.cgi?id=6">http://biobank.ndph.ox.ac.uk/showcase/coding.cgi?id=6</ext-link>). Excluded conditions were Alzheimer’s disease; alcohol, opioid, and other dependencies; amyotrophic lateral sclerosis; brain injury; brain abscess; chronic neurological problem; encephalitis; epilepsy; hemorrhage; head injury; meningitis; multiple sclerosis; Parkinson’s disease; skull fracture. Same criteria were applied to HCHS individuals based on the neuroradiological evaluation and self-reported diagnoses variables. To enhance comparability to previous studies we supplemented a case-control analysis enabling to complement continuous multivariate statistical analyses by group statistics. Therefore, a MetS sample was identified based on the consensus definition of the International Diabetes Federation (<xref ref-type="table" rid="app1table6">Appendix 1—table 6</xref>) and matched to a control cohort.</p></sec><sec id="s4-2"><title>Ethics approval</title><p>The UKB was ethically approved by the North West Multi-Centre Research Ethics Committee (MREC). Details on the UKB Ethics and Governance framework are provided online (<ext-link ext-link-type="uri" xlink:href="https://www.ukbiobank.ac.uk/media/0xsbmfmw/egf.pdf">https://www.ukbiobank.ac.uk/media/0xsbmfmw/egf.pdf</ext-link>). The HCHS was approved by the local ethics committee of the Landesärztekammer Hamburg (State of Hamburg Chamber of Medical Practitioners, PV5131). Good Clinical Practice (GCP), Good Epidemiological Practice (GEP), and the Declaration of Helsinki were the ethical guidelines that governed the conduct of the HCHS (<xref ref-type="bibr" rid="bib58">Petersen et al., 2020</xref>). Written informed consent was obtained from all participants investigated in this work.</p></sec><sec id="s4-3"><title>Clinical assessment</title><p>In the UK Biobank, a battery of cognitive tests is administered, most of which represent shortened and computerized versions of established tests aiming for a comprehensive and concise assessment of cognition (<xref ref-type="bibr" rid="bib77">Sudlow et al., 2015</xref>). From this battery, we investigated tests for executive function and processing speed (Reaction Time Test, Symbol Digit Substitution Test, Tower Rearranging Test, Trail Making Tests A and B), memory (Numeric Memory Test, Paired Associate Learning Test, Prospective Memory Test), and reasoning (Fluid Intelligence Test, Matrix Pattern Completion Test). Detailed descriptions of the individual tests can be found elsewhere (<xref ref-type="bibr" rid="bib18">Fawns-Ritchie and Deary, 2020</xref>). Furthermore, some tests (Matrix Pattern Completion Test, Numeric Memory Test, Paired Associate Learning Test, Symbol Digit Substitution Test, Trail Making Test, and Tower Rearranging Test) are only administered to a subsample of the UKB imaging cohort explaining the missing test results for a subgroup of participants.</p><p>In the HCHS, cognitive testing was administered by a trained study nurse and included the Animal Naming Test, Trail Making Test A and B, Multiple Choice Vocabulary Intelligence Test B, and Word List Recall subtests of the Consortium to Establish a Registry for Alzheimer’s Disease Neuropsychological Assessment Battery (CERAD-Plus), as well as the Clock Drawing Test (<xref ref-type="bibr" rid="bib54">Morris et al., 1989</xref>; <xref ref-type="bibr" rid="bib76">Shulman, 2000</xref>).</p></sec><sec id="s4-4"><title>MRI acquisition</title><p>The full UKB neuroimaging protocol can be found online (<ext-link ext-link-type="uri" xlink:href="https://biobank.ctsu.ox.ac.uk/crystal/crystal/docs/brain_mri.pdf">https://biobank.ctsu.ox.ac.uk/crystal/crystal/docs/brain_mri.pdf</ext-link>; <xref ref-type="bibr" rid="bib53">Miller et al., 2016</xref>). MR images were acquired on a 3 T Siemens Skyra MRI scanner (Siemens, Erlangen, Germany). T1-weighted MRI used a 3D MPRAGE sequence with 1 mm isotropic resolution with the following sequence parameters: repetition time = 2000 ms, echo time = 2.01 ms, 256 axial slices, slice thickness = 1 mm, and in-plane resolution = 1 × 1 mm. In the HCHS, MR images were acquired as well on a 3 T Siemens Skyra MRI scanner. Measurements were performed with a protocol as described in previous work (<xref ref-type="bibr" rid="bib58">Petersen et al., 2020</xref>). In detail, for 3D T1-weighted anatomical images, rapid acquisition gradient-echo sequence (MPRAGE) was used with the following sequence parameters: repetition time = 2500 ms, echo time = 2.12 ms, 256 axial slices, slice thickness = 0.94 mm, and in-plane resolution = 0.83 × 0.83 mm.</p></sec><sec id="s4-5"><title>Estimation of brain morphological measures</title><p>To achieve comparability and reproducibility, the preconfigured and containerized CAT12 pipeline (CAT12.7 r1743; <ext-link ext-link-type="uri" xlink:href="https://github.com/m-wierzba/cat-container">https://github.com/m-wierzba/cat-container</ext-link>; <xref ref-type="bibr" rid="bib89">Wierzba and Hoffstaedter, 2022</xref>) was employed for surface reconstruction and cortical thickness measurement building upon a projection-based thickness estimation method as well as computation of subcortical volumes (<xref ref-type="bibr" rid="bib22">Gaser et al., 2022</xref>). Cortical thickness measures were normalized from individual to 32 k fsLR surface space (conte69) to ensure vertex correspondence across subjects. Subcortical volumes were computed for the Melbourne Subcortex Atlas parcellation resolution 1 (<xref ref-type="bibr" rid="bib80">Tian et al., 2020</xref>). Volumetric measures for the anterior and posterior thalamus parcels were averaged to obtain a single measure for the thalamus. Individuals with a CAT12 image quality rating lower than 75% were excluded during the quality assessment. To facilitate large-scale data management while ensuring provenance tracking and reproducibility, we employed the DataLad-based FAIRly big workflow for image data processing (<xref ref-type="bibr" rid="bib87">Wagner et al., 2022</xref>).</p></sec><sec id="s4-6"><title>Statistical analysis</title><p>Statistical computations and plotting were performed in python 3.9.7 leveraging bctpy (v. 0.6.0), brainstat (v. 0.3.6), brainSMASH (v. 0.11.0), and the ENIGMA toolbox (v. 1.1.3). matplotlib (v. 3.5.1), neuromaps (v. 0.0.1), numpy (v. 1.22.3), pandas (v. 1.4.2), pingouin (v. 0.5.1), pyls (v. 0.0.1), scikit-learn (v. 1.0.2), scipy (v. 1.7.3), seaborn (v. 0.11.2) as well as in matlab (v. 2021b) using ABAnnotate (v. 0.1.1).</p><sec id="s4-6-1"><title>Partial least squares correlation analysis</title><p>To relate MetS components and brain morphology, we performed a PLS using pyls (<ext-link ext-link-type="uri" xlink:href="https://github.com/rmarkello/pyls">https://github.com/rmarkello/pyls</ext-link>; <xref ref-type="bibr" rid="bib48">Markello, 2021</xref>). PLS identifies covariance profiles that relate to two sets of variables in a data-driven multivariate analysis (<xref ref-type="bibr" rid="bib33">Krishnan et al., 2011</xref>). Here, we related regional cortical thickness and subcortical volumes to clinical measurements of MetS components, i.e., obesity (waist circumference, hip circumference, waist-hip ratio, body mass index), arterial hypertension (systolic blood pressure, diastolic blood pressure), dyslipidemia (high-density lipoprotein, low-density lipoprotein, total cholesterol, triglycerides) and insulin resistance (HbA1c, non-fasting blood glucose). Before conducting the PLS, missing values were imputed via k-nearest neighbor imputation (n<sub>neighbor</sub> = 4) with imputation only taking into account variables of the same group, i.e., MetS component variables were imputed based on the remaining MetS component data only and not based on demographic variables. To account for age, sex, education, and cohort (UKB/HCHS) as potential confounds, they were regressed out of brain morphological and MetS component data.</p><p>We then performed PLS as described in previous work (<xref ref-type="bibr" rid="bib60">Petersen et al., 2022b</xref>). Methodological details are covered in <xref ref-type="fig" rid="fig1">Figure 1a</xref> and <xref ref-type="box" rid="box1">Box 1</xref>. Brain morphological measures were randomly permuted (n<sub>permute</sub> = 5000) to assess the statistical significance of derived latent variables and their corresponding covariance profiles. Subject-specific PLS scores, including a clinical score and an imaging score, were computed. Higher scores indicate stronger adherence to the respective covariance profiles: a high clinical score signifies pronounced expression of the clinical profile, and a high imaging score reflects marked adherence to the brain morphological profile. Bootstrap resampling (n<sub>bootstrap</sub> = 5000) was performed to assess the contribution of individual variables to the imaging-clinical relationship. Confidence intervals (95%) of singular vector weights were computed for clinical variables to assess the significance of their contribution. To estimate the contributions of brain regions, bootstrap ratios were computed as the singular vector weight divided by the bootstrap-estimated standard error. A high bootstrap ratio is indicative of a region’s contribution, as a relevant region shows a high singular vector weight alongside a small standard error implying stability across bootstraps. The bootstrap ratio equals a z-score in the case of a normally distributed bootstrap. Hence, brain region contributions were considered significant if the bootstrap ratio was &gt;1.96 or &lt;−1.96 (95% confidence interval). Overall model robustness was assessed via a 10-fold cross-validation by correlating out-of-sample PLS scores within each fold.</p><boxed-text id="box1"><label>Box 1.</label><caption><title>Partial least squares correlation analysis explained.</title></caption><p>Regional morphometric information (Schaefer 400- and Melbourne Subcortical Atlas-parcellated) and clinical data (age sex, education, and MetS component data) were arranged in two matrices <inline-formula><mml:math id="inf73"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and <inline-formula><mml:math id="inf74"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>Y</mml:mi><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and then z-scored. Subsequently, a clinical-anatomical correlation matrix was calculated. Singular value decomposition was performed on the correlation matrix which resulted in a set of mutually orthogonal latent variables. The smaller dimension of the correlation matrix – its rank – equals the latent variable count. In our case, this was the number of clinical variables. Singular value decomposition results in a left singular vector matrix (<inline-formula><mml:math id="inf75"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>U</mml:mi><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>), right singular vector matrix (<inline-formula><mml:math id="inf76"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>) and a diagonal matrix of singular values (<inline-formula><mml:math id="inf77"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi mathvariant="normal">Δ</mml:mi><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>). Together, these represent a set of latent variables with a latent variable being composed of a left and right singular vector and a corresponding singular value. Each latent variable represents a specific covariance profile within the input data. A singular vector weights the corresponding original variables to maximize their covariance, i.e., the weighted regional values of a singular vector <inline-formula><mml:math id="inf78"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>U</mml:mi><mml:mrow><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>,</mml:mo><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> can be interpreted as a maximally covarying brain morphology pattern and its corresponding clinical substrate (<inline-formula><mml:math id="inf79"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>,</mml:mo><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>). The explained variance of a latent variable was calculated as the ratio of its corresponding squared singular value to the sum of the remaining squared singular values. Significance of a latent variable was assessed by comparing the observed explained variance to a non-parametric distribution of permuted values acquired by permuting the subject order in <italic>X</italic> (n<sub>permute</sub> = 5000).</p><p>Subject-specific PLS scores measure to which extent an individual expresses a covariance profile represented by a latent variable. Thus, scores can be thought of as factor weightings in factor analysis. A high score describes the high agreement of a participant with the identified pattern. They were calculated by projecting <italic>U</italic> on <italic>X</italic> for an imaging score<disp-formula id="equ1"><mml:math id="m1"><mml:mrow><mml:mi>I</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mo>=</mml:mo><mml:mi>U</mml:mi><mml:mi>X</mml:mi></mml:mrow></mml:math></disp-formula></p><p>and <italic>V</italic> on <italic>Y</italic> for a clinical score<disp-formula id="equ2"><mml:math id="m2"><mml:mrow><mml:mi>C</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mo>=</mml:mo><mml:mi>V</mml:mi><mml:mi>Y</mml:mi></mml:mrow></mml:math></disp-formula></p><p>Bootstrap resampling was performed to identify brain regions and clinical variables with a high and robust contribution to the clinical-anatomical association. Individuals were randomly sampled from <italic>X</italic> and <italic>Y</italic> with replacement (n=5000) which resulted in a set of resampled correlation matrices propagated to singular value decomposition resulting in a sampling distribution of singular vector weights for each input variable. This enabled the computation of 95% confidence intervals for the clinical variables and a bootstrap ratio for the brain regions.<disp-formula id="equ3"><mml:math id="m3"><mml:mrow><mml:mi>B</mml:mi><mml:mi>o</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>p</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>S</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mi>u</mml:mi><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mi>t</mml:mi><mml:mspace width="thinmathspace"/><mml:msub><mml:mi>U</mml:mi><mml:mrow><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">i</mml:mi><mml:mo>,</mml:mo><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>d</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>b</mml:mi><mml:mi>o</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>p</mml:mi><mml:mi>p</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula></p><p>The bootstrap ratio measures a brain region’s contribution to the observed covariance profile of a respective latent variable, as a relevant region shows a high singular vector weight alongside a small standard error implying stability across bootstraps.</p></boxed-text></sec><sec id="s4-6-2"><title>Mediation analysis</title><p>In a post-hoc mediation analysis, we investigated how the subject-specific clinical PLS score of the first latent variable, reflecting the degree of an individual’s expression of the identified MetS risk profile, relates to cognitive test outcomes, and whether this relationship is influenced by the imaging PLS score of the first latent variable, which represents the degree of brain morphological differences (<xref ref-type="fig" rid="fig1">Figure 1b</xref>). This analysis allows to separate the total effect of the clinical PLS score on cognitive performance into: (1) a direct effect (the immediate link of clinical scores and cognition), and (2) an indirect effect (the portion influenced by the imaging PLS score). This approach helps to disentangle the complex interplay between MetS and cognitive function by examining the role of brain structural effects as a potential intermediary. We considered an indirect effect as mediating if there was a significant association between the clinical and imaging PLS scores, the imaging PLS score was significantly associated with the cognitive outcome, and if the link between clinical scores and cognitive outcomes weakened (partial mediation) or became insignificant (full mediation) after accounting for imaging scores. The significance of mediation was assessed using bootstrapping (n<sub>bootstrap</sub> = 5000), with models adjusted for age, sex, and education. To obtain standardized estimates, mediation analysis inputs were z-scored beforehand. Given the variation in cognitive test batteries between the UKB and HCHS cohorts, only individuals with results from the respective tests were considered in each mediation analysis. To account for the different versions of the Trail Making Tests A and B used in both cohorts, test results were harmonized through z-scoring within the individual subsamples before a pooled z-scoring step.</p></sec><sec id="s4-6-3"><title>Contextualization analysis</title><p>We investigated the link of MetS and regional brain morphological measurements in the context of cell-specific gene expression profiles and structural and functional brain network characteristics (<xref ref-type="fig" rid="fig1">Figure 1c</xref>). Therefore, we used the Schaefer-parcellated (400×7 and 100×7, v.1) bootstrap ratio map and related it to indices representing different gene expression and network topological properties of the human cortex via spatial correlations (Spearman correlation, <inline-formula><mml:math id="inf80"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) on a group-level (<xref ref-type="bibr" rid="bib70">Schaefer et al., 2018</xref>).</p><p>Virtual histology analysis. We performed a virtual histology analysis leveraging gene transcription information to quantify the density of different cell populations across the cortex employing the ABAnnotate toolbox (<xref ref-type="bibr" rid="bib43">Lotter, 2022</xref>; <xref ref-type="bibr" rid="bib16">Dukart et al., 2021</xref>). Genes corresponding with specific cell populations of the central nervous system were identified based on a classification derived from single nucleus-RNA sequencing data (<xref ref-type="bibr" rid="bib34">Lake et al., 2016</xref>). The gene-cell type mapping is provided by the PsychENCODE database (<ext-link ext-link-type="uri" xlink:href="http://resource.psychencode.org/Datasets/Derived/SC_Decomp/DER-19_Single_cell_markergenes_TPM.xlsx">http://resource.psychencode.org/Datasets/Derived/SC_Decomp/DER-19_Single_cell_markergenes_TPM.xlsx</ext-link>; <xref ref-type="bibr" rid="bib88">Wang et al., 2018</xref>). The abagen toolbox (v. 0.1.3) was used to obtain regional microarray expression data of these genes for Schaefer 100×7 parcels based on the Allen Human Brain Atlas (AHBA) (<xref ref-type="bibr" rid="bib49">Markello et al., 2021</xref>). The Schaefer 100×7 atlas was used as it better matches the sampling density of the AHBA eventually resulting in no parcels with missing values. Regional expression patterns of genes corresponding to astrocytes, endothelial cells, excitatory neuron populations (Ex1-8), inhibitory neuron populations (In1-8), microglia, and oligodendrocytes were extracted. Instead of assessing the correspondence between MetS effects and the expression pattern of each gene directly, we employed ensemble-based gene category enrichment analysis (GCEA) (<xref ref-type="bibr" rid="bib21">Fulcher et al., 2021</xref>). This approach represents a modification to customary GCEA addressing the issues of gene-gene dependency through within-category co-expression which is caused by shared spatial embedding as well as spatial autocorrelation of cortical transcriptomics data. In brief, gene transcription indices were averaged within categories (here cell populations) and spatially correlated with the bootstrap ratio map. Statistical significance was assessed by comparing the empirical correlation coefficients against a null distribution derived from surrogate maps with preserved spatial embedding and autocorrelation computed via a spatial lag model (<xref ref-type="bibr" rid="bib10">Burt et al., 2018</xref>). Further details on the processing steps covered by ABAnnotate can be found elsewhere (<ext-link ext-link-type="uri" xlink:href="https://osf.io/gcxun">https://osf.io/gcxun</ext-link>; <xref ref-type="bibr" rid="bib44">Lotter et al., 2023</xref>).</p><p>Brain network topology. To investigate the cortical MetS effects pattern in the context of brain network topology, three connectivity metrics were leveraged based on data from structural and functional brain imaging: weighted degree centrality, neighborhood abnormality as well as macroscale functional connectivity gradients as described previously (<xref ref-type="bibr" rid="bib60">Petersen et al., 2022b</xref>). These were computed based on functional and structural consensus connectomes at group-level derived from the Human Connectome Project Young Adults dataset comprised in the ENIGMA toolbox (<xref ref-type="bibr" rid="bib36">Larivière et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Larivière et al., 2020</xref>). The preprocessing of these connectomes is described elsewhere (<xref ref-type="bibr" rid="bib35">Larivière et al., 2020</xref>).</p><p>Weighted degree centrality. Weighted degree centrality is a measure of a brain region’s topological relevance and is commonly used for the identification of brain network hubs (<xref ref-type="bibr" rid="bib84">van den Heuvel and Sporns, 2013</xref>). The degree centrality of a node <inline-formula><mml:math id="inf81"><mml:mi>i</mml:mi></mml:math></inline-formula> was computed as the sum of its functional or structural connection weights (<xref ref-type="bibr" rid="bib66">Rubinov and Sporns, 2010</xref>). The resulting values were ranked before further analysis.</p><p>Neighborhood abnormality. Neighborhood abnormality represents a summary measure of a cortical property in the node neighborhood defined by functional or structural brain network connectivity (<xref ref-type="bibr" rid="bib75">Shafiei et al., 2020</xref>). In this work, the MetS-related morphological abnormalities (bootstrap ratio or t-statistic) in nodes <inline-formula><mml:math id="inf82"><mml:mi>j</mml:mi></mml:math></inline-formula> connected to node <inline-formula><mml:math id="inf83"><mml:mi>i</mml:mi></mml:math></inline-formula> were averaged and weighted by their respective functional or structural seed connectivity (<inline-formula><mml:math id="inf84"><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>):<disp-formula id="equ4"><mml:math id="m4"><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mrow><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>∈</mml:mo><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:munder><mml:mrow><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf85"><mml:mi>j</mml:mi></mml:math></inline-formula> is one of the connected nodes <inline-formula><mml:math id="inf86"><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> , <inline-formula><mml:math id="inf87"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the measure of MetS-related effects on cortical thickness and the corresponding connection weight <inline-formula><mml:math id="inf88"><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> . The term <inline-formula><mml:math id="inf89"><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:mfrac></mml:math></inline-formula> corrects for the nodal degree by normalizing the number of connections. For example, a high positive or negative <inline-formula><mml:math id="inf90"><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> represents strong connectivity to nodes of pronounced MetS effects (<xref ref-type="bibr" rid="bib60">Petersen et al., 2022b</xref>).</p><p>Functional connectivity gradients. To contextualize the MetS-related morphological abnormalities with the functional network hierarchy, we derived macroscale functional connectivity gradients as a proxy of the canonical sensorimotor-association axis, which determines the distribution of manifold cortical properties (<xref ref-type="bibr" rid="bib47">Margulies et al., 2016</xref>; <xref ref-type="bibr" rid="bib78">Sydnor et al., 2021</xref>). Functional connectivity gradients were derived by applying diffusion map embedding on the HCP functional connectivity matrix using BrainSpace (<xref ref-type="bibr" rid="bib86">Vos de Wael et al., 2020</xref>). A functional connectivity gradient can be interpreted as a spatial axis of connectivity variation spanning the cortical surface, as nodes of similar connectivity profiles are closely located on these axes.</p><p>For this analysis, the statistical significance of spatial correlations was assessed via spin permutations (n=1000) which represent a null model preserving the inherent spatial autocorrelation of cortical information (<xref ref-type="bibr" rid="bib3">Alexander-Bloch et al., 2018</xref>). Spin permutations are performed by projecting parcel-wise data onto a sphere which then is randomly rotated. After rotation, information is projected back on the surface, and a permuted <inline-formula><mml:math id="inf91"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is computed. A p-value is computed comparing the empirical correlation coefficient to the permuted distribution. To assure that our results do not depend on null model choice, we additionally tested our results against a variogram-based null model implemented in the brainSMASH toolbox (<ext-link ext-link-type="uri" xlink:href="https://github.com/murraylab/brainsmash">https://github.com/murraylab/brainsmash</ext-link>; <xref ref-type="bibr" rid="bib12">Burt and Murray, 2020</xref>) as well as a network rewiring null model with preserved density and degree sequence (<xref ref-type="bibr" rid="bib11">Burt et al., 2020</xref>; <xref ref-type="bibr" rid="bib50">Maslov et al., 2004</xref>).</p><p>All p-values resulting from both contextualization analyses were FDR-corrected for multiple comparisons. As we conducted this study mindful of the reuse of our resources, the MetS effect maps are provided as separate supplementary files to enable further analyses (<xref ref-type="supplementary-material" rid="supp1 supp2 supp3">Supplementary files 1-3</xref>).</p></sec><sec id="s4-6-4"><title>Sensitivity analyses</title><p>For a sensitivity analysis, we reperformed the PLS separately within the UKB and HCHS cohorts. In contrast to the PLS main analysis, in these subset-specific PLS analyses cognitive test performances were also incorporated as clinical variables as cognitive batteries were subset-specific. This approach was employed to evaluate the stability of the results and to determine if cognitive tests contribute to the latent variables.</p><p>To test whether the PLS indeed captures the link of MetS and brain morphology, we conducted a group comparison as in previous studies of MetS. Besides descriptive group statistics, the cortical thickness of individuals with MetS and matched controls was compared on a surface vertex-level leveraging the BrainStat toolbox (v 0.3.6, <ext-link ext-link-type="uri" xlink:href="https://brainstat.readthedocs.io/">https://brainstat.readthedocs.io/</ext-link>) (<xref ref-type="bibr" rid="bib37">Larivière et al., 2023</xref>). A general linear model was applied correcting for age, sex, education, and cohort effects. Vertex-wise p-values were FDR-corrected for multiple comparisons. To demonstrate the correspondence between the t-statistic and cortical bootstrap ratio maps, we related them via spatial correlation analyses. The t-statistic map was also used for sensitivity analysis of the virtual histology analysis and brain network contextualization.</p><p>To ensure that the brain network contextualization results were not biased by the connectome choice, we reperformed the analysis with structural and functional group consensus connectomes based on resting-state functional and diffusion-weighted MRI data from the HCHS. The corresponding connectome reconstruction approaches were described elsewhere (<xref ref-type="bibr" rid="bib60">Petersen et al., 2022b</xref>).</p></sec></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>TZ is listed as co-inventor of an international patent on the use of a computing device to estimate the probability of myocardial infarction (PCT/EP2021/073193, International Publication Number WO2022043229A1). TZ is shareholder of the company ART-EMIS GmbH Hamburg</p></fn><fn fn-type="COI-statement" id="conf3"><p>JG has received speaker fees from Lundbeck, Janssen-Cilag, Lilly, Otsuka and Boehringer outside the submitted work</p></fn><fn fn-type="COI-statement" id="conf4"><p>JF reported receiving personal fees from Acandis, Cerenovus, Microvention, Medtronic, Phenox, and Penumbra; receiving grants from Stryker and Route 92; being managing director of eppdata; and owning shares in Tegus and Vastrax; all outside the submitted work</p></fn><fn fn-type="COI-statement" id="conf5"><p>RT is listed as co-inventor of an international patent on the use of a computing device to estimate the probability of myocardial infarction (PCT/EP2021/073193, International Publication Number WO2022043229A1). RT is shareholder of the company ART-EMIS GmbH Hamburg</p></fn><fn fn-type="COI-statement" id="conf6"><p>GT has received fees as consultant or lecturer from Acandis, Alexion, Amarin, Bayer, Boehringer Ingelheim, BristolMyersSquibb/Pfizer, Daichi Sankyo, Portola, and Stryker outside the submitted work</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Resources, Data curation, Software, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con13"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con14"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con15"><p>Resources, Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con16"><p>Supervision, Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con17"><p>Conceptualization, Resources, Supervision, Funding acquisition, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>The UKB was ethically approved by the North West Multi-Centre Research Ethics Committee (MREC). Details on the UKB Ethics and Governance framework are provided online (<ext-link ext-link-type="uri" xlink:href="https://www.ukbiobank.ac.uk/media/0xsbmfmw/egf.pdf">https://www.ukbiobank.ac.uk/media/0xsbmfmw/egf.pdf</ext-link>). The HCHS was approved by the local ethics committee of the Landesärztekammer Hamburg (State of Hamburg Chamber of Medical Practitioners, PV5131). Good Clinical Practice (GCP), Good Epidemiological Practice (GEP) and the Declaration of Helsinki were the ethical guidelines that governed the conduct of the HCHS (Petersen et al., 2020). Written informed consent was obtained from all participants investigated in this work.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Schaefer 400×7-parcellated maps of metabolic syndrome (MetS)-related brain morphological abnormalities (bootstrap ratio from PLS, t-statistic from group comparison).</title></caption><media xlink:href="elife-93246-supp1-v1.csv" mimetype="application" mime-subtype="octet-stream"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Schaefer 100×7-parcellated bootstrap ratio map.</title></caption><media xlink:href="elife-93246-supp2-v1.csv" mimetype="application" mime-subtype="octet-stream"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>t-statistic from group comparison on fsLR.</title></caption><media xlink:href="elife-93246-supp3-v1.csv" mimetype="application" mime-subtype="octet-stream"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-93246-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>UK Biobank data can be obtained via its standardized data access procedure (<ext-link ext-link-type="uri" xlink:href="https://www.ukbiobank.ac.uk/">https://www.ukbiobank.ac.uk/</ext-link>). HCHS participant data used in this analysis is not publicly available for privacy reasons, but access can be established via request to the HCHS steering committee. The analysis code is publicly available on GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/csi-hamburg/2023_petersen_mets_brain_morphology">https://github.com/csi-hamburg/2023_petersen_mets_brain_morphology</ext-link> (copy archived at <xref ref-type="bibr" rid="bib61">Petersen, 2023</xref>) and <ext-link ext-link-type="uri" xlink:href="https://github.com/csi-hamburg/CSIframe/wiki/Structural-processing-with-CAT">https://github.com/csi-hamburg/CSIframe/wiki/Structural-processing-with-CAT</ext-link>).</p></sec><ack id="ack"><title>Acknowledgements</title><p>German Research Foundation, Schwerpunktprogramm (SPP) 2041, (grant number 454012190) to SBE, GT; German Research Foundation, Sonderforschungsbereich (SFB) 936 (grant number 178316478) project C2 - MP, CM, JF, GT and BC and C7 - SK, JG; German Research Foundation, SFB 1451 &amp; IRTG 2150 to SBE; National Institute of Health, R01 (grant number MH074457) to SBE; European Union’s Horizon 2020 Research and Innovation Program (grant number 945539, 826421) to SBE; German Center for Cardiovascular Research (FKZ 81Z1710101 and FKZ 81Z0710102); the Hamburg City Health Study is also supported by Amgen, Astra Zeneca, Bayer, BASF, Deutsche Gesetzliche Unfallversicherung (DGUV), Deutsches Institut für Ernährungsforschung, the Innovative medicine initiative (IMI) under grant number No. 116074, the Fondation Leducq under grant number 16 CVD 03., the euCanSHare grant agreement under grant number 825903-euCanSHare H2020, Novartis, Pfizer, Schiller, Siemens, Unilever, and 'Förderverein zur Förderung der HCHS e.V.'</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar</surname><given-names>M</given-names></name><name><surname>Bhuket</surname><given-names>T</given-names></name><name><surname>Torres</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Wong</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Prevalence of the metabolic syndrome in the United States, 2003-2012</article-title><source>JAMA</source><volume>313</volume><fpage>1973</fpage><lpage>1974</lpage><pub-id pub-id-type="doi">10.1001/jama.2015.4260</pub-id><pub-id pub-id-type="pmid">25988468</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberti</surname><given-names>K</given-names></name><name><surname>Zimmet</surname><given-names>P</given-names></name><name><surname>Shaw</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Metabolic syndrome--a new world-wide definition. A consensus statement from the international diabetes federation</article-title><source>Diabetic Medicine</source><volume>23</volume><fpage>469</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1111/j.1464-5491.2006.01858.x</pub-id><pub-id pub-id-type="pmid">16681555</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander-Bloch</surname><given-names>AF</given-names></name><name><surname>Shou</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Satterthwaite</surname><given-names>TD</given-names></name><name><surname>Glahn</surname><given-names>DC</given-names></name><name><surname>Shinohara</surname><given-names>RT</given-names></name><name><surname>Vandekar</surname><given-names>SN</given-names></name><name><surname>Raznahan</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>On testing for spatial correspondence between maps of human brain structure and function</article-title><source>NeuroImage</source><volume>178</volume><fpage>540</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2018.05.070</pub-id><pub-id pub-id-type="pmid">29860082</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atti</surname><given-names>AR</given-names></name><name><surname>Valente</surname><given-names>S</given-names></name><name><surname>Iodice</surname><given-names>A</given-names></name><name><surname>Caramella</surname><given-names>I</given-names></name><name><surname>Ferrari</surname><given-names>B</given-names></name><name><surname>Albert</surname><given-names>U</given-names></name><name><surname>Mandelli</surname><given-names>L</given-names></name><name><surname>De Ronchi</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Metabolic syndrome, mild cognitive impairment, and dementia: A meta-analysis of longitudinal studies</article-title><source>The American Journal of Geriatric Psychiatry</source><volume>27</volume><fpage>625</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1016/j.jagp.2019.01.214</pub-id><pub-id pub-id-type="pmid">30917904</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beltrán-Sánchez</surname><given-names>H</given-names></name><name><surname>Harhay</surname><given-names>MO</given-names></name><name><surname>Harhay</surname><given-names>MM</given-names></name><name><surname>McElligott</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010</article-title><source>Journal of the American College of Cardiology</source><volume>62</volume><fpage>697</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2013.05.064</pub-id><pub-id pub-id-type="pmid">23810877</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beyer</surname><given-names>F</given-names></name><name><surname>Kharabian Masouleh</surname><given-names>S</given-names></name><name><surname>Kratzsch</surname><given-names>J</given-names></name><name><surname>Schroeter</surname><given-names>ML</given-names></name><name><surname>Röhr</surname><given-names>S</given-names></name><name><surname>Riedel-Heller</surname><given-names>SG</given-names></name><name><surname>Villringer</surname><given-names>A</given-names></name><name><surname>Witte</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A metabolic obesity profile is associated with decreased gray matter volume in cognitively healthy older adults</article-title><source>Frontiers in Aging Neuroscience</source><volume>11</volume><elocation-id>202</elocation-id><pub-id pub-id-type="doi">10.3389/fnagi.2019.00202</pub-id><pub-id pub-id-type="pmid">31427957</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birdsill</surname><given-names>AC</given-names></name><name><surname>Carlsson</surname><given-names>CM</given-names></name><name><surname>Willette</surname><given-names>AA</given-names></name><name><surname>Okonkwo</surname><given-names>OC</given-names></name><name><surname>Johnson</surname><given-names>SC</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Oh</surname><given-names>JM</given-names></name><name><surname>Gallagher</surname><given-names>CL</given-names></name><name><surname>Koscik</surname><given-names>RL</given-names></name><name><surname>Jonaitis</surname><given-names>EM</given-names></name><name><surname>Hermann</surname><given-names>BP</given-names></name><name><surname>LaRue</surname><given-names>A</given-names></name><name><surname>Rowley</surname><given-names>HA</given-names></name><name><surname>Asthana</surname><given-names>S</given-names></name><name><surname>Sager</surname><given-names>MA</given-names></name><name><surname>Bendlin</surname><given-names>BB</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Low cerebral blood flow is associated with lower memory function in metabolic syndrome</article-title><source>Obesity</source><volume>21</volume><fpage>1313</fpage><lpage>1320</lpage><pub-id pub-id-type="doi">10.1002/oby.20170</pub-id><pub-id pub-id-type="pmid">23687103</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boden-Albala</surname><given-names>B</given-names></name><name><surname>Sacco</surname><given-names>RL</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Grahame-Clarke</surname><given-names>C</given-names></name><name><surname>Rundek</surname><given-names>T</given-names></name><name><surname>Elkind</surname><given-names>MV</given-names></name><name><surname>Wright</surname><given-names>C</given-names></name><name><surname>Giardina</surname><given-names>EGV</given-names></name><name><surname>DiTullio</surname><given-names>MR</given-names></name><name><surname>Homma</surname><given-names>S</given-names></name><name><surname>Paik</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Metabolic syndrome and ischemic stroke risk</article-title><source>Stroke</source><volume>39</volume><fpage>30</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.107.496588</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borshchev</surname><given-names>Yy</given-names></name><name><surname>Uspensky</surname><given-names>YP</given-names></name><name><surname>Galagudza</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Pathogenetic pathways of cognitive dysfunction and dementia in metabolic syndrome</article-title><source>Life Sciences</source><volume>237</volume><elocation-id>116932</elocation-id><pub-id pub-id-type="doi">10.1016/j.lfs.2019.116932</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burt</surname><given-names>JB</given-names></name><name><surname>Demirtaş</surname><given-names>M</given-names></name><name><surname>Eckner</surname><given-names>WJ</given-names></name><name><surname>Navejar</surname><given-names>NM</given-names></name><name><surname>Ji</surname><given-names>JL</given-names></name><name><surname>Martin</surname><given-names>WJ</given-names></name><name><surname>Bernacchia</surname><given-names>A</given-names></name><name><surname>Anticevic</surname><given-names>A</given-names></name><name><surname>Murray</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Hierarchy of transcriptomic specialization across human cortex captured by structural neuroimaging topography</article-title><source>Nature Neuroscience</source><volume>21</volume><fpage>1251</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0195-0</pub-id><pub-id pub-id-type="pmid">30082915</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burt</surname><given-names>JB</given-names></name><name><surname>Helmer</surname><given-names>M</given-names></name><name><surname>Shinn</surname><given-names>M</given-names></name><name><surname>Anticevic</surname><given-names>A</given-names></name><name><surname>Murray</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Generative modeling of brain maps with spatial autocorrelation</article-title><source>NeuroImage</source><volume>220</volume><elocation-id>117038</elocation-id><pub-id pub-id-type="doi">10.1016/j.neuroimage.2020.117038</pub-id><pub-id pub-id-type="pmid">32585343</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Burt</surname><given-names>JB</given-names></name><name><surname>Murray</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>brainSMASH</data-title><version designator="0.11">0.11</version><source>Github</source><ext-link ext-link-type="uri" xlink:href="https://github.com/murraylab/brainsmash">https://github.com/murraylab/brainsmash</ext-link></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>SR</given-names></name><name><surname>Lyall</surname><given-names>DM</given-names></name><name><surname>Ritchie</surname><given-names>SJ</given-names></name><name><surname>Bastin</surname><given-names>ME</given-names></name><name><surname>Harris</surname><given-names>MA</given-names></name><name><surname>Buchanan</surname><given-names>CR</given-names></name><name><surname>Fawns-Ritchie</surname><given-names>C</given-names></name><name><surname>Barbu</surname><given-names>MC</given-names></name><name><surname>de Nooij</surname><given-names>L</given-names></name><name><surname>Reus</surname><given-names>LM</given-names></name><name><surname>Alloza</surname><given-names>C</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Neilson</surname><given-names>E</given-names></name><name><surname>Alderson</surname><given-names>HL</given-names></name><name><surname>Hunter</surname><given-names>S</given-names></name><name><surname>Liewald</surname><given-names>DC</given-names></name><name><surname>Whalley</surname><given-names>HC</given-names></name><name><surname>McIntosh</surname><given-names>AM</given-names></name><name><surname>Lawrie</surname><given-names>SM</given-names></name><name><surname>Pell</surname><given-names>JP</given-names></name><name><surname>Tucker-Drob</surname><given-names>EM</given-names></name><name><surname>Wardlaw</surname><given-names>JM</given-names></name><name><surname>Gale</surname><given-names>CR</given-names></name><name><surname>Deary</surname><given-names>IJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Associations between vascular risk factors and brain MRI indices in UK Biobank</article-title><source>European Heart Journal</source><volume>40</volume><fpage>2290</fpage><lpage>2300</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehz100</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denes</surname><given-names>A</given-names></name><name><surname>Drake</surname><given-names>C</given-names></name><name><surname>Stordy</surname><given-names>J</given-names></name><name><surname>Chamberlain</surname><given-names>J</given-names></name><name><surname>McColl</surname><given-names>BW</given-names></name><name><surname>Gram</surname><given-names>H</given-names></name><name><surname>Crossman</surname><given-names>D</given-names></name><name><surname>Francis</surname><given-names>S</given-names></name><name><surname>Allan</surname><given-names>SM</given-names></name><name><surname>Rothwell</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Interleukin-1 mediates neuroinflammatory changes associated with diet-induced atherosclerosis</article-title><source>Journal of the American Heart Association</source><volume>1</volume><elocation-id>e002006</elocation-id><pub-id pub-id-type="doi">10.1161/JAHA.112.002006</pub-id><pub-id pub-id-type="pmid">23130147</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dheen</surname><given-names>ST</given-names></name><name><surname>Kaur</surname><given-names>C</given-names></name><name><surname>Ling</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Microglial activation and its implications in the brain diseases</article-title><source>Current Medicinal Chemistry</source><volume>14</volume><fpage>1189</fpage><lpage>1197</lpage><pub-id pub-id-type="doi">10.2174/092986707780597961</pub-id><pub-id pub-id-type="pmid">17504139</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dukart</surname><given-names>J</given-names></name><name><surname>Holiga</surname><given-names>S</given-names></name><name><surname>Rullmann</surname><given-names>M</given-names></name><name><surname>Lanzenberger</surname><given-names>R</given-names></name><name><surname>Hawkins</surname><given-names>PCT</given-names></name><name><surname>Mehta</surname><given-names>MA</given-names></name><name><surname>Hesse</surname><given-names>S</given-names></name><name><surname>Barthel</surname><given-names>H</given-names></name><name><surname>Sabri</surname><given-names>O</given-names></name><name><surname>Jech</surname><given-names>R</given-names></name><name><surname>Eickhoff</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps</article-title><source>Human Brain Mapping</source><volume>42</volume><fpage>555</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1002/hbm.25244</pub-id><pub-id pub-id-type="pmid">33079453</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckel</surname><given-names>RH</given-names></name><name><surname>Grundy</surname><given-names>SM</given-names></name><name><surname>Zimmet</surname><given-names>PZ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The metabolic syndrome</article-title><source>The Lancet</source><volume>365</volume><fpage>1415</fpage><lpage>1428</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(05)66378-7</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fawns-Ritchie</surname><given-names>C</given-names></name><name><surname>Deary</surname><given-names>IJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Reliability and validity of the UK Biobank cognitive tests</article-title><source>PLOS ONE</source><volume>15</volume><elocation-id>e0231627</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0231627</pub-id><pub-id pub-id-type="pmid">32310977</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fornito</surname><given-names>A</given-names></name><name><surname>Zalesky</surname><given-names>A</given-names></name><name><surname>Breakspear</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The connectomics of brain disorders</article-title><source>Nature Reviews. Neuroscience</source><volume>16</volume><fpage>159</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1038/nrn3901</pub-id><pub-id pub-id-type="pmid">25697159</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>BM</given-names></name><name><surname>Petersen</surname><given-names>M</given-names></name><name><surname>Mayer</surname><given-names>C</given-names></name><name><surname>Schulz</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>B</given-names></name><name><surname>Thomalla</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Characterization of white matter hyperintensities in large-scale MRI-studies</article-title><source>Frontiers in Neurology</source><volume>10</volume><elocation-id>238</elocation-id><pub-id pub-id-type="doi">10.3389/fneur.2019.00238</pub-id><pub-id pub-id-type="pmid">30972001</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulcher</surname><given-names>BD</given-names></name><name><surname>Arnatkeviciute</surname><given-names>A</given-names></name><name><surname>Fornito</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Overcoming false-positive gene-category enrichment in the analysis of spatially resolved transcriptomic brain atlas data</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>2669</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-22862-1</pub-id><pub-id pub-id-type="pmid">33976144</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Gaser</surname><given-names>C</given-names></name><name><surname>Dahnke</surname><given-names>R</given-names></name><name><surname>Thompson</surname><given-names>PM</given-names></name><name><surname>Kurth</surname><given-names>F</given-names></name><name><surname>Luders</surname><given-names>E</given-names></name><collab>Alzheimer’s Disease Neuroimaging Initiative</collab></person-group><year iso-8601-date="2022">2022</year><article-title>CAT – A Computational Anatomy Toolbox for the Analysis of Structural MRI Data</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2022.06.11.495736</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelber</surname><given-names>RP</given-names></name><name><surname>Ross</surname><given-names>GW</given-names></name><name><surname>Petrovitch</surname><given-names>H</given-names></name><name><surname>Masaki</surname><given-names>KH</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>White</surname><given-names>LR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Antihypertensive medication use and risk of cognitive impairment: the Honolulu-Asia Aging Study</article-title><source>Neurology</source><volume>81</volume><fpage>888</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e3182a351d4</pub-id><pub-id pub-id-type="pmid">23911753</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Gell</surname><given-names>M</given-names></name><name><surname>Eickhoff</surname><given-names>SB</given-names></name><name><surname>Omidvarnia</surname><given-names>A</given-names></name><name><surname>Küppers</surname><given-names>V</given-names></name><name><surname>Patil</surname><given-names>KR</given-names></name><name><surname>Satterthwaite</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The Burden of Reliability: How Measurement Noise Limits Brain-Behaviour Predictions</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2023.02.09.527898</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genon</surname><given-names>S</given-names></name><name><surname>Eickhoff</surname><given-names>SB</given-names></name><name><surname>Kharabian</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Linking interindividual variability in brain structure to behaviour</article-title><source>Nature Reviews. Neuroscience</source><volume>23</volume><fpage>307</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1038/s41583-022-00584-7</pub-id><pub-id pub-id-type="pmid">35365814</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamer</surname><given-names>M</given-names></name><name><surname>Batty</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Association of body mass index and waist-to-hip ratio with brain structure: UK Biobank study</article-title><source>Neurology</source><volume>92</volume><fpage>e594</fpage><lpage>e600</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000006879</pub-id><pub-id pub-id-type="pmid">30626649</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawrylycz</surname><given-names>MJ</given-names></name><name><surname>Lein</surname><given-names>ES</given-names></name><name><surname>Guillozet-Bongaarts</surname><given-names>AL</given-names></name><name><surname>Shen</surname><given-names>EH</given-names></name><name><surname>Ng</surname><given-names>L</given-names></name><name><surname>Miller</surname><given-names>JA</given-names></name><name><surname>van de Lagemaat</surname><given-names>LN</given-names></name><name><surname>Smith</surname><given-names>KA</given-names></name><name><surname>Ebbert</surname><given-names>A</given-names></name><name><surname>Riley</surname><given-names>ZL</given-names></name><name><surname>Abajian</surname><given-names>C</given-names></name><name><surname>Beckmann</surname><given-names>CF</given-names></name><name><surname>Bernard</surname><given-names>A</given-names></name><name><surname>Bertagnolli</surname><given-names>D</given-names></name><name><surname>Boe</surname><given-names>AF</given-names></name><name><surname>Cartagena</surname><given-names>PM</given-names></name><name><surname>Chakravarty</surname><given-names>MM</given-names></name><name><surname>Chapin</surname><given-names>M</given-names></name><name><surname>Chong</surname><given-names>J</given-names></name><name><surname>Dalley</surname><given-names>RA</given-names></name><name><surname>David Daly</surname><given-names>B</given-names></name><name><surname>Dang</surname><given-names>C</given-names></name><name><surname>Datta</surname><given-names>S</given-names></name><name><surname>Dee</surname><given-names>N</given-names></name><name><surname>Dolbeare</surname><given-names>TA</given-names></name><name><surname>Faber</surname><given-names>V</given-names></name><name><surname>Feng</surname><given-names>D</given-names></name><name><surname>Fowler</surname><given-names>DR</given-names></name><name><surname>Goldy</surname><given-names>J</given-names></name><name><surname>Gregor</surname><given-names>BW</given-names></name><name><surname>Haradon</surname><given-names>Z</given-names></name><name><surname>Haynor</surname><given-names>DR</given-names></name><name><surname>Hohmann</surname><given-names>JG</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name><name><surname>Howard</surname><given-names>RE</given-names></name><name><surname>Jeromin</surname><given-names>A</given-names></name><name><surname>Jochim</surname><given-names>JM</given-names></name><name><surname>Kinnunen</surname><given-names>M</given-names></name><name><surname>Lau</surname><given-names>C</given-names></name><name><surname>Lazarz</surname><given-names>ET</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Lemon</surname><given-names>TA</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Morris</surname><given-names>JA</given-names></name><name><surname>Overly</surname><given-names>CC</given-names></name><name><surname>Parker</surname><given-names>PD</given-names></name><name><surname>Parry</surname><given-names>SE</given-names></name><name><surname>Reding</surname><given-names>M</given-names></name><name><surname>Royall</surname><given-names>JJ</given-names></name><name><surname>Schulkin</surname><given-names>J</given-names></name><name><surname>Sequeira</surname><given-names>PA</given-names></name><name><surname>Slaughterbeck</surname><given-names>CR</given-names></name><name><surname>Smith</surname><given-names>SC</given-names></name><name><surname>Sodt</surname><given-names>AJ</given-names></name><name><surname>Sunkin</surname><given-names>SM</given-names></name><name><surname>Swanson</surname><given-names>BE</given-names></name><name><surname>Vawter</surname><given-names>MP</given-names></name><name><surname>Williams</surname><given-names>D</given-names></name><name><surname>Wohnoutka</surname><given-names>P</given-names></name><name><surname>Zielke</surname><given-names>HR</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name><name><surname>Hof</surname><given-names>PR</given-names></name><name><surname>Smith</surname><given-names>SM</given-names></name><name><surname>Koch</surname><given-names>C</given-names></name><name><surname>Grant</surname><given-names>SGN</given-names></name><name><surname>Jones</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>An anatomically comprehensive atlas of the adult human brain transcriptome</article-title><source>Nature</source><volume>489</volume><fpage>391</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1038/nature11405</pub-id><pub-id pub-id-type="pmid">22996553</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>B</given-names></name><name><surname>Fang</surname><given-names>C</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Blood-brain barrier breakdown: An emerging biomarker of cognitive impairment in normal aging and dementia</article-title><source>Frontiers in Neuroscience</source><volume>15</volume><elocation-id>688090</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2021.688090</pub-id><pub-id pub-id-type="pmid">34489623</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jagodzinski</surname><given-names>A</given-names></name><name><surname>Johansen</surname><given-names>C</given-names></name><name><surname>Koch-Gromus</surname><given-names>U</given-names></name><name><surname>Aarabi</surname><given-names>G</given-names></name><name><surname>Adam</surname><given-names>G</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name><name><surname>Augustin</surname><given-names>M</given-names></name><name><surname>der Kellen</surname><given-names>RB</given-names></name><name><surname>Beikler</surname><given-names>T</given-names></name><name><surname>Behrendt</surname><given-names>C-A</given-names></name><name><surname>Betz</surname><given-names>CS</given-names></name><name><surname>Bokemeyer</surname><given-names>C</given-names></name><name><surname>Borof</surname><given-names>K</given-names></name><name><surname>Briken</surname><given-names>P</given-names></name><name><surname>Busch</surname><given-names>C-J</given-names></name><name><surname>Büchel</surname><given-names>C</given-names></name><name><surname>Brassen</surname><given-names>S</given-names></name><name><surname>Debus</surname><given-names>ES</given-names></name><name><surname>Eggers</surname><given-names>L</given-names></name><name><surname>Fiehler</surname><given-names>J</given-names></name><name><surname>Gallinat</surname><given-names>J</given-names></name><name><surname>Gellißen</surname><given-names>S</given-names></name><name><surname>Gerloff</surname><given-names>C</given-names></name><name><surname>Girdauskas</surname><given-names>E</given-names></name><name><surname>Gosau</surname><given-names>M</given-names></name><name><surname>Graefen</surname><given-names>M</given-names></name><name><surname>Härter</surname><given-names>M</given-names></name><name><surname>Harth</surname><given-names>V</given-names></name><name><surname>Heidemann</surname><given-names>C</given-names></name><name><surname>Heydecke</surname><given-names>G</given-names></name><name><surname>Huber</surname><given-names>TB</given-names></name><name><surname>Hussein</surname><given-names>Y</given-names></name><name><surname>Kampf</surname><given-names>MO</given-names></name><name><surname>von dem Knesebeck</surname><given-names>O</given-names></name><name><surname>Konnopka</surname><given-names>A</given-names></name><name><surname>König</surname><given-names>H-H</given-names></name><name><surname>Kromer</surname><given-names>R</given-names></name><name><surname>Kubisch</surname><given-names>C</given-names></name><name><surname>Kühn</surname><given-names>S</given-names></name><name><surname>Loges</surname><given-names>S</given-names></name><name><surname>Löwe</surname><given-names>B</given-names></name><name><surname>Lund</surname><given-names>G</given-names></name><name><surname>Meyer</surname><given-names>C</given-names></name><name><surname>Nagel</surname><given-names>L</given-names></name><name><surname>Nienhaus</surname><given-names>A</given-names></name><name><surname>Pantel</surname><given-names>K</given-names></name><name><surname>Petersen</surname><given-names>E</given-names></name><name><surname>Püschel</surname><given-names>K</given-names></name><name><surname>Reichenspurner</surname><given-names>H</given-names></name><name><surname>Sauter</surname><given-names>G</given-names></name><name><surname>Scherer</surname><given-names>M</given-names></name><name><surname>Scherschel</surname><given-names>K</given-names></name><name><surname>Schiffner</surname><given-names>U</given-names></name><name><surname>Schnabel</surname><given-names>RB</given-names></name><name><surname>Schulz</surname><given-names>H</given-names></name><name><surname>Smeets</surname><given-names>R</given-names></name><name><surname>Sokalskis</surname><given-names>V</given-names></name><name><surname>Spitzer</surname><given-names>MS</given-names></name><name><surname>Terschüren</surname><given-names>C</given-names></name><name><surname>Thederan</surname><given-names>I</given-names></name><name><surname>Thoma</surname><given-names>T</given-names></name><name><surname>Thomalla</surname><given-names>G</given-names></name><name><surname>Waschki</surname><given-names>B</given-names></name><name><surname>Wegscheider</surname><given-names>K</given-names></name><name><surname>Wenzel</surname><given-names>J-P</given-names></name><name><surname>Wiese</surname><given-names>S</given-names></name><name><surname>Zyriax</surname><given-names>B-C</given-names></name><name><surname>Zeller</surname><given-names>T</given-names></name><name><surname>Blankenberg</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Rationale and design of the hamburg city health study</article-title><source>European Journal of Epidemiology</source><volume>35</volume><fpage>169</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1007/s10654-019-00577-4</pub-id><pub-id pub-id-type="pmid">31705407</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Ye</surname><given-names>BS</given-names></name><name><surname>Yoon</surname><given-names>CW</given-names></name><name><surname>Noh</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>GH</given-names></name><name><surname>Cho</surname><given-names>H</given-names></name><name><surname>Jeon</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Kim</surname><given-names>J-H</given-names></name><name><surname>Seong</surname><given-names>J-K</given-names></name><name><surname>Kim</surname><given-names>C-H</given-names></name><name><surname>Choe</surname><given-names>YS</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>ST</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Park</surname><given-names>SE</given-names></name><name><surname>Kim</surname><given-names>J-H</given-names></name><name><surname>Chin</surname><given-names>J</given-names></name><name><surname>Cho</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Weiner</surname><given-names>MW</given-names></name><name><surname>Na</surname><given-names>DL</given-names></name><name><surname>Seo</surname><given-names>SW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cortical thickness and hippocampal shape in pure vascular mild cognitive impairment and dementia of subcortical type</article-title><source>European Journal of Neurology</source><volume>21</volume><fpage>744</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1111/ene.12376</pub-id><pub-id pub-id-type="pmid">24495089</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotkowski</surname><given-names>E</given-names></name><name><surname>Price</surname><given-names>LR</given-names></name><name><surname>Franklin</surname><given-names>C</given-names></name><name><surname>Salazar</surname><given-names>M</given-names></name><name><surname>Woolsey</surname><given-names>M</given-names></name><name><surname>DeFronzo</surname><given-names>RA</given-names></name><name><surname>Blangero</surname><given-names>J</given-names></name><name><surname>Glahn</surname><given-names>DC</given-names></name><name><surname>Fox</surname><given-names>PT</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A neural signature of metabolic syndrome</article-title><source>Human Brain Mapping</source><volume>40</volume><fpage>3575</fpage><lpage>3588</lpage><pub-id pub-id-type="doi">10.1002/hbm.24617</pub-id><pub-id pub-id-type="pmid">31062906</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnadas</surname><given-names>R</given-names></name><name><surname>McLean</surname><given-names>J</given-names></name><name><surname>Batty</surname><given-names>GD</given-names></name><name><surname>Burns</surname><given-names>H</given-names></name><name><surname>Deans</surname><given-names>KA</given-names></name><name><surname>Ford</surname><given-names>I</given-names></name><name><surname>McConnachie</surname><given-names>A</given-names></name><name><surname>McGinty</surname><given-names>A</given-names></name><name><surname>McLean</surname><given-names>JS</given-names></name><name><surname>Millar</surname><given-names>K</given-names></name><name><surname>Sattar</surname><given-names>N</given-names></name><name><surname>Shiels</surname><given-names>PG</given-names></name><name><surname>Velupillai</surname><given-names>YN</given-names></name><name><surname>Packard</surname><given-names>CJ</given-names></name><name><surname>Cavanagh</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: Results from the psychological, social and biological determinants of ill health (pSoBid) study</article-title><source>NeuroImage. Clinical</source><volume>2</volume><fpage>646</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1016/j.nicl.2013.04.012</pub-id><pub-id pub-id-type="pmid">24179815</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>LJ</given-names></name><name><surname>McIntosh</surname><given-names>AR</given-names></name><name><surname>Abdi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Partial Least Squares (PLS) methods for neuroimaging: A tutorial and review</article-title><source>NeuroImage</source><volume>56</volume><fpage>455</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.07.034</pub-id><pub-id pub-id-type="pmid">20656037</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lake</surname><given-names>BB</given-names></name><name><surname>Ai</surname><given-names>R</given-names></name><name><surname>Kaeser</surname><given-names>GE</given-names></name><name><surname>Salathia</surname><given-names>NS</given-names></name><name><surname>Yung</surname><given-names>YC</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Wildberg</surname><given-names>A</given-names></name><name><surname>Gao</surname><given-names>D</given-names></name><name><surname>Fung</surname><given-names>H-L</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Vijayaraghavan</surname><given-names>R</given-names></name><name><surname>Wong</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><name><surname>Sheng</surname><given-names>X</given-names></name><name><surname>Kaper</surname><given-names>F</given-names></name><name><surname>Shen</surname><given-names>R</given-names></name><name><surname>Ronaghi</surname><given-names>M</given-names></name><name><surname>Fan</surname><given-names>J-B</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Chun</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain</article-title><source>Science</source><volume>352</volume><fpage>1586</fpage><lpage>1590</lpage><pub-id pub-id-type="doi">10.1126/science.aaf1204</pub-id><pub-id pub-id-type="pmid">27339989</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larivière</surname><given-names>S</given-names></name><name><surname>Rodríguez-Cruces</surname><given-names>R</given-names></name><name><surname>Royer</surname><given-names>J</given-names></name><name><surname>Caligiuri</surname><given-names>ME</given-names></name><name><surname>Gambardella</surname><given-names>A</given-names></name><name><surname>Concha</surname><given-names>L</given-names></name><name><surname>Keller</surname><given-names>SS</given-names></name><name><surname>Cendes</surname><given-names>F</given-names></name><name><surname>Yasuda</surname><given-names>C</given-names></name><name><surname>Bonilha</surname><given-names>L</given-names></name><name><surname>Gleichgerrcht</surname><given-names>E</given-names></name><name><surname>Focke</surname><given-names>NK</given-names></name><name><surname>Domin</surname><given-names>M</given-names></name><name><surname>von Podewills</surname><given-names>F</given-names></name><name><surname>Langner</surname><given-names>S</given-names></name><name><surname>Rummel</surname><given-names>C</given-names></name><name><surname>Wiest</surname><given-names>R</given-names></name><name><surname>Martin</surname><given-names>P</given-names></name><name><surname>Kotikalapudi</surname><given-names>R</given-names></name><name><surname>O’Brien</surname><given-names>TJ</given-names></name><name><surname>Sinclair</surname><given-names>B</given-names></name><name><surname>Vivash</surname><given-names>L</given-names></name><name><surname>Desmond</surname><given-names>PM</given-names></name><name><surname>Alhusaini</surname><given-names>S</given-names></name><name><surname>Doherty</surname><given-names>CP</given-names></name><name><surname>Cavalleri</surname><given-names>GL</given-names></name><name><surname>Delanty</surname><given-names>N</given-names></name><name><surname>Kälviäinen</surname><given-names>R</given-names></name><name><surname>Jackson</surname><given-names>GD</given-names></name><name><surname>Kowalczyk</surname><given-names>M</given-names></name><name><surname>Mascalchi</surname><given-names>M</given-names></name><name><surname>Semmelroch</surname><given-names>M</given-names></name><name><surname>Thomas</surname><given-names>RH</given-names></name><name><surname>Soltanian-Zadeh</surname><given-names>H</given-names></name><name><surname>Davoodi-Bojd</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Lenge</surname><given-names>M</given-names></name><name><surname>Guerrini</surname><given-names>R</given-names></name><name><surname>Bartolini</surname><given-names>E</given-names></name><name><surname>Hamandi</surname><given-names>K</given-names></name><name><surname>Foley</surname><given-names>S</given-names></name><name><surname>Weber</surname><given-names>B</given-names></name><name><surname>Depondt</surname><given-names>C</given-names></name><name><surname>Absil</surname><given-names>J</given-names></name><name><surname>Carr</surname><given-names>SJA</given-names></name><name><surname>Abela</surname><given-names>E</given-names></name><name><surname>Richardson</surname><given-names>MP</given-names></name><name><surname>Devinsky</surname><given-names>O</given-names></name><name><surname>Severino</surname><given-names>M</given-names></name><name><surname>Striano</surname><given-names>P</given-names></name><name><surname>Tortora</surname><given-names>D</given-names></name><name><surname>Hatton</surname><given-names>SN</given-names></name><name><surname>Vos</surname><given-names>SB</given-names></name><name><surname>Duncan</surname><given-names>JS</given-names></name><name><surname>Whelan</surname><given-names>CD</given-names></name><name><surname>Thompson</surname><given-names>PM</given-names></name><name><surname>Sisodiya</surname><given-names>SM</given-names></name><name><surname>Bernasconi</surname><given-names>A</given-names></name><name><surname>Labate</surname><given-names>A</given-names></name><name><surname>McDonald</surname><given-names>CR</given-names></name><name><surname>Bernasconi</surname><given-names>N</given-names></name><name><surname>Bernhardt</surname><given-names>BC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eabc6457</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abc6457</pub-id><pub-id pub-id-type="pmid">33208365</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larivière</surname><given-names>S</given-names></name><name><surname>Paquola</surname><given-names>C</given-names></name><name><surname>Park</surname><given-names>B-Y</given-names></name><name><surname>Royer</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Benkarim</surname><given-names>O</given-names></name><name><surname>Vos de Wael</surname><given-names>R</given-names></name><name><surname>Valk</surname><given-names>SL</given-names></name><name><surname>Thomopoulos</surname><given-names>SI</given-names></name><name><surname>Kirschner</surname><given-names>M</given-names></name><name><surname>Lewis</surname><given-names>LB</given-names></name><name><surname>Evans</surname><given-names>AC</given-names></name><name><surname>Sisodiya</surname><given-names>SM</given-names></name><name><surname>McDonald</surname><given-names>CR</given-names></name><name><surname>Thompson</surname><given-names>PM</given-names></name><name><surname>Bernhardt</surname><given-names>BC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The ENIGMA Toolbox: multiscale neural contextualization of multisite neuroimaging datasets</article-title><source>Nature Methods</source><volume>18</volume><fpage>698</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1038/s41592-021-01186-4</pub-id><pub-id pub-id-type="pmid">34194050</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larivière</surname><given-names>S</given-names></name><name><surname>Bayrak</surname><given-names>Ş</given-names></name><name><surname>Vos de Wael</surname><given-names>R</given-names></name><name><surname>Benkarim</surname><given-names>O</given-names></name><name><surname>Herholz</surname><given-names>P</given-names></name><name><surname>Rodriguez-Cruces</surname><given-names>R</given-names></name><name><surname>Paquola</surname><given-names>C</given-names></name><name><surname>Hong</surname><given-names>SJ</given-names></name><name><surname>Misic</surname><given-names>B</given-names></name><name><surname>Evans</surname><given-names>AC</given-names></name><name><surname>Valk</surname><given-names>SL</given-names></name><name><surname>Bernhardt</surname><given-names>BC</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>BrainStat: A toolbox for brain-wide statistics and multimodal feature associations</article-title><source>NeuroImage</source><volume>266</volume><elocation-id>119807</elocation-id><pub-id pub-id-type="doi">10.1016/j.neuroimage.2022.119807</pub-id><pub-id pub-id-type="pmid">36513290</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurent</surname><given-names>JS</given-names></name><name><surname>Watts</surname><given-names>R</given-names></name><name><surname>Adise</surname><given-names>S</given-names></name><name><surname>Allgaier</surname><given-names>N</given-names></name><name><surname>Chaarani</surname><given-names>B</given-names></name><name><surname>Garavan</surname><given-names>H</given-names></name><name><surname>Potter</surname><given-names>A</given-names></name><name><surname>Mackey</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Associations among body mass index, cortical thickness, and executive function in children</article-title><source>JAMA Pediatrics</source><volume>174</volume><fpage>170</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1001/jamapediatrics.2019.4708</pub-id><pub-id pub-id-type="pmid">31816020</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lennon</surname><given-names>MJ</given-names></name><name><surname>Lam</surname><given-names>BCP</given-names></name><name><surname>Lipnicki</surname><given-names>DM</given-names></name><name><surname>Crawford</surname><given-names>JD</given-names></name><name><surname>Peters</surname><given-names>R</given-names></name><name><surname>Schutte</surname><given-names>AE</given-names></name><name><surname>Brodaty</surname><given-names>H</given-names></name><name><surname>Thalamuthu</surname><given-names>A</given-names></name><name><surname>Rydberg-Sterner</surname><given-names>T</given-names></name><name><surname>Najar</surname><given-names>J</given-names></name><name><surname>Skoog</surname><given-names>I</given-names></name><name><surname>Riedel-Heller</surname><given-names>SG</given-names></name><name><surname>Röhr</surname><given-names>S</given-names></name><name><surname>Pabst</surname><given-names>A</given-names></name><name><surname>Lobo</surname><given-names>A</given-names></name><name><surname>De-la-Cámara</surname><given-names>C</given-names></name><name><surname>Lobo</surname><given-names>E</given-names></name><name><surname>Bello</surname><given-names>T</given-names></name><name><surname>Gureje</surname><given-names>O</given-names></name><name><surname>Ojagbemi</surname><given-names>A</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Katz</surname><given-names>MJ</given-names></name><name><surname>Derby</surname><given-names>CA</given-names></name><name><surname>Kim</surname><given-names>KW</given-names></name><name><surname>Han</surname><given-names>JW</given-names></name><name><surname>Oh</surname><given-names>DJ</given-names></name><name><surname>Rolandi</surname><given-names>E</given-names></name><name><surname>Davin</surname><given-names>A</given-names></name><name><surname>Rossi</surname><given-names>M</given-names></name><name><surname>Scarmeas</surname><given-names>N</given-names></name><name><surname>Yannakoulia</surname><given-names>M</given-names></name><name><surname>Dardiotis</surname><given-names>T</given-names></name><name><surname>Hendrie</surname><given-names>HC</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>Carrière</surname><given-names>I</given-names></name><name><surname>Ritchie</surname><given-names>K</given-names></name><name><surname>Anstey</surname><given-names>KJ</given-names></name><name><surname>Cherbuin</surname><given-names>N</given-names></name><name><surname>Xiao</surname><given-names>S</given-names></name><name><surname>Yue</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Guerchet</surname><given-names>MM</given-names></name><name><surname>Preux</surname><given-names>P-M</given-names></name><name><surname>Aboyans</surname><given-names>V</given-names></name><name><surname>Haan</surname><given-names>MN</given-names></name><name><surname>Aiello</surname><given-names>AE</given-names></name><name><surname>Ng</surname><given-names>TP</given-names></name><name><surname>Nyunt</surname><given-names>MSZ</given-names></name><name><surname>Gao</surname><given-names>Q</given-names></name><name><surname>Scazufca</surname><given-names>M</given-names></name><name><surname>Sachdev</surname><given-names>PSS</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Use of antihypertensives, blood pressure, and estimated risk of dementia in late life</article-title><source>JAMA Network Open</source><volume>6</volume><elocation-id>e2333353</elocation-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2023.33353</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leritz</surname><given-names>EC</given-names></name><name><surname>Salat</surname><given-names>DH</given-names></name><name><surname>Williams</surname><given-names>VJ</given-names></name><name><surname>Schnyer</surname><given-names>DM</given-names></name><name><surname>Rudolph</surname><given-names>JL</given-names></name><name><surname>Lipsitz</surname><given-names>L</given-names></name><name><surname>Fischl</surname><given-names>B</given-names></name><name><surname>McGlinchey</surname><given-names>RE</given-names></name><name><surname>Milberg</surname><given-names>WP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Thickness of the human cerebral cortex is associated with metrics of cerebrovascular health in a normative sample of community dwelling older adults</article-title><source>NeuroImage</source><volume>54</volume><fpage>2659</fpage><lpage>2671</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.10.050</pub-id><pub-id pub-id-type="pmid">21035552</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libby</surname><given-names>P</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Maseri</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Inflammation and atherosclerosis</article-title><source>Circulation</source><volume>105</volume><fpage>1135</fpage><lpage>1143</lpage><pub-id pub-id-type="doi">10.1161/hc0902.104353</pub-id><pub-id pub-id-type="pmid">11877368</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lind</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Endothelium-dependent vasodilation, insulin resistance and the metabolic syndrome in an elderly cohort: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study</article-title><source>Atherosclerosis</source><volume>196</volume><fpage>795</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2007.01.014</pub-id><pub-id pub-id-type="pmid">17335830</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Lotter</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Leondlotter/Abannotate: 0.1.1</data-title><version designator="Version v0.1.1">Version v0.1.1</version><source>Zenodo</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.6640855">https://doi.org/10.5281/zenodo.6640855</ext-link></element-citation></ref><ref id="bib44"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Lotter</surname><given-names>LD</given-names></name><name><surname>Saberi</surname><given-names>A</given-names></name><name><surname>Hansen</surname><given-names>JY</given-names></name><name><surname>Misic</surname><given-names>B</given-names></name><name><surname>Paquola</surname><given-names>C</given-names></name><name><surname>Barker</surname><given-names>GJ</given-names></name><name><surname>Bokde</surname><given-names>ALW</given-names></name><name><surname>Desrivières</surname><given-names>S</given-names></name><name><surname>Flor</surname><given-names>H</given-names></name><name><surname>Grigis</surname><given-names>A</given-names></name><name><surname>Garavan</surname><given-names>H</given-names></name><name><surname>Gowland</surname><given-names>P</given-names></name><name><surname>Heinz</surname><given-names>A</given-names></name><name><surname>Brühl</surname><given-names>R</given-names></name><name><surname>Martinot</surname><given-names>JL</given-names></name><name><surname>Paillère</surname><given-names>ML</given-names></name><name><surname>Artiges</surname><given-names>E</given-names></name><name><surname>Orfanos</surname><given-names>DP</given-names></name><name><surname>Paus</surname><given-names>T</given-names></name><name><surname>Poustka</surname><given-names>L</given-names></name><name><surname>Hohmann</surname><given-names>S</given-names></name><name><surname>Fröhner</surname><given-names>JH</given-names></name><name><surname>Smolka</surname><given-names>MN</given-names></name><name><surname>Vaidya</surname><given-names>N</given-names></name><name><surname>Walter</surname><given-names>H</given-names></name><name><surname>Whelan</surname><given-names>R</given-names></name><name><surname>Schumann</surname><given-names>G</given-names></name><name><surname>Nees</surname><given-names>F</given-names></name><name><surname>Banaschewski</surname><given-names>T</given-names></name><name><surname>Eickhoff</surname><given-names>SB</given-names></name><name><surname>Dukart</surname><given-names>J</given-names></name><collab>IMAGEN Consortium</collab></person-group><year iso-8601-date="2023">2023</year><article-title>Human Cortex Development Is Shaped by Molecular and Cellular Brain Systems</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2023.05.05.539537</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>R</given-names></name><name><surname>Aziz</surname><given-names>NA</given-names></name><name><surname>Diers</surname><given-names>K</given-names></name><name><surname>Stöcker</surname><given-names>T</given-names></name><name><surname>Reuter</surname><given-names>M</given-names></name><name><surname>Breteler</surname><given-names>MMB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Insulin resistance accounts for metabolic syndrome-related alterations in brain structure</article-title><source>Human Brain Mapping</source><volume>42</volume><fpage>2434</fpage><lpage>2444</lpage><pub-id pub-id-type="doi">10.1002/hbm.25377</pub-id><pub-id pub-id-type="pmid">33769661</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marek</surname><given-names>S</given-names></name><name><surname>Tervo-Clemmens</surname><given-names>B</given-names></name><name><surname>Calabro</surname><given-names>FJ</given-names></name><name><surname>Montez</surname><given-names>DF</given-names></name><name><surname>Kay</surname><given-names>BP</given-names></name><name><surname>Hatoum</surname><given-names>AS</given-names></name><name><surname>Donohue</surname><given-names>MR</given-names></name><name><surname>Foran</surname><given-names>W</given-names></name><name><surname>Miller</surname><given-names>RL</given-names></name><name><surname>Hendrickson</surname><given-names>TJ</given-names></name><name><surname>Malone</surname><given-names>SM</given-names></name><name><surname>Kandala</surname><given-names>S</given-names></name><name><surname>Feczko</surname><given-names>E</given-names></name><name><surname>Miranda-Dominguez</surname><given-names>O</given-names></name><name><surname>Graham</surname><given-names>AM</given-names></name><name><surname>Earl</surname><given-names>EA</given-names></name><name><surname>Perrone</surname><given-names>AJ</given-names></name><name><surname>Cordova</surname><given-names>M</given-names></name><name><surname>Doyle</surname><given-names>O</given-names></name><name><surname>Moore</surname><given-names>LA</given-names></name><name><surname>Conan</surname><given-names>GM</given-names></name><name><surname>Uriarte</surname><given-names>J</given-names></name><name><surname>Snider</surname><given-names>K</given-names></name><name><surname>Lynch</surname><given-names>BJ</given-names></name><name><surname>Wilgenbusch</surname><given-names>JC</given-names></name><name><surname>Pengo</surname><given-names>T</given-names></name><name><surname>Tam</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Newbold</surname><given-names>DJ</given-names></name><name><surname>Zheng</surname><given-names>A</given-names></name><name><surname>Seider</surname><given-names>NA</given-names></name><name><surname>Van</surname><given-names>AN</given-names></name><name><surname>Metoki</surname><given-names>A</given-names></name><name><surname>Chauvin</surname><given-names>RJ</given-names></name><name><surname>Laumann</surname><given-names>TO</given-names></name><name><surname>Greene</surname><given-names>DJ</given-names></name><name><surname>Petersen</surname><given-names>SE</given-names></name><name><surname>Garavan</surname><given-names>H</given-names></name><name><surname>Thompson</surname><given-names>WK</given-names></name><name><surname>Nichols</surname><given-names>TE</given-names></name><name><surname>Yeo</surname><given-names>BTT</given-names></name><name><surname>Barch</surname><given-names>DM</given-names></name><name><surname>Luna</surname><given-names>B</given-names></name><name><surname>Fair</surname><given-names>DA</given-names></name><name><surname>Dosenbach</surname><given-names>NUF</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Reproducible brain-wide association studies require thousands of individuals</article-title><source>Nature</source><volume>603</volume><fpage>654</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04492-9</pub-id><pub-id pub-id-type="pmid">35296861</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margulies</surname><given-names>DS</given-names></name><name><surname>Ghosh</surname><given-names>SS</given-names></name><name><surname>Goulas</surname><given-names>A</given-names></name><name><surname>Falkiewicz</surname><given-names>M</given-names></name><name><surname>Huntenburg</surname><given-names>JM</given-names></name><name><surname>Langs</surname><given-names>G</given-names></name><name><surname>Bezgin</surname><given-names>G</given-names></name><name><surname>Eickhoff</surname><given-names>SB</given-names></name><name><surname>Castellanos</surname><given-names>FX</given-names></name><name><surname>Petrides</surname><given-names>M</given-names></name><name><surname>Jefferies</surname><given-names>E</given-names></name><name><surname>Smallwood</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Situating the default-mode network along a principal gradient of macroscale cortical organization</article-title><source>PNAS</source><volume>113</volume><fpage>12574</fpage><lpage>12579</lpage><pub-id pub-id-type="doi">10.1073/pnas.1608282113</pub-id><pub-id pub-id-type="pmid">27791099</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Markello</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Pylsversion</data-title><version designator="0.0.1">0.0.1</version><source>Github</source><ext-link ext-link-type="uri" xlink:href="https://github.com/rmarkello/pyls">https://github.com/rmarkello/pyls</ext-link></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markello</surname><given-names>RD</given-names></name><name><surname>Arnatkeviciute</surname><given-names>A</given-names></name><name><surname>Poline</surname><given-names>JB</given-names></name><name><surname>Fulcher</surname><given-names>BD</given-names></name><name><surname>Fornito</surname><given-names>A</given-names></name><name><surname>Misic</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Standardizing workflows in imaging transcriptomics with the abagen toolbox</article-title><source>eLife</source><volume>10</volume><elocation-id>e72129</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.72129</pub-id><pub-id pub-id-type="pmid">34783653</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maslov</surname><given-names>S</given-names></name><name><surname>Sneppen</surname><given-names>K</given-names></name><name><surname>Zaliznyak</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Detection of topological patterns in complex networks: correlation profile of the internet</article-title><source>Physica A</source><volume>333</volume><fpage>529</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1016/j.physa.2003.06.002</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>C</given-names></name><name><surname>Frey</surname><given-names>BM</given-names></name><name><surname>Schlemm</surname><given-names>E</given-names></name><name><surname>Petersen</surname><given-names>M</given-names></name><name><surname>Engelke</surname><given-names>K</given-names></name><name><surname>Hanning</surname><given-names>U</given-names></name><name><surname>Jagodzinski</surname><given-names>A</given-names></name><name><surname>Borof</surname><given-names>K</given-names></name><name><surname>Fiehler</surname><given-names>J</given-names></name><name><surname>Gerloff</surname><given-names>C</given-names></name><name><surname>Thomalla</surname><given-names>G</given-names></name><name><surname>Cheng</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Linking cortical atrophy to white matter hyperintensities of presumed vascular origin</article-title><source>Journal of Cerebral Blood Flow &amp; Metabolism</source><volume>41</volume><fpage>1682</fpage><lpage>1691</lpage><pub-id pub-id-type="doi">10.1177/0271678X20974170</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntosh</surname><given-names>EC</given-names></name><name><surname>Jacobson</surname><given-names>A</given-names></name><name><surname>Kemmotsu</surname><given-names>N</given-names></name><name><surname>Pongpipat</surname><given-names>E</given-names></name><name><surname>Green</surname><given-names>E</given-names></name><name><surname>Haase</surname><given-names>L</given-names></name><name><surname>Murphy</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Does medial temporal lobe thickness mediate the association between risk factor burden and memory performance in middle-aged or older adults with metabolic syndrome?</article-title><source>Neuroscience Letters</source><volume>636</volume><fpage>225</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2016.10.010</pub-id><pub-id pub-id-type="pmid">27717834</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>KL</given-names></name><name><surname>Alfaro-Almagro</surname><given-names>F</given-names></name><name><surname>Bangerter</surname><given-names>NK</given-names></name><name><surname>Thomas</surname><given-names>DL</given-names></name><name><surname>Yacoub</surname><given-names>E</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Bartsch</surname><given-names>AJ</given-names></name><name><surname>Jbabdi</surname><given-names>S</given-names></name><name><surname>Sotiropoulos</surname><given-names>SN</given-names></name><name><surname>Andersson</surname><given-names>JLR</given-names></name><name><surname>Griffanti</surname><given-names>L</given-names></name><name><surname>Douaud</surname><given-names>G</given-names></name><name><surname>Okell</surname><given-names>TW</given-names></name><name><surname>Weale</surname><given-names>P</given-names></name><name><surname>Dragonu</surname><given-names>I</given-names></name><name><surname>Garratt</surname><given-names>S</given-names></name><name><surname>Hudson</surname><given-names>S</given-names></name><name><surname>Collins</surname><given-names>R</given-names></name><name><surname>Jenkinson</surname><given-names>M</given-names></name><name><surname>Matthews</surname><given-names>PM</given-names></name><name><surname>Smith</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Multimodal population brain imaging in the UK Biobank prospective epidemiological study</article-title><source>Nature Neuroscience</source><volume>19</volume><fpage>1523</fpage><lpage>1536</lpage><pub-id pub-id-type="doi">10.1038/nn.4393</pub-id><pub-id pub-id-type="pmid">27643430</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>JC</given-names></name><name><surname>Heyman</surname><given-names>A</given-names></name><name><surname>Mohs</surname><given-names>RC</given-names></name><name><surname>Hughes</surname><given-names>JP</given-names></name><name><surname>van Belle</surname><given-names>G</given-names></name><name><surname>Fillenbaum</surname><given-names>G</given-names></name><name><surname>Mellits</surname><given-names>ED</given-names></name><name><surname>Clark</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease</article-title><source>Neurology</source><volume>39</volume><fpage>1159</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.1212/wnl.39.9.1159</pub-id><pub-id pub-id-type="pmid">2771064</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morys</surname><given-names>F</given-names></name><name><surname>Potvin</surname><given-names>O</given-names></name><name><surname>Zeighami</surname><given-names>Y</given-names></name><name><surname>Vogel</surname><given-names>J</given-names></name><name><surname>Lamontagne-Caron</surname><given-names>R</given-names></name><name><surname>Duchesne</surname><given-names>S</given-names></name><name><surname>Dagher</surname><given-names>A</given-names></name><collab>Alzheimer’s Disease Neuroimaging Initiative</collab></person-group><year iso-8601-date="2023">2023</year><article-title>Obesity-associated neurodegeneration pattern mimics alzheimer’s disease in an observational cohort study</article-title><source>Journal of Alzheimer’s Disease</source><volume>91</volume><fpage>1059</fpage><lpage>1071</lpage><pub-id pub-id-type="doi">10.3233/JAD-220535</pub-id><pub-id pub-id-type="pmid">36565111</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullins</surname><given-names>CA</given-names></name><name><surname>Gannaban</surname><given-names>RB</given-names></name><name><surname>Khan</surname><given-names>MS</given-names></name><name><surname>Shah</surname><given-names>H</given-names></name><name><surname>Siddik</surname><given-names>MAB</given-names></name><name><surname>Hegde</surname><given-names>VK</given-names></name><name><surname>Reddy</surname><given-names>PH</given-names></name><name><surname>Shin</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Neural underpinnings of obesity: The role of oxidative stress and inflammation in the brain</article-title><source>Antioxidants</source><volume>9</volume><elocation-id>1018</elocation-id><pub-id pub-id-type="doi">10.3390/antiox9101018</pub-id><pub-id pub-id-type="pmid">33092099</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opel</surname><given-names>N</given-names></name><name><surname>Thalamuthu</surname><given-names>A</given-names></name><name><surname>Milaneschi</surname><given-names>Y</given-names></name><name><surname>Grotegerd</surname><given-names>D</given-names></name><name><surname>Flint</surname><given-names>C</given-names></name><name><surname>Leenings</surname><given-names>R</given-names></name><name><surname>Goltermann</surname><given-names>J</given-names></name><name><surname>Richter</surname><given-names>M</given-names></name><name><surname>Hahn</surname><given-names>T</given-names></name><name><surname>Woditsch</surname><given-names>G</given-names></name><name><surname>Berger</surname><given-names>K</given-names></name><name><surname>Hermesdorf</surname><given-names>M</given-names></name><name><surname>McIntosh</surname><given-names>A</given-names></name><name><surname>Whalley</surname><given-names>HC</given-names></name><name><surname>Harris</surname><given-names>MA</given-names></name><name><surname>MacMaster</surname><given-names>FP</given-names></name><name><surname>Walter</surname><given-names>H</given-names></name><name><surname>Veer</surname><given-names>IM</given-names></name><name><surname>Frodl</surname><given-names>T</given-names></name><name><surname>Carballedo</surname><given-names>A</given-names></name><name><surname>Krug</surname><given-names>A</given-names></name><name><surname>Nenadic</surname><given-names>I</given-names></name><name><surname>Kircher</surname><given-names>T</given-names></name><name><surname>Aleman</surname><given-names>A</given-names></name><name><surname>Groenewold</surname><given-names>NA</given-names></name><name><surname>Stein</surname><given-names>DJ</given-names></name><name><surname>Soares</surname><given-names>JC</given-names></name><name><surname>Zunta-Soares</surname><given-names>GB</given-names></name><name><surname>Mwangi</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>MJ</given-names></name><name><surname>Walter</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Harrison</surname><given-names>BJ</given-names></name><name><surname>Davey</surname><given-names>CG</given-names></name><name><surname>Cullen</surname><given-names>KR</given-names></name><name><surname>Klimes-Dougan</surname><given-names>B</given-names></name><name><surname>Mueller</surname><given-names>BA</given-names></name><name><surname>Sämann</surname><given-names>PG</given-names></name><name><surname>Penninx</surname><given-names>B</given-names></name><name><surname>Nawijn</surname><given-names>L</given-names></name><name><surname>Veltman</surname><given-names>DJ</given-names></name><name><surname>Aftanas</surname><given-names>L</given-names></name><name><surname>Brak</surname><given-names>IV</given-names></name><name><surname>Filimonova</surname><given-names>EA</given-names></name><name><surname>Osipov</surname><given-names>EA</given-names></name><name><surname>Reneman</surname><given-names>L</given-names></name><name><surname>Schrantee</surname><given-names>A</given-names></name><name><surname>Grabe</surname><given-names>HJ</given-names></name><name><surname>Van der Auwera</surname><given-names>S</given-names></name><name><surname>Wittfeld</surname><given-names>K</given-names></name><name><surname>Hosten</surname><given-names>N</given-names></name><name><surname>Völzke</surname><given-names>H</given-names></name><name><surname>Sim</surname><given-names>K</given-names></name><name><surname>Gotlib</surname><given-names>IH</given-names></name><name><surname>Sacchet</surname><given-names>MD</given-names></name><name><surname>Lagopoulos</surname><given-names>J</given-names></name><name><surname>Hatton</surname><given-names>SN</given-names></name><name><surname>Hickie</surname><given-names>I</given-names></name><name><surname>Pozzi</surname><given-names>E</given-names></name><name><surname>Thompson</surname><given-names>PM</given-names></name><name><surname>Jahanshad</surname><given-names>N</given-names></name><name><surname>Schmaal</surname><given-names>L</given-names></name><name><surname>Baune</surname><given-names>BT</given-names></name><name><surname>Dannlowski</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders</article-title><source>Molecular Psychiatry</source><volume>26</volume><fpage>4839</fpage><lpage>4852</lpage><pub-id pub-id-type="doi">10.1038/s41380-020-0774-9</pub-id><pub-id pub-id-type="pmid">32467648</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>M</given-names></name><name><surname>Frey</surname><given-names>BM</given-names></name><name><surname>Schlemm</surname><given-names>E</given-names></name><name><surname>Mayer</surname><given-names>C</given-names></name><name><surname>Hanning</surname><given-names>U</given-names></name><name><surname>Engelke</surname><given-names>K</given-names></name><name><surname>Fiehler</surname><given-names>J</given-names></name><name><surname>Borof</surname><given-names>K</given-names></name><name><surname>Jagodzinski</surname><given-names>A</given-names></name><name><surname>Gerloff</surname><given-names>C</given-names></name><name><surname>Thomalla</surname><given-names>G</given-names></name><name><surname>Cheng</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Network localisation of white matter damage in cerebral small vessel disease</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>9210</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-66013-w</pub-id><pub-id pub-id-type="pmid">32514044</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>M</given-names></name><name><surname>Frey</surname><given-names>BM</given-names></name><name><surname>Mayer</surname><given-names>C</given-names></name><name><surname>Kühn</surname><given-names>S</given-names></name><name><surname>Gallinat</surname><given-names>J</given-names></name><name><surname>Hanning</surname><given-names>U</given-names></name><name><surname>Fiehler</surname><given-names>J</given-names></name><name><surname>Borof</surname><given-names>K</given-names></name><name><surname>Jagodzinski</surname><given-names>A</given-names></name><name><surname>Gerloff</surname><given-names>C</given-names></name><name><surname>Thomalla</surname><given-names>G</given-names></name><name><surname>Cheng</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2022">2022a</year><article-title>Fixel based analysis of white matter alterations in early stage cerebral small vessel disease</article-title><source>Scientific Reports</source><volume>12</volume><elocation-id>1581</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-022-05665-2</pub-id><pub-id pub-id-type="pmid">35091684</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>M</given-names></name><name><surname>Nägele</surname><given-names>FL</given-names></name><name><surname>Mayer</surname><given-names>C</given-names></name><name><surname>Schell</surname><given-names>M</given-names></name><name><surname>Rimmele</surname><given-names>DL</given-names></name><name><surname>Petersen</surname><given-names>E</given-names></name><name><surname>Kühn</surname><given-names>S</given-names></name><name><surname>Gallinat</surname><given-names>J</given-names></name><name><surname>Hanning</surname><given-names>U</given-names></name><name><surname>Fiehler</surname><given-names>J</given-names></name><name><surname>Twerenbold</surname><given-names>R</given-names></name><name><surname>Gerloff</surname><given-names>C</given-names></name><name><surname>Thomalla</surname><given-names>G</given-names></name><name><surname>Cheng</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2022">2022b</year><article-title>Brain network architecture constrains age-related cortical thinning</article-title><source>NeuroImage</source><volume>264</volume><elocation-id>119721</elocation-id><pub-id pub-id-type="doi">10.1016/j.neuroimage.2022.119721</pub-id><pub-id pub-id-type="pmid">36341953</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>2023_Petersen_Mets_Brain_Morphology</data-title><version designator="swh:1:rev:e2d655a401fb8da036ba2dc2d8495619f2d223f6">swh:1:rev:e2d655a401fb8da036ba2dc2d8495619f2d223f6</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:363e6d203e471a16d0edc269281eb10c4e165fbd;origin=https://github.com/csi-hamburg/2023_petersen_mets_brain_morphology;visit=swh:1:snp:b531e1fb70dae65f218043a270ce04dfb0192195;anchor=swh:1:rev:e2d655a401fb8da036ba2dc2d8495619f2d223f6">https://archive.softwareheritage.org/swh:1:dir:363e6d203e471a16d0edc269281eb10c4e165fbd;origin=https://github.com/csi-hamburg/2023_petersen_mets_brain_morphology;visit=swh:1:snp:b531e1fb70dae65f218043a270ce04dfb0192195;anchor=swh:1:rev:e2d655a401fb8da036ba2dc2d8495619f2d223f6</ext-link></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>AE</given-names></name><name><surname>Stutz</surname><given-names>SJ</given-names></name><name><surname>Hommel</surname><given-names>JD</given-names></name><name><surname>Anastasio</surname><given-names>NC</given-names></name><name><surname>Cunningham</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Anterior insula activity regulates the associated behaviors of high fat food binge intake and cue reactivity in male rats</article-title><source>Appetite</source><volume>133</volume><fpage>231</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1016/j.appet.2018.11.011</pub-id><pub-id pub-id-type="pmid">30447231</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>Q</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Xing</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Lipid metabolism in the development and progression of vascular cognitive impairment: A systematic review</article-title><source>Frontiers in Neurology</source><volume>12</volume><elocation-id>709134</elocation-id><pub-id pub-id-type="doi">10.3389/fneur.2021.709134</pub-id><pub-id pub-id-type="pmid">34867708</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolls</surname><given-names>ET</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Reward systems in the brain and nutrition</article-title><source>Annual Review of Nutrition</source><volume>36</volume><fpage>435</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1146/annurev-nutr-071715-050725</pub-id><pub-id pub-id-type="pmid">27146018</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolls</surname><given-names>ET</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The orbitofrontal cortex, food reward, body weight and obesity</article-title><source>Social Cognitive and Affective Neuroscience</source><volume>18</volume><elocation-id>nsab044</elocation-id><pub-id pub-id-type="doi">10.1093/scan/nsab044</pub-id><pub-id pub-id-type="pmid">33830272</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubinov</surname><given-names>M</given-names></name><name><surname>Sporns</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Complex network measures of brain connectivity: uses and interpretations</article-title><source>NeuroImage</source><volume>52</volume><fpage>1059</fpage><lpage>1069</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2009.10.003</pub-id><pub-id pub-id-type="pmid">19819337</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sala</surname><given-names>M</given-names></name><name><surname>de Roos</surname><given-names>A</given-names></name><name><surname>van den Berg</surname><given-names>A</given-names></name><name><surname>Altmann-Schneider</surname><given-names>I</given-names></name><name><surname>Slagboom</surname><given-names>PE</given-names></name><name><surname>Westendorp</surname><given-names>RG</given-names></name><name><surname>van Buchem</surname><given-names>MA</given-names></name><name><surname>de Craen</surname><given-names>AJM</given-names></name><name><surname>van der Grond</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Microstructural brain tissue damage in metabolic syndrome</article-title><source>Diabetes Care</source><volume>37</volume><fpage>493</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.2337/dc13-1160</pub-id><pub-id pub-id-type="pmid">24089543</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>S</given-names></name><name><surname>Caroni</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration</article-title><source>Neuron</source><volume>71</volume><fpage>35</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.06.031</pub-id><pub-id pub-id-type="pmid">21745636</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaare</surname><given-names>HL</given-names></name><name><surname>Kharabian Masouleh</surname><given-names>S</given-names></name><name><surname>Beyer</surname><given-names>F</given-names></name><name><surname>Kumral</surname><given-names>D</given-names></name><name><surname>Uhlig</surname><given-names>M</given-names></name><name><surname>Reinelt</surname><given-names>JD</given-names></name><name><surname>Reiter</surname><given-names>AMF</given-names></name><name><surname>Lampe</surname><given-names>L</given-names></name><name><surname>Babayan</surname><given-names>A</given-names></name><name><surname>Erbey</surname><given-names>M</given-names></name><name><surname>Roebbig</surname><given-names>J</given-names></name><name><surname>Schroeter</surname><given-names>ML</given-names></name><name><surname>Okon-Singer</surname><given-names>H</given-names></name><name><surname>Müller</surname><given-names>K</given-names></name><name><surname>Mendes</surname><given-names>N</given-names></name><name><surname>Margulies</surname><given-names>DS</given-names></name><name><surname>Witte</surname><given-names>AV</given-names></name><name><surname>Gaebler</surname><given-names>M</given-names></name><name><surname>Villringer</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Association of peripheral blood pressure with gray matter volume in 19- to 40-year-old adults</article-title><source>Neurology</source><volume>92</volume><fpage>e758</fpage><lpage>e773</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000006947</pub-id><pub-id pub-id-type="pmid">30674602</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaefer</surname><given-names>A</given-names></name><name><surname>Kong</surname><given-names>R</given-names></name><name><surname>Gordon</surname><given-names>EM</given-names></name><name><surname>Laumann</surname><given-names>TO</given-names></name><name><surname>Zuo</surname><given-names>X-N</given-names></name><name><surname>Holmes</surname><given-names>AJ</given-names></name><name><surname>Eickhoff</surname><given-names>SB</given-names></name><name><surname>Yeo</surname><given-names>BTT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Local-global parcellation of the human cerebral cortex from intrinsic functional connectivity MRI</article-title><source>Cerebral Cortex</source><volume>28</volume><fpage>3095</fpage><lpage>3114</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhx179</pub-id><pub-id pub-id-type="pmid">28981612</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scuteri</surname><given-names>A</given-names></name><name><surname>Laurent</surname><given-names>S</given-names></name><name><surname>Cucca</surname><given-names>F</given-names></name><name><surname>Cockcroft</surname><given-names>J</given-names></name><name><surname>Cunha</surname><given-names>PG</given-names></name><name><surname>Mañas</surname><given-names>LR</given-names></name><name><surname>Mattace Raso</surname><given-names>FU</given-names></name><name><surname>Muiesan</surname><given-names>ML</given-names></name><name><surname>Ryliškytė</surname><given-names>L</given-names></name><name><surname>Rietzschel</surname><given-names>E</given-names></name><name><surname>Strait</surname><given-names>J</given-names></name><name><surname>Vlachopoulos</surname><given-names>C</given-names></name><name><surname>Völzke</surname><given-names>H</given-names></name><name><surname>Lakatta</surname><given-names>EG</given-names></name><name><surname>Nilsson</surname><given-names>PM</given-names></name><collab>Metabolic Syndrome and Arteries Research Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Metabolic syndrome across Europe: different clusters of risk factors</article-title><source>European Journal of Preventive Cardiology</source><volume>22</volume><fpage>486</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1177/2047487314525529</pub-id><pub-id pub-id-type="pmid">24647805</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segura</surname><given-names>B</given-names></name><name><surname>Jurado</surname><given-names>MA</given-names></name><name><surname>Freixenet</surname><given-names>N</given-names></name><name><surname>Falcón</surname><given-names>C</given-names></name><name><surname>Junqué</surname><given-names>C</given-names></name><name><surname>Arboix</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Microstructural white matter changes in metabolic syndrome: a diffusion tensor imaging study</article-title><source>Neurology</source><volume>73</volume><fpage>438</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e3181b163cd</pub-id><pub-id pub-id-type="pmid">19667318</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seidlitz</surname><given-names>J</given-names></name><name><surname>Nadig</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Bethlehem</surname><given-names>RAI</given-names></name><name><surname>Vértes</surname><given-names>PE</given-names></name><name><surname>Morgan</surname><given-names>SE</given-names></name><name><surname>Váša</surname><given-names>F</given-names></name><name><surname>Romero-Garcia</surname><given-names>R</given-names></name><name><surname>Lalonde</surname><given-names>FM</given-names></name><name><surname>Clasen</surname><given-names>LS</given-names></name><name><surname>Blumenthal</surname><given-names>JD</given-names></name><name><surname>Paquola</surname><given-names>C</given-names></name><name><surname>Bernhardt</surname><given-names>B</given-names></name><name><surname>Wagstyl</surname><given-names>K</given-names></name><name><surname>Polioudakis</surname><given-names>D</given-names></name><name><surname>de la Torre-Ubieta</surname><given-names>L</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name><name><surname>Han</surname><given-names>JC</given-names></name><name><surname>Lee</surname><given-names>NR</given-names></name><name><surname>Murphy</surname><given-names>DG</given-names></name><name><surname>Bullmore</surname><given-names>ET</given-names></name><name><surname>Raznahan</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>3358</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-17051-5</pub-id><pub-id pub-id-type="pmid">32620757</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>SW</given-names></name><name><surname>Ahn</surname><given-names>J</given-names></name><name><surname>Yoon</surname><given-names>U</given-names></name><name><surname>Im</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Tae Kim</surname><given-names>S</given-names></name><name><surname>Ahn</surname><given-names>HJ</given-names></name><name><surname>Chin</surname><given-names>J</given-names></name><name><surname>Jeong</surname><given-names>Y</given-names></name><name><surname>Na</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cortical thinning in vascular mild cognitive impairment and vascular dementia of subcortical type</article-title><source>Journal of Neuroimaging</source><volume>20</volume><fpage>37</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1111/j.1552-6569.2008.00293.x</pub-id><pub-id pub-id-type="pmid">19220710</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shafiei</surname><given-names>G</given-names></name><name><surname>Markello</surname><given-names>RD</given-names></name><name><surname>Makowski</surname><given-names>C</given-names></name><name><surname>Talpalaru</surname><given-names>A</given-names></name><name><surname>Kirschner</surname><given-names>M</given-names></name><name><surname>Devenyi</surname><given-names>GA</given-names></name><name><surname>Guma</surname><given-names>E</given-names></name><name><surname>Hagmann</surname><given-names>P</given-names></name><name><surname>Cashman</surname><given-names>NR</given-names></name><name><surname>Lepage</surname><given-names>M</given-names></name><name><surname>Chakravarty</surname><given-names>MM</given-names></name><name><surname>Dagher</surname><given-names>A</given-names></name><name><surname>Mišić</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Spatial patterning of tissue volume loss in schizophrenia reflects brain network architecture</article-title><source>Biological Psychiatry</source><volume>87</volume><fpage>727</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2019.09.031</pub-id><pub-id pub-id-type="pmid">31837746</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shulman</surname><given-names>KI</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Clock-drawing: is it the ideal cognitive screening test?</article-title><source>International Journal of Geriatric Psychiatry</source><volume>15</volume><fpage>548</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1002/1099-1166(200006)15:6&lt;548::aid-gps242&gt;3.0.co;2-u</pub-id><pub-id pub-id-type="pmid">10861923</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudlow</surname><given-names>C</given-names></name><name><surname>Gallacher</surname><given-names>J</given-names></name><name><surname>Allen</surname><given-names>N</given-names></name><name><surname>Beral</surname><given-names>V</given-names></name><name><surname>Burton</surname><given-names>P</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Downey</surname><given-names>P</given-names></name><name><surname>Elliott</surname><given-names>P</given-names></name><name><surname>Green</surname><given-names>J</given-names></name><name><surname>Landray</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Matthews</surname><given-names>P</given-names></name><name><surname>Ong</surname><given-names>G</given-names></name><name><surname>Pell</surname><given-names>J</given-names></name><name><surname>Silman</surname><given-names>A</given-names></name><name><surname>Young</surname><given-names>A</given-names></name><name><surname>Sprosen</surname><given-names>T</given-names></name><name><surname>Peakman</surname><given-names>T</given-names></name><name><surname>Collins</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age</article-title><source>PLOS Medicine</source><volume>12</volume><elocation-id>e1001779</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1001779</pub-id><pub-id pub-id-type="pmid">25826379</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sydnor</surname><given-names>VJ</given-names></name><name><surname>Larsen</surname><given-names>B</given-names></name><name><surname>Bassett</surname><given-names>DS</given-names></name><name><surname>Alexander-Bloch</surname><given-names>A</given-names></name><name><surname>Fair</surname><given-names>DA</given-names></name><name><surname>Liston</surname><given-names>C</given-names></name><name><surname>Mackey</surname><given-names>AP</given-names></name><name><surname>Milham</surname><given-names>MP</given-names></name><name><surname>Pines</surname><given-names>A</given-names></name><name><surname>Roalf</surname><given-names>DR</given-names></name><name><surname>Seidlitz</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Raznahan</surname><given-names>A</given-names></name><name><surname>Satterthwaite</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Neurodevelopment of the association cortices: Patterns, mechanisms, and implications for psychopathology</article-title><source>Neuron</source><volume>109</volume><fpage>2820</fpage><lpage>2846</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2021.06.016</pub-id><pub-id pub-id-type="pmid">34270921</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Neocortical layer 6, a review</article-title><source>Frontiers in Neuroanatomy</source><volume>4</volume><elocation-id>13</elocation-id><pub-id pub-id-type="doi">10.3389/fnana.2010.00013</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Margulies</surname><given-names>DS</given-names></name><name><surname>Breakspear</surname><given-names>M</given-names></name><name><surname>Zalesky</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Topographic organization of the human subcortex unveiled with functional connectivity gradients</article-title><source>Nature Neuroscience</source><volume>23</volume><fpage>1421</fpage><lpage>1432</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-00711-6</pub-id><pub-id pub-id-type="pmid">32989295</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiehuis</surname><given-names>AM</given-names></name><name><surname>van der Graaf</surname><given-names>Y</given-names></name><name><surname>Mali</surname><given-names>WPTM</given-names></name><name><surname>Vincken</surname><given-names>K</given-names></name><name><surname>Muller</surname><given-names>M</given-names></name><name><surname>Geerlings</surname><given-names>MI</given-names></name><collab>SMART Study Group</collab></person-group><year iso-8601-date="2014">2014</year><article-title>Metabolic syndrome, prediabetes, and brain abnormalities on MRI in patients with manifest arterial disease: the SMART-MR study</article-title><source>Diabetes Care</source><volume>37</volume><fpage>2515</fpage><lpage>2521</lpage><pub-id pub-id-type="doi">10.2337/dc14-0154</pub-id><pub-id pub-id-type="pmid">24947788</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tucsek</surname><given-names>Z</given-names></name><name><surname>Toth</surname><given-names>P</given-names></name><name><surname>Sosnowska</surname><given-names>D</given-names></name><name><surname>Gautam</surname><given-names>T</given-names></name><name><surname>Mitschelen</surname><given-names>M</given-names></name><name><surname>Koller</surname><given-names>A</given-names></name><name><surname>Szalai</surname><given-names>G</given-names></name><name><surname>Sonntag</surname><given-names>WE</given-names></name><name><surname>Ungvari</surname><given-names>Z</given-names></name><name><surname>Csiszar</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: Effects on expression of genes involved in beta-amyloid generation and alzheimer’s disease</article-title><source>The Journals of Gerontology Series A</source><volume>69</volume><fpage>1212</fpage><lpage>1226</lpage><pub-id pub-id-type="doi">10.1093/gerona/glt177</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuulari</surname><given-names>JJ</given-names></name><name><surname>Karlsson</surname><given-names>HK</given-names></name><name><surname>Hirvonen</surname><given-names>J</given-names></name><name><surname>Salminen</surname><given-names>P</given-names></name><name><surname>Nuutila</surname><given-names>P</given-names></name><name><surname>Nummenmaa</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Neural circuits for cognitive appetite control in healthy and obese individuals: an fMRI study</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0116640</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0116640</pub-id><pub-id pub-id-type="pmid">25658479</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Heuvel</surname><given-names>MP</given-names></name><name><surname>Sporns</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Network hubs in the human brain</article-title><source>Trends in Cognitive Sciences</source><volume>17</volume><fpage>683</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1016/j.tics.2013.09.012</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veronese</surname><given-names>N</given-names></name><name><surname>Facchini</surname><given-names>S</given-names></name><name><surname>Stubbs</surname><given-names>B</given-names></name><name><surname>Luchini</surname><given-names>C</given-names></name><name><surname>Solmi</surname><given-names>M</given-names></name><name><surname>Manzato</surname><given-names>E</given-names></name><name><surname>Sergi</surname><given-names>G</given-names></name><name><surname>Maggi</surname><given-names>S</given-names></name><name><surname>Cosco</surname><given-names>T</given-names></name><name><surname>Fontana</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Weight loss is associated with improvements in cognitive function among overweight and obese people: A systematic review and meta-analysis</article-title><source>Neuroscience &amp; Biobehavioral Reviews</source><volume>72</volume><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.11.017</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vos de Wael</surname><given-names>R</given-names></name><name><surname>Benkarim</surname><given-names>O</given-names></name><name><surname>Paquola</surname><given-names>C</given-names></name><name><surname>Lariviere</surname><given-names>S</given-names></name><name><surname>Royer</surname><given-names>J</given-names></name><name><surname>Tavakol</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Hong</surname><given-names>S-J</given-names></name><name><surname>Langs</surname><given-names>G</given-names></name><name><surname>Valk</surname><given-names>S</given-names></name><name><surname>Misic</surname><given-names>B</given-names></name><name><surname>Milham</surname><given-names>M</given-names></name><name><surname>Margulies</surname><given-names>D</given-names></name><name><surname>Smallwood</surname><given-names>J</given-names></name><name><surname>Bernhardt</surname><given-names>BC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>BrainSpace: a toolbox for the analysis of macroscale gradients in neuroimaging and connectomics datasets</article-title><source>Communications Biology</source><volume>3</volume><elocation-id>103</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-020-0794-7</pub-id><pub-id pub-id-type="pmid">32139786</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>AS</given-names></name><name><surname>Waite</surname><given-names>LK</given-names></name><name><surname>Wierzba</surname><given-names>M</given-names></name><name><surname>Hoffstaedter</surname><given-names>F</given-names></name><name><surname>Waite</surname><given-names>AQ</given-names></name><name><surname>Poldrack</surname><given-names>B</given-names></name><name><surname>Eickhoff</surname><given-names>SB</given-names></name><name><surname>Hanke</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>FAIRly big: A framework for computationally reproducible processing of large-scale data</article-title><source>Scientific Data</source><volume>9</volume><elocation-id>80</elocation-id><pub-id pub-id-type="doi">10.1038/s41597-022-01163-2</pub-id><pub-id pub-id-type="pmid">35277501</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Warrell</surname><given-names>J</given-names></name><name><surname>Won</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Navarro</surname><given-names>FCP</given-names></name><name><surname>Clarke</surname><given-names>D</given-names></name><name><surname>Gu</surname><given-names>M</given-names></name><name><surname>Emani</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>YT</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Gandal</surname><given-names>MJ</given-names></name><name><surname>Lou</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>JJ</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Rhie</surname><given-names>SK</given-names></name><name><surname>Manakongtreecheep</surname><given-names>K</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Nathan</surname><given-names>A</given-names></name><name><surname>Peters</surname><given-names>M</given-names></name><name><surname>Mattei</surname><given-names>E</given-names></name><name><surname>Fitzgerald</surname><given-names>D</given-names></name><name><surname>Brunetti</surname><given-names>T</given-names></name><name><surname>Moore</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Girdhar</surname><given-names>K</given-names></name><name><surname>Hoffman</surname><given-names>GE</given-names></name><name><surname>Kalayci</surname><given-names>S</given-names></name><name><surname>Gümüş</surname><given-names>ZH</given-names></name><name><surname>Crawford</surname><given-names>GE</given-names></name><collab>PsychENCODE Consortium</collab><name><surname>Roussos</surname><given-names>P</given-names></name><name><surname>Akbarian</surname><given-names>S</given-names></name><name><surname>Jaffe</surname><given-names>AE</given-names></name><name><surname>White</surname><given-names>KP</given-names></name><name><surname>Weng</surname><given-names>Z</given-names></name><name><surname>Sestan</surname><given-names>N</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name><name><surname>Knowles</surname><given-names>JA</given-names></name><name><surname>Gerstein</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Comprehensive functional genomic resource and integrative model for the human brain</article-title><source>Science</source><volume>362</volume><elocation-id>eaat8464</elocation-id><pub-id pub-id-type="doi">10.1126/science.aat8464</pub-id><pub-id pub-id-type="pmid">30545857</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Wierzba</surname><given-names>M</given-names></name><name><surname>Hoffstaedter</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>CAT - computational anatomy Toolbox</data-title><version designator="12.7">12.7</version><source>Github</source><ext-link ext-link-type="uri" xlink:href="https://github.com/m-wierzba/cat-container">https://github.com/m-wierzba/cat-container</ext-link></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>EJ</given-names></name><name><surname>Sadeh</surname><given-names>N</given-names></name><name><surname>Leritz</surname><given-names>EC</given-names></name><name><surname>Logue</surname><given-names>MW</given-names></name><name><surname>Stoop</surname><given-names>TB</given-names></name><name><surname>McGlinchey</surname><given-names>R</given-names></name><name><surname>Milberg</surname><given-names>W</given-names></name><name><surname>Miller</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Posttraumatic stress disorder as a catalyst for the association between metabolic syndrome and reduced cortical thickness</article-title><source>Biological Psychiatry</source><volume>80</volume><fpage>363</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2015.11.023</pub-id><pub-id pub-id-type="pmid">26826875</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yates</surname><given-names>KF</given-names></name><name><surname>Sweat</surname><given-names>V</given-names></name><name><surname>Yau</surname><given-names>PL</given-names></name><name><surname>Turchiano</surname><given-names>MM</given-names></name><name><surname>Convit</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Impact of metabolic syndrome on cognition and brain: A selected review of the literature</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>32</volume><fpage>2060</fpage><lpage>2067</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.112.252759</pub-id><pub-id pub-id-type="pmid">22895667</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeighami</surname><given-names>Y</given-names></name><name><surname>Fereshtehnejad</surname><given-names>S-M</given-names></name><name><surname>Dadar</surname><given-names>M</given-names></name><name><surname>Collins</surname><given-names>DL</given-names></name><name><surname>Postuma</surname><given-names>RB</given-names></name><name><surname>Mišić</surname><given-names>B</given-names></name><name><surname>Dagher</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A clinical-anatomical signature of Parkinson’s disease identified with partial least squares and magnetic resonance imaging</article-title><source>NeuroImage</source><volume>190</volume><fpage>69</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.12.050</pub-id><pub-id pub-id-type="pmid">29277406</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>AH</given-names></name><name><surname>Salminen</surname><given-names>LE</given-names></name><name><surname>Thompson</surname><given-names>PM</given-names></name><name><surname>Jahanshad</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>UK Biobank data parser</data-title><source>Github</source><ext-link ext-link-type="uri" xlink:href="https://github.com/USC-IGC/ukbb_parser">https://github.com/USC-IGC/ukbb_parser</ext-link></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><sec sec-type="appendix" id="s8"><title>General appendix</title><fig id="app1fig1" position="float"><label>Appendix 1—figure 1.</label><caption><title>Flowchart sample selection procedure.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-app1-fig1-v1.tif"/></fig><fig id="app1fig2" position="float"><label>Appendix 1—figure 2.</label><caption><title>Correlation matrix of metabolic syndrome-related risk factors.</title><p>The upper triangle of the matrix displays Pearson correlations with dot size and color representing the magnitude of the coefficients. The diagonal shows kernel density plots. The lower triangle illustrates the variables’ linear relationships via regression plots. Of note, non fasting plasma glucose was investigated in this analysis. Abbreviations: BP – blood pressure.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-app1-fig2-v1.tif"/></fig><table-wrap id="app1table1" position="float"><label>Appendix 1—table 1.</label><caption><title>Partial least squares analysis - latent variables.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Latent variable</th><th align="left" valign="bottom">Explained variance (%)</th><th align="left" valign="bottom">p-value</th></tr></thead><tbody><tr><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">71.20</td><td align="char" char="." valign="bottom">0.0002</td></tr><tr><td align="char" char="." valign="bottom">1</td><td align="char" char="." valign="bottom">22.33</td><td align="char" char="." valign="bottom">0.0002</td></tr><tr><td align="char" char="." valign="bottom">2</td><td align="char" char="." valign="bottom">2.12</td><td align="char" char="." valign="bottom">0.0002</td></tr><tr><td align="char" char="." valign="bottom">3</td><td align="char" char="." valign="bottom">1.84</td><td align="char" char="." valign="bottom">0.0006</td></tr><tr><td align="char" char="." valign="bottom">4</td><td align="char" char="." valign="bottom">1.03</td><td align="char" char="." valign="bottom">0.0026</td></tr><tr><td align="char" char="." valign="bottom">5</td><td align="char" char="." valign="bottom">0.52</td><td align="char" char="." valign="bottom">0.0266</td></tr><tr><td align="char" char="." valign="bottom">6</td><td align="char" char="." valign="bottom">0.38</td><td align="char" char="." valign="bottom">0.0100</td></tr><tr><td align="char" char="." valign="bottom">7</td><td align="char" char="." valign="bottom">0.23</td><td align="char" char="." valign="bottom">0.0032</td></tr><tr><td align="char" char="." valign="bottom">8</td><td align="char" char="." valign="bottom">0.18</td><td align="char" char="." valign="bottom">0.1178</td></tr><tr><td align="char" char="." valign="bottom">9</td><td align="char" char="." valign="bottom">0.16</td><td align="char" char="." valign="bottom">0.2122</td></tr><tr><td align="char" char="." valign="bottom">10</td><td align="char" char="." valign="bottom">0.00</td><td align="char" char="." valign="bottom">0.3137</td></tr><tr><td align="char" char="." valign="bottom">11</td><td align="char" char="." valign="bottom">0.00</td><td align="char" char="." valign="bottom">0.0608</td></tr><tr><td align="char" char="." valign="bottom">12</td><td align="char" char="." valign="bottom">0.00</td><td align="char" char="." valign="bottom">1</td></tr><tr><td align="char" char="." valign="bottom">13</td><td align="char" char="." valign="bottom">0.00</td><td align="char" char="." valign="bottom">1</td></tr><tr><td align="char" char="." valign="bottom">14</td><td align="char" char="." valign="bottom">0.00</td><td align="char" char="." valign="bottom">1</td></tr><tr><td align="char" char="." valign="bottom">15</td><td align="char" char="." valign="bottom">0.00</td><td align="char" char="." valign="bottom">1</td></tr></tbody></table></table-wrap><table-wrap id="app1table2" position="float"><label>Appendix 1—table 2.</label><caption><title>Partial least squares analysis-Cross-validation.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">CV fold</th><th align="left" valign="bottom">r<sub>sp</sub></th></tr></thead><tbody><tr><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0.17</td></tr><tr><td align="char" char="." valign="bottom">1</td><td align="char" char="." valign="bottom">0.21</td></tr><tr><td align="char" char="." valign="bottom">2</td><td align="char" char="." valign="bottom">0.22</td></tr><tr><td align="char" char="." valign="bottom">3</td><td align="char" char="." valign="bottom">0.16</td></tr><tr><td align="char" char="." valign="bottom">4</td><td align="char" char="." valign="bottom">0.15</td></tr><tr><td align="char" char="." valign="bottom">5</td><td align="char" char="." valign="bottom">0.18</td></tr><tr><td align="char" char="." valign="bottom">6</td><td align="char" char="." valign="bottom">0.23</td></tr><tr><td align="char" char="." valign="bottom">7</td><td align="char" char="." valign="bottom">0.13</td></tr><tr><td align="char" char="." valign="bottom">8</td><td align="char" char="." valign="bottom">0.20</td></tr><tr><td align="char" char="." valign="bottom">9</td><td align="char" char="." valign="bottom">0.22</td></tr></tbody></table></table-wrap><table-wrap id="app1table3" position="float"><label>Appendix 1—table 3.</label><caption><title>Virtual histology analysis - Bootstrap ratio (partial least squares, PLS).</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Cell type</th><th align="left" valign="bottom">Zr<sub>sp</sub></th><th align="left" valign="bottom">p<sub>FDR</sub></th></tr></thead><tbody><tr><td align="left" valign="bottom">Endo</td><td align="char" char="." valign="bottom">0.190</td><td align="char" char="." valign="bottom">0.016</td></tr><tr><td align="left" valign="bottom">Micro</td><td align="char" char="." valign="bottom">0.271</td><td align="char" char="." valign="bottom">0.016</td></tr><tr><td align="left" valign="bottom">Ex8</td><td align="char" char="." valign="bottom">0.165</td><td align="char" char="." valign="bottom">0.016</td></tr><tr><td align="left" valign="bottom">In1</td><td align="char" char="." valign="bottom">0.363</td><td align="char" char="." valign="bottom">0.036</td></tr><tr><td align="left" valign="bottom">Ex6</td><td align="char" char="." valign="bottom">0.146</td><td align="char" char="." valign="bottom">0.034</td></tr><tr><td align="left" valign="bottom">Oligo</td><td align="char" char="." valign="bottom">0.207</td><td align="char" char="." valign="bottom">0.057</td></tr><tr><td align="left" valign="bottom">In7</td><td align="char" char="." valign="bottom">0.079</td><td align="char" char="." valign="bottom">0.083</td></tr><tr><td align="left" valign="bottom">Ex1</td><td align="char" char="." valign="bottom">0.122</td><td align="char" char="." valign="bottom">0.144</td></tr><tr><td align="left" valign="bottom">In2</td><td align="char" char="." valign="bottom">0.058</td><td align="char" char="." valign="bottom">0.179</td></tr><tr><td align="left" valign="bottom">In3</td><td align="char" char="." valign="bottom">0.047</td><td align="char" char="." valign="bottom">0.208</td></tr><tr><td align="left" valign="bottom">Astro</td><td align="char" char="." valign="bottom">0.071</td><td align="char" char="." valign="bottom">0.259</td></tr><tr><td align="left" valign="bottom">In8</td><td align="char" char="." valign="bottom">0.055</td><td align="char" char="." valign="bottom">0.299</td></tr><tr><td align="left" valign="bottom">Ex7</td><td align="char" char="." valign="bottom">0.044</td><td align="char" char="." valign="bottom">0.336</td></tr><tr><td align="left" valign="bottom">In5</td><td align="char" char="." valign="bottom">0.037</td><td align="char" char="." valign="bottom">0.388</td></tr><tr><td align="left" valign="bottom">Ex4</td><td align="char" char="." valign="bottom">–0.020</td><td align="char" char="." valign="bottom">0.776</td></tr><tr><td align="left" valign="bottom">Ex5</td><td align="char" char="." valign="bottom">–0.055</td><td align="char" char="." valign="bottom">0.924</td></tr><tr><td align="left" valign="bottom">In4</td><td align="char" char="." valign="bottom">–0.056</td><td align="char" char="." valign="bottom">0.949</td></tr><tr><td align="left" valign="bottom">In6</td><td align="char" char="." valign="bottom">–0.099</td><td align="char" char="." valign="bottom">0.949</td></tr><tr><td align="left" valign="bottom">Ex2</td><td align="char" char="." valign="bottom">–0.102</td><td align="char" char="." valign="bottom">0.967</td></tr><tr><td align="left" valign="bottom">Ex3</td><td align="char" char="." valign="bottom">–0.289</td><td align="char" char="." valign="bottom">0.999</td></tr></tbody></table></table-wrap><table-wrap id="app1table4" position="float"><label>Appendix 1—table 4.</label><caption><title>Virtual histology analysis - t-statistic (group comparison).</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Cell type</th><th align="left" valign="bottom">Zr<sub>sp</sub></th><th align="left" valign="bottom">p<sub>FDR</sub></th></tr></thead><tbody><tr><td align="left" valign="bottom">Endo</td><td align="char" char="." valign="bottom">0.208</td><td align="char" char="." valign="bottom">0.020</td></tr><tr><td align="left" valign="bottom">Micro</td><td align="char" char="." valign="bottom">0.321</td><td align="char" char="." valign="bottom">0.040</td></tr><tr><td align="left" valign="bottom">Ex8</td><td align="char" char="." valign="bottom">0.208</td><td align="char" char="." valign="bottom">0.040</td></tr><tr><td align="left" valign="bottom">Oligo</td><td align="char" char="." valign="bottom">0.233</td><td align="char" char="." valign="bottom">0.055</td></tr><tr><td align="left" valign="bottom">In1</td><td align="char" char="." valign="bottom">0.432</td><td align="char" char="." valign="bottom">0.108</td></tr><tr><td align="left" valign="bottom">Ex6</td><td align="char" char="." valign="bottom">0.145</td><td align="char" char="." valign="bottom">0.123</td></tr><tr><td align="left" valign="bottom">Ex1</td><td align="char" char="." valign="bottom">0.156</td><td align="char" char="." valign="bottom">0.229</td></tr><tr><td align="left" valign="bottom">In3</td><td align="char" char="." valign="bottom">0.058</td><td align="char" char="." valign="bottom">0.233</td></tr><tr><td align="left" valign="bottom">Astro</td><td align="char" char="." valign="bottom">0.120</td><td align="char" char="." valign="bottom">0.233</td></tr><tr><td align="left" valign="bottom">In7</td><td align="char" char="." valign="bottom">0.059</td><td align="char" char="." valign="bottom">0.233</td></tr><tr><td align="left" valign="bottom">In2</td><td align="char" char="." valign="bottom">0.063</td><td align="char" char="." valign="bottom">0.233</td></tr><tr><td align="left" valign="bottom">Ex7</td><td align="char" char="." valign="bottom">0.089</td><td align="char" char="." valign="bottom">0.263</td></tr><tr><td align="left" valign="bottom">In5</td><td align="char" char="." valign="bottom">0.063</td><td align="char" char="." valign="bottom">0.300</td></tr><tr><td align="left" valign="bottom">In8</td><td align="char" char="." valign="bottom">0.066</td><td align="char" char="." valign="bottom">0.317</td></tr><tr><td align="left" valign="bottom">Ex4</td><td align="char" char="." valign="bottom">0.015</td><td align="char" char="." valign="bottom">0.585</td></tr><tr><td align="left" valign="bottom">Ex5</td><td align="char" char="." valign="bottom">–0.007</td><td align="char" char="." valign="bottom">0.690</td></tr><tr><td align="left" valign="bottom">In6</td><td align="char" char="." valign="bottom">–0.078</td><td align="char" char="." valign="bottom">0.861</td></tr><tr><td align="left" valign="bottom">Ex2</td><td align="char" char="." valign="bottom">–0.070</td><td align="char" char="." valign="bottom">0.861</td></tr><tr><td align="left" valign="bottom">In4</td><td align="char" char="." valign="bottom">–0.087</td><td align="char" char="." valign="bottom">0.901</td></tr><tr><td align="left" valign="bottom">Ex3</td><td align="char" char="." valign="bottom">–0.341</td><td align="char" char="." valign="bottom">0.997</td></tr></tbody></table></table-wrap><table-wrap id="app1table5" position="float"><label>Appendix 1—table 5.</label><caption><title>UK Biobank field IDs.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Age</th><th align="left" valign="bottom">21003</th></tr></thead><tbody><tr><td align="left" valign="bottom">Sex</td><td align="left" valign="bottom">31</td></tr><tr><td align="left" valign="bottom">Education</td><td align="left" valign="bottom">6133<xref ref-type="table-fn" rid="app1table5fn2">*</xref></td></tr><tr><td align="left" valign="bottom">Waist circumference</td><td align="left" valign="bottom">48</td></tr><tr><td align="left" valign="bottom">Hip circumference</td><td align="left" valign="bottom">49</td></tr><tr><td align="left" valign="bottom">Body mass index</td><td align="left" valign="bottom">21001</td></tr><tr><td align="left" valign="bottom">RR<sub>systolic</sub></td><td align="left" valign="bottom">4080</td></tr><tr><td align="left" valign="bottom">RR<sub>diastolic</sub></td><td align="left" valign="bottom">4079</td></tr><tr><td align="left" valign="bottom">HDL</td><td align="left" valign="bottom">30760</td></tr><tr><td align="left" valign="bottom">LDL</td><td align="left" valign="bottom">30780</td></tr><tr><td align="left" valign="bottom">Cholesterol</td><td align="left" valign="bottom">30690</td></tr><tr><td align="left" valign="bottom">Triglycerides</td><td align="left" valign="bottom">30870</td></tr><tr><td align="left" valign="bottom">HbA1c</td><td align="left" valign="bottom">30750</td></tr><tr><td align="left" valign="bottom">Blood glucose</td><td align="left" valign="bottom">30740</td></tr><tr><td align="left" valign="bottom">Medication for cholesterol, blood pressure, diabetes</td><td align="left" valign="bottom">6153</td></tr><tr><td align="left" valign="bottom">Fluid Intelligence</td><td align="left" valign="bottom">20191</td></tr><tr><td align="left" valign="bottom">Matrix Pattern Completion</td><td align="left" valign="bottom">6373</td></tr><tr><td align="left" valign="bottom">Numeric Memory Test</td><td align="left" valign="bottom">20240</td></tr><tr><td align="left" valign="bottom">Paired Associate Learning</td><td align="left" valign="bottom">20197</td></tr><tr><td align="left" valign="bottom">Prospective Memory</td><td align="left" valign="bottom">20018</td></tr><tr><td align="left" valign="bottom">Reaction Time</td><td align="left" valign="bottom">20023</td></tr><tr><td align="left" valign="bottom">Symbol Digit Substitution</td><td align="left" valign="bottom">20159</td></tr><tr><td align="left" valign="bottom">Tower Rearranging Test</td><td align="left" valign="bottom">21004</td></tr><tr><td align="left" valign="bottom">Trail Making Test A</td><td align="left" valign="bottom">6348</td></tr><tr><td align="left" valign="bottom">Trail Making Test B</td><td align="left" valign="bottom">6350</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: RR = blood pressure<ext-link ext-link-type="uri" xlink:href="https://github.com/USC-IGC/ukbb_parser">.</ext-link></p></fn><fn id="app1table5fn2"><label>*</label><p>Converted to International Standard Classification of Education (ISCED) via the UKBB parser (<ext-link ext-link-type="uri" xlink:href="https://github.com/USC-IGC/ukbb_parser">https://github.com/USC-IGC/ukbb_parser</ext-link>; <xref ref-type="bibr" rid="bib93">Zhu et al., 2019</xref>).</p></fn></table-wrap-foot></table-wrap><table-wrap id="app1table6" position="float"><label>Appendix 1—table 6.</label><caption><title>Metabolic syndrome Criteria of the International Diabetes Federation (IDF) (<xref ref-type="bibr" rid="bib2">Alberti et al., 2006</xref>).</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" colspan="2">Metabolic syndrome = obesity + two further criteria</th></tr></thead><tbody><tr><td align="left" valign="bottom">Obesity</td><td align="left" valign="bottom">waist circumference ♀:≥80 cm; ♂:≥94 cm</td></tr><tr><td align="left" valign="bottom">Dyslipidemia (raised triglycerides)</td><td align="left" valign="bottom">≥150 mg/dL (1.7 mmol/L) or lipid lowering medication</td></tr><tr><td align="left" valign="bottom">Dyslipidemia (reduced HDL cholesterol)</td><td align="left" valign="bottom">♀:&lt;50 mg/dL (1.29 mmol/L); ♂:&lt;40 mg/dL (1.03 mmol/L) in males</td></tr><tr><td align="left" valign="bottom">Arterial hypertension (raised blood pressure)</td><td align="left" valign="bottom">systolic BP ≥130 or diastolic BP ≥85 mm Hg or antihypertensive medication or diagnosis of hypertension</td></tr><tr><td align="left" valign="bottom">Insuline resistance</td><td align="left" valign="bottom">Fasting plasma glucose ≥100 mg/dL (5.6 mmol/L) or antidiabetic therapy or diagnosis of diabetes mellitus type 2<xref ref-type="table-fn" rid="app1table6fn1">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="app1table6fn1"><label>*</label><p>Measurements of fasting plasma glucose were not available for the study sample. Consequently, the criterion of insulin resistance was only based on the diagnosis of diabetes mellitus and administration of antidiabetic therapy.</p></fn></table-wrap-foot></table-wrap></sec></app><app id="appendix-2"><title>Appendix 2</title><sec sec-type="appendix" id="s9"><title>Case-control analysis</title><p>As a sensitivity analysis and to facilitate the comparison with previous reports which mainly rely on group statistics, we supplemented the continuous partial least squares correlation analysis with a group analysis based on a case-control design.</p><sec sec-type="appendix" id="s9-1"><title>Matching procedure</title><p>After quality assessment, individuals with metabolic syndrome were identified based on the consensus criteria of the <italic>International Diabetes Federation</italic> (n<sub>UKB</sub> = 6746, n<sub>HCHS</sub> = 759). An individual was considered to exhibit MetS in case of obesity (increased waist circumference) and two further criteria being raised plasma triglycerides, reduced HDL cholesterol, arterial hypertension or insulin resistance. Of note, measurements of fasting plasma glucose were not available for the study sample. Consequently, the criterion of insulin resistance was only based on the diagnosis of diabetes mellitus and administration of antidiabetic therapy. Within each cohort, an equally sized control cohort was sampled which was matched for age, sex and education (International Standard Classification of Education) using propensity score matching as implemented in the matchit (v4.3.3) R package. MetS and control samples from both cohorts were pooled yielding an analysis sample of 15,010 individuals (n<sub>MetS</sub> = 7505,, n<sub>controls</sub> = 7505). For detailed matching results refer to <xref ref-type="fig" rid="app2fig1">Appendix 2—figures 1</xref> and <xref ref-type="fig" rid="app2fig2">2</xref> shown below.</p></sec><sec sec-type="appendix" id="s9-2"><title>Group comparison of clinical data</title><p>Sample characteristics were compared between participants with MetS and controls using <inline-formula><mml:math id="inf92"><mml:msup><mml:mrow><mml:mi mathvariant="normal">χ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula> -tests for binary and two-sample t-tests for continuous data. Cognitive variables were compared within UKB and HCHS subgroups via analyses of covariance (ANCOVA) adjusting for age, sex and education. Resulting test statistics were converted to Cohen’s d which quantifies the group difference in standard deviations. P-values were false-discovery rate (FDR)-corrected for multiple comparisons. Separate group statistics of demographic, risk and cognitive variables for the UKB and HCHS are shown in <xref ref-type="table" rid="app1table2">Appendix 1—table 1–2</xref>. Individuals with MetS exhibited a more severe risk profile indicating that the group definitions captured considerable differences in the MetS components profile. Group differences regarding MetS criteria proportions are visualized in <xref ref-type="fig" rid="app2fig3">Appendix 2—figure 3</xref>. As the cognitive assessment of the UKB and HCHS differed, cognitive scores were compared between groups within the individual studies. UKB subjects with MetS performed significantly worse in the Fluid Intelligence Test (6.66±2.10 vs 6.82±2.09, Cohen’s d=0.08, <inline-formula><mml:math id="inf93"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt; 0.001), Numeric Memory Test (6.64±1.61 vs 6.84±1.53, Cohen’s d=.12, <inline-formula><mml:math id="inf94"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt; 0.001), Paired Associate Learning Test (6.45±2.60 vs 6.73±2.61, Cohen’s d=0.10, <inline-formula><mml:math id="inf95"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt; 0.001) and Symbol Digit Substitution Test (18.47±5.12 vs 19.00±5.16, Cohen’s d=0.10, <inline-formula><mml:math id="inf96"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt; 0.001). HCHS subjects exhibiting MetS showed worse cognitive performance in the Animal Naming Test (23.71±6.46 vs 24.77±6.75, Cohen’s d=0.16, <inline-formula><mml:math id="inf97"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt; 0.009) and Multiple-choice Vocabulary Intelligence Test (31.18±3.43 vs 31.71±3.22, Cohen’s d=0.16, <inline-formula><mml:math id="inf98"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt; 0.034).</p></sec><sec sec-type="appendix" id="s9-3"><title>Vertex-wise cortical thickness analysis</title><p>The cortical thickness of individuals with MetS and matched controls were compared on a surface vertex-level leveraging the BrainStat toolbox (v 0.3.6, <ext-link ext-link-type="uri" xlink:href="https://brainstat.readthedocs.io/">https://brainstat.readthedocs.io/</ext-link>). Corresponding results are shown in <xref ref-type="fig" rid="app2fig4">Appendix 2—figure 4</xref>. The vertex-wise t-statistic, which captures the differential MetS effects across the cortical surface, was Schaefer 400 and Schaefer 100-parcellated and propagated to further analyses. The t-statistic map strongly correlated with the bootstrap ratio maps derived from the PLS analyses. Furthermore, the t-statistic map was significantly associated with density of endothelial cells (<inline-formula><mml:math id="inf99"><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></inline-formula> = 0.208, <inline-formula><mml:math id="inf100"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.040), microglia (<inline-formula><mml:math id="inf101"><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></inline-formula> = 0.321, <inline-formula><mml:math id="inf102"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.040), excitatory neurons type 8 (<inline-formula><mml:math id="inf103"><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:math></inline-formula> = 0.208, <inline-formula><mml:math id="inf104"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>D</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.004) and also correlated significantly with the functional neighborhood abnormality (<inline-formula><mml:math id="inf105"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.313, <inline-formula><mml:math id="inf106"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.024, <inline-formula><mml:math id="inf107"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.018, <inline-formula><mml:math id="inf108"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt; 0.001) and structural neighborhood abnormality (<inline-formula><mml:math id="inf109"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0.775, <inline-formula><mml:math id="inf110"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = &lt;0.001, <inline-formula><mml:math id="inf111"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt; 0.001, <inline-formula><mml:math id="inf112"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> &lt; 0.001).</p><fig id="app2fig1" position="float"><label>Appendix 2—figure 1.</label><caption><title>Matching - UK Biobank.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-app2-fig1-v1.tif"/></fig><fig id="app2fig2" position="float"><label>Appendix 2—figure 2.</label><caption><title>Matching – Hamburg City Health Study.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-app2-fig2-v1.tif"/></fig><table-wrap id="app2table1" position="float"><label>Appendix 2—table 1.</label><caption><title>Descriptive group statistics - UK Biobank.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Metric<xref ref-type="table-fn" rid="app2table1fn2">*</xref></th><th align="left" valign="bottom">Individuals with MetS</th><th align="left" valign="bottom">Matched controls</th><th align="left" valign="bottom">P<sub>uncorr</sub></th><th align="left" valign="bottom">P<sub>FDR</sub></th><th align="left" valign="bottom">Stat<xref ref-type="table-fn" rid="app2table1fn3"><sup>†</sup></xref></th></tr></thead><tbody><tr><td align="left" valign="bottom">Age (years)</td><td align="left" valign="bottom">64.73±7.42 (6746)</td><td align="left" valign="bottom">64.51±7.27 (6746)</td><td align="left" valign="bottom">0.095</td><td align="left" valign="bottom">0.154</td><td align="left" valign="bottom">–0.03</td></tr><tr><td align="left" valign="bottom">Sex (% female)</td><td align="left" valign="bottom">18.81 (6746)</td><td align="left" valign="bottom">18.81 (6746)</td><td align="left" valign="bottom">&gt;0.99</td><td align="left" valign="bottom">&gt;0.99</td><td align="left" valign="bottom">0</td></tr><tr><td align="left" valign="bottom">Education (ISCED)</td><td align="left" valign="bottom">2.63±0.73 (6746)</td><td align="left" valign="bottom">2.67±0.71 (6746)</td><td align="left" valign="bottom">0.036</td><td align="left" valign="bottom">0.069</td><td align="left" valign="bottom">0.04</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><underline>Metabolic syndrome criteria</underline></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Waist circumference (cm)</td><td align="left" valign="bottom">97.39±10.21 (6726)</td><td align="left" valign="bottom">88.22±10.59 (6595)</td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">&lt;0.001 <xref ref-type="table-fn" rid="app2table1fn4"><sup>‡</sup></xref></td><td align="left" valign="bottom">–0.88</td></tr><tr><td align="left" valign="bottom">RR<sub>systolic</sub> (mmHg)</td><td align="left" valign="bottom">146.41±15.38 (6213)</td><td align="left" valign="bottom">135.57±17.71 (5397)</td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">&lt;0.001 <xref ref-type="table-fn" rid="app2table1fn4"><sup>‡</sup></xref></td><td align="left" valign="bottom">–0.66</td></tr><tr><td align="left" valign="bottom">RR<sub>diastolic</sub> (mmHg)</td><td align="left" valign="bottom">82.26±9.39 (6214)</td><td align="left" valign="bottom">77.58±9.79 (5397)</td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">&lt;0.001 <xref ref-type="table-fn" rid="app2table1fn4"><sup>‡</sup></xref></td><td align="left" valign="bottom">–0.49</td></tr><tr><td align="left" valign="bottom">Antihypertensive therapy (%)</td><td align="left" valign="bottom">9.96 (6746)</td><td align="left" valign="bottom">9.68 (6746)</td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">&lt;0.001 <xref ref-type="table-fn" rid="app2table1fn4"><sup>‡</sup></xref></td><td align="left" valign="bottom">7.07</td></tr><tr><td align="left" valign="bottom">HDL (mmol/L)</td><td align="left" valign="bottom">1.18±0.26 (6225)</td><td align="left" valign="bottom">1.49±0.32 (6332)</td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">&lt;0.001 <xref ref-type="table-fn" rid="app2table1fn4"><sup>‡</sup></xref></td><td align="left" valign="bottom">1.08</td></tr><tr><td align="left" valign="bottom">Triglycerides (mmol/L)</td><td align="left" valign="bottom">2.43±1.13 (6617)</td><td align="left" valign="bottom">1.30±0.59 (6543)</td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">&lt;0.001 <xref ref-type="table-fn" rid="app2table1fn4"><sup>‡</sup></xref></td><td align="left" valign="bottom">–1.25</td></tr><tr><td align="left" valign="bottom">Lipid-lowering therapy (%)</td><td align="left" valign="bottom">39.05 (6746)</td><td align="left" valign="bottom">7.07 (6746)</td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">&lt;.001 <xref ref-type="table-fn" rid="app2table1fn4"><sup>‡</sup></xref></td><td align="left" valign="bottom">2446.5</td></tr><tr><td align="left" valign="bottom">Blood glucose (mmol/L)</td><td align="left" valign="bottom">5.18±1.41 (6219)</td><td align="left" valign="bottom">4.92±0.68 (6325)</td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">&lt;.001 <xref ref-type="table-fn" rid="app2table1fn4"><sup>‡</sup></xref></td><td align="left" valign="bottom">–0.23</td></tr><tr><td align="left" valign="bottom">Antidiabetic therapy (%)</td><td align="left" valign="bottom">0.06 (6746)</td><td align="left" valign="bottom">0.19 (6746)</td><td align="left" valign="bottom">0.052</td><td align="left" valign="bottom">0.097</td><td align="left" valign="bottom">3.77</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><underline>Cognitive scores</underline></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Fluid Intelligence</td><td align="left" valign="bottom">6.66±2.10 (6221)</td><td align="left" valign="bottom">6.82±2.09 (6241)</td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">&lt;0.001 <xref ref-type="table-fn" rid="app2table1fn4"><sup>‡</sup></xref></td><td align="left" valign="bottom">0.08</td></tr><tr><td align="left" valign="bottom">Matrix Pattern Completion</td><td align="left" valign="bottom">8.02±2.13 (4283)</td><td align="left" valign="bottom">8.14±2.06 (4355)</td><td align="left" valign="bottom">0.055</td><td align="left" valign="bottom">0.096</td><td align="left" valign="bottom">0.06</td></tr><tr><td align="left" valign="bottom">Numeric Memory Test</td><td align="left" valign="bottom">6.64±1.61 (4419)</td><td align="left" valign="bottom">6.84±1.53 (4505)</td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">&lt;0.001 <xref ref-type="table-fn" rid="app2table1fn4"><sup>‡</sup></xref></td><td align="left" valign="bottom">0.12</td></tr><tr><td align="left" valign="bottom">Paired Associate Learning</td><td align="left" valign="bottom">6.45±2.60 (4337)</td><td align="left" valign="bottom">6.73±2.61 (4392)</td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">&lt;0.001 <xref ref-type="table-fn" rid="app2table1fn4"><sup>‡</sup></xref></td><td align="left" valign="bottom">0.10</td></tr><tr><td align="left" valign="bottom">Prospective Memory</td><td align="left" valign="bottom">1.05±0.40 (6362)</td><td align="left" valign="bottom">1.06±0.39 (6349)</td><td align="left" valign="bottom">0.221</td><td align="left" valign="bottom">0.339</td><td align="left" valign="bottom">0.02</td></tr><tr><td align="left" valign="bottom">Reaction Time</td><td align="left" valign="bottom">590.75±108.27 (6331)</td><td align="left" valign="bottom">590.15±111.13 (6325)</td><td align="left" valign="bottom">0.792</td><td align="left" valign="bottom">0.858</td><td align="left" valign="bottom">–0.005</td></tr><tr><td align="left" valign="bottom">Symbol Digit Substitution</td><td align="left" valign="bottom">18.47±5.12 (4292)</td><td align="left" valign="bottom">19.00±5.16 (4353)</td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">&lt;0.001 <xref ref-type="table-fn" rid="app2table1fn4"><sup>‡</sup></xref></td><td align="left" valign="bottom">0.10</td></tr><tr><td align="left" valign="bottom">Tower Rearranging Test</td><td align="left" valign="bottom">10.00±3.28 (4255)</td><td align="left" valign="bottom">10.08±3.20 (4325)</td><td align="left" valign="bottom">0.747</td><td align="left" valign="bottom">0.845</td><td align="left" valign="bottom">0.02</td></tr><tr><td align="left" valign="bottom">Trail Making Test A (sec)</td><td align="left" valign="bottom">226.83±86.26 (4337)</td><td align="left" valign="bottom">224.06±83.06 (4392)</td><td align="left" valign="bottom">0.643</td><td align="left" valign="bottom">0.836</td><td align="left" valign="bottom">–0.03</td></tr><tr><td align="left" valign="bottom">Trail Making Test B (sec)</td><td align="left" valign="bottom">561.81±271.39 (4337)</td><td align="left" valign="bottom">553.62±282.55 (4392)</td><td align="left" valign="bottom">0.611</td><td align="left" valign="bottom">0.756</td><td align="left" valign="bottom">–0.03</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><underline>Imaging</underline></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Mean cortical thickness (mm)</td><td align="left" valign="bottom">2.392±0.09 (6746)</td><td align="left" valign="bottom">2.397±0.09 (6746)</td><td align="left" valign="bottom">0.035</td><td align="left" valign="bottom">0.071</td><td align="left" valign="bottom">0.05</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: cm = centimeter, dL = deciliter, HDL = high-density lipoprotein, ISCED = International Standard Classification of Education, MetS = metabolic syndrome, mg = milligram, mm = millimeter, mmHg = millimeters of mercury, mmol/L = millimole perliter, PC = principal component, Puncor = uncorrected p-values, PFDR = false-discovery rate-corrected p-values, RR = Blood pressure, sec = seconds.</p></fn><fn id="app2table1fn2"><label>*</label><p>Presented as mean ± SD (N).</p></fn><fn id="app2table1fn3"><label>†</label><p>Presented as <italic>χ</italic>2 for categorical and Cohen’s d for continuous data.</p></fn><fn id="app2table1fn4"><label>‡</label><p>Denotes statistical significance at FDR-corrected p&lt;0.001</p></fn></table-wrap-foot></table-wrap><table-wrap id="app2table2" position="float"><label>Appendix 2—table 2.</label><caption><title>Descriptive group statistics Hamburg City Health Study (HCHS).</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Metric<xref ref-type="table-fn" rid="app2table2fn2">*</xref></th><th align="left" valign="bottom">Individuals with MetS</th><th align="left" valign="bottom">Matched controls</th><th align="left" valign="bottom"><italic>P<sub>uncorr</sub></italic></th><th align="left" valign="bottom"><italic>P<sub>FDR</sub></italic></th><th align="left" valign="bottom"><italic>Stat</italic></th></tr></thead><tbody><tr><td align="left" valign="bottom">Age (years)</td><td align="left" valign="bottom">65.77±7.40 (759)</td><td align="left" valign="bottom">65.97±7.52 (759)</td><td align="char" char="." valign="bottom">0.613</td><td align="char" char="." valign="bottom">0.647</td><td align="left" valign="bottom">0.03</td></tr><tr><td align="left" valign="bottom">Sex (% female)</td><td align="left" valign="bottom">33.47</td><td align="left" valign="bottom">36.50</td><td align="char" char="." valign="bottom">0.236</td><td align="char" char="." valign="bottom">0.281</td><td align="left" valign="bottom">1.4</td></tr><tr><td align="left" valign="bottom">Education (ISCED)</td><td align="left" valign="bottom">2.37±0.58 (759)</td><td align="left" valign="bottom">2.42±0.60 (759)</td><td align="char" char="." valign="bottom">0.09</td><td align="char" char="." valign="bottom">0.114</td><td align="left" valign="bottom">0.09</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><underline>Metabolic syndrome criteria</underline></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Waist circumference (cm)</td><td align="left" valign="bottom">103.38±11.23 (754)</td><td align="left" valign="bottom">91.45±11.36 (747)</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">&lt;0.001<xref ref-type="table-fn" rid="app2table2fn3"><sup>†</sup></xref></td><td align="left" valign="bottom">–1.06</td></tr><tr><td align="left" valign="bottom">RR<sub>systolic</sub> (mmHg)</td><td align="left" valign="bottom">145.66±18.54 (740)</td><td align="left" valign="bottom">140.17±21.10 (746)</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">&lt;0.001<xref ref-type="table-fn" rid="app2table2fn3"><sup>†</sup></xref></td><td align="left" valign="bottom">–.28</td></tr><tr><td align="left" valign="bottom">RR<sub>diastolic</sub> (mmHg)</td><td align="left" valign="bottom">83.75±10.11 (740)</td><td align="left" valign="bottom">82.00±10.40 (746)</td><td align="char" char="." valign="bottom">0.001</td><td align="char" char="." valign="bottom">0.002</td><td align="left" valign="bottom">–.17</td></tr><tr><td align="left" valign="bottom">Antihypertensive therapy (%)</td><td align="left" valign="bottom">52.60%</td><td align="left" valign="bottom">26.22%</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">&lt;0.001<xref ref-type="table-fn" rid="app2table2fn3"><sup>†</sup></xref></td><td align="left" valign="bottom">108.89</td></tr><tr><td align="left" valign="bottom">HDL (mg/dL)</td><td align="left" valign="bottom">54.60±16.13 (751)</td><td align="left" valign="bottom">67.63±17.46 (759)</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">&lt;0.001<xref ref-type="table-fn" rid="app2table2fn3"><sup>†</sup></xref></td><td align="left" valign="bottom">0.78</td></tr><tr><td align="left" valign="bottom">Triglycerides (mg/dL)</td><td align="left" valign="bottom">161.53±92.61 (751)</td><td align="left" valign="bottom">91.23±30.62 (759)</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">&lt;0.001<xref ref-type="table-fn" rid="app2table2fn3"><sup>†</sup></xref></td><td align="left" valign="bottom">–1.02</td></tr><tr><td align="left" valign="bottom">Lipid lowering therapy (%)</td><td align="left" valign="bottom">40.85%</td><td align="left" valign="bottom">7.64%</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">&lt;0.001<xref ref-type="table-fn" rid="app2table2fn3"><sup>†</sup></xref></td><td align="left" valign="bottom">225.29</td></tr><tr><td align="left" valign="bottom">Blood glucose (mg/dL)</td><td align="left" valign="bottom">107.47±28.59 (742)</td><td align="left" valign="bottom">90.99±10.87 (753)</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">&lt;0.001<xref ref-type="table-fn" rid="app2table2fn3"><sup>†</sup></xref></td><td align="left" valign="bottom">–0.76</td></tr><tr><td align="left" valign="bottom">Antidiabetic therapy (%)</td><td align="left" valign="bottom">14.42%</td><td align="left" valign="bottom">1.45%</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="char" char="." valign="bottom">&lt;0.001<xref ref-type="table-fn" rid="app2table2fn3"><sup>†</sup></xref></td><td align="left" valign="bottom">85.47</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><underline>Cognitive scores</underline></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Animal Naming Test</td><td align="left" valign="bottom">23.71±6.46 (712)</td><td align="left" valign="bottom">24.77±6.75 (711)</td><td align="char" char="." valign="bottom">0.005</td><td align="char" char="." valign="bottom">0.009</td><td align="left" valign="bottom">0.16</td></tr><tr><td align="left" valign="bottom">Clock Drawing Test</td><td align="left" valign="bottom">6.36±1.17 (730)</td><td align="left" valign="bottom">6.39±1.16 (733)</td><td align="char" char="." valign="bottom">0.774</td><td align="char" char="." valign="bottom">0.774</td><td align="left" valign="bottom">0.02</td></tr><tr><td align="left" valign="bottom">Trail Making Test A (sec)</td><td align="left" valign="bottom">41.26±14.28 (685)</td><td align="left" valign="bottom">40.42±14.54 (675)</td><td align="char" char="." valign="bottom">0.321</td><td align="char" char="." valign="bottom">0.359</td><td align="left" valign="bottom">–0.06</td></tr><tr><td align="left" valign="bottom">Trail Making Test B (sec)</td><td align="left" valign="bottom">93.74±37.30 (675)</td><td align="left" valign="bottom">89.89±37.69 (671)</td><td align="char" char="." valign="bottom">0.086</td><td align="char" char="." valign="bottom">0.114</td><td align="left" valign="bottom">–0.10</td></tr><tr><td align="left" valign="bottom">Multiple-Choice Vocabulary Intelligence Test</td><td align="left" valign="bottom">31.18±3.43 (603)</td><td align="left" valign="bottom">31.71±3.22 (619)</td><td align="char" char="." valign="bottom">0.019</td><td align="char" char="." valign="bottom">0.034</td><td align="left" valign="bottom">0.16</td></tr><tr><td align="left" valign="bottom">Word List Recall</td><td align="left" valign="bottom">7.42±1.89 (691)</td><td align="left" valign="bottom">7.64±1.84 (673)</td><td align="char" char="." valign="bottom">0.057</td><td align="char" char="." valign="bottom">0.083</td><td align="left" valign="bottom">0.12</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"><underline>Imaging</underline></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Mean cortical thickness (mm)</td><td align="left" valign="bottom">2.327±0.08 (759)</td><td align="left" valign="bottom">2.334±0.08 (757)</td><td align="char" char="." valign="bottom">0.045</td><td align="char" char="." valign="bottom">0.071</td><td align="left" valign="bottom">0.1</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: cm = centimeter, dL = deciliter, HDL = high-density lipoprotein, ISCED = International Standard Classification of Education, MetS = metabolic syndrome, mg = milligram, mm = millimeter, mmHg = millimeters of mercury, Puncor = uncorrected p-values, PFDR = false-discovery rate-corrected p-values, RR = Blood pressure, sec = seconds.</p></fn><fn id="app2table2fn2"><label>*</label><p>Presented as mean ± SD (N).</p></fn><fn id="app2table2fn3"><label>†</label><p>Denotes statistical significance at FDR-corrected p&lt;0.001.</p></fn></table-wrap-foot></table-wrap><fig id="app2fig3" position="float"><label>Appendix 2—figure 3.</label><caption><title>Proportion of metabolic syndrome criteria.</title><p>Barplots indicate the percentage amount of metabolic syndrome (MetS) criteria that apply by group for the pooled sample. Significant group differences in χ2-tests are highlighted by asterisks.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-app2-fig3-v1.tif"/></fig><fig id="app2fig4" position="float"><label>Appendix 2—figure 4.</label><caption><title>Vertix-wise group comparison of cortical thickness.</title><p>Vertex-level group comparison between individuals with metabolic syndrome and matched controls. Resulting surface maps of standardized <italic>t</italic>-statistic estimates encode the group-differences between patients and controls, with lower cortical thickness in the metabolic syndrome (MetS) group being represented by a positive <italic>t</italic> and lower by a negative <italic>t</italic>. The vertex-wise t-statistic map was Schaefer-parcellated for the downstream analyses.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-93246-app2-fig4-v1.tif"/></fig></sec></sec></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.93246.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lerch</surname><given-names>Jason P</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of Oxford</institution><country>United Kingdom</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This <bold>important</bold> work contributes to our understanding of the combined effects of metabolic syndrome on fronto-temporal gray matter morphology from two large-scale datasets. The evidence based on state-of-the art multivariate imaging analysis and detailed micro- and macrostructural contextualization analyses is <bold>convincing</bold> and provides an understanding of the neurological correlates of metabolic syndrome, although the study would have benefitted from the inclusion of longitudinal data.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.93246.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In their study, Petersen et al. investigated the relationship between parameters of metabolic syndrome (MetS) and cortical thickness using partial least-squares correlation analysis (PLS) and performed subsequently a group comparison (sensitivity analysis). To do this, they utilized data from two large-scale population-based cohorts: the UK BioBank (UKB) and the Hamburg City Health Study (HCHS). They identified a latent variable that explained 77% of the shared variance, driven by several measures related to MetS, with obesity-related measures having the strongest contribution. Their results highlighted that higher cortical thickness in the orbitofrontal, lateral prefrontal, insular, anterior cingulate, and temporal areas is associated with lower MetS severity. Conversely, the opposite pattern was observed in the superior frontal, parietal, and occipital regions. A similar pattern was then observed in the sensitivity analysis when comparing two groups (MetS vs. matched controls) separately.</p><p>Interestingly, after including HbA1c (a blood glycemic marker, which reflects insulin resistance much better than non-fasting glucose) in their revision, the authors identified a second latent variable accounting for 22% of shared variance mostly driven by HbA1c and blood glucose. The authors conclude that the distinct covariance profile of this variable likely indicates a separate pathological mechanistic connection between MetS components and brain morphology.</p><p>They then mapped local cellular and network topological attributes to the observed cortical changes associated with MetS. This was achieved using cell-type-specific gene expressions from the Allen Human Brain Atlas and the group consensus functional and structural connectomes of the Human Connectome Project (HCP), respectively. This contextualization analysis allowed them to identify potential cellular contributions in these structures driven by endothelial cells, microglial cells, and excitatory neurons. It also indicated functional and structural interconnectedness of areas experiencing similar MetS effects.</p><p>Strengths:</p><p>The effects of metabolic syndrome on the brain are still incompletely understood, and such multi-scale analyses are important for the field. Despite the study's sole 'correlation-based' nature, it yields valuable results, including several scales of brain parameters (cortical thickness, cellular, and network-based). The results are robust and benefit from two 'large-scale' datasets, resulting in highly powered statistics</p><p>Weaknesses:</p><p>The weakness of this study lies mostly on the non-causative approach used here. Nevertheless, the authors are aware of the limitations of the study and carefully frame their language accordingly.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.93246.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this manuscript, Petersen et al. aimed for a comprehensive assessment of the relationship between cardiometabolic risk factors and cortical thickness. They found that a latent variable reflecting higher obesity, hypertension, LDL cholesterol, triglyerides, non-fasting glucose, HbA1c and lower HDL cholesterol was associated with lower cortical thickness in orbitofrontal, lateral prefrontal, insular, anterior cingulate and temporal areas as well as lower subcortical volumes. In sensitivity analyses they showed that this pattern replicated across cohorts and was also consistent with a clinical definition of the metabolic syndrome.</p><p>Further, when including cognition into the multivariate analysis, the pattern remained unchanged and mediation analyses showed that the relationship between the first latent variable and worse cognitive performance across several tests was mediated by the brain morphological differences.</p><p>The authors investigated the cell types implicated in the regions associated with cardiometabolic risk using the Allen Brain Atlas and found that the density of excitatory neurons type 8, endothelial cells and microglia reliably co-located with the pattern of cortical thickness. Furthermore, they showed that cortial regions more strongly associated with MetS were more closely structurally &amp; functionally connected than others.</p><p>Strengths:</p><p>This study performed a comprehensive assessment of the combined association of cardiometabolic risk factors and brain structure and investigated micro-and macroscopic underpinnings. A major strength of the study is the methodological approach of partial least squares which allows one to not single out risk factors but to take them into account simultaneously. The large sample size from two cohorts allowed for different sensitivity analyses and convincing evidence for the stability of the first latent variable. The authors demonstrated that the component was also reliably related to cognitive performance and that the association of the individual cardiometabolic risk on cognition was mediated by brain morphological differences, replicating multiple previous studies which evidenced associations of different components of the MetS with worse cognitive performance.</p><p>The novel contribution of the study lies in the virtual histology and brain topology investigation of the cortical pattern related to MetS. The virtual histology provided convincing evidence of the co-localization of endothelial, glial and excitatory neuronal cells with the regions of MetS-associated cortical thinning while the brain topology analysis highlighted the disproportionate structural and functional connectivity between associated regions. This analysis provides insights into the role of inflammatory processes and the intricate link between gray matter morphology and microvasculature, both locally and in relation to long-range connectivity. This information is valuable to inform future mechanistic studies.</p><p>Weaknesses:</p><p>The study is exclusively cross-sectional which does not allow disentangling potential causes from consequences. While studies indicate that most of the differences seen in middle age are probably consequences of the MetS on the vasculature, blood-brain barrier or inflammatory processes, differences in cortical morphology might also represent a risk factor for weight gain.</p><p>The study is exploratory in nature and for the contextualization analyses it is difficult to judge whether those were selected from a larger pool of analyses.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.93246.3.sa3</article-id><title-group><article-title>Author Response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Petersen</surname><given-names>Marvin</given-names></name><role specific-use="author">Author</role><aff><institution>University Medical Center Hamburg-Eppendorf</institution><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Hoffstaedter</surname><given-names>Felix</given-names></name><role specific-use="author">Author</role><aff><institution>Research Centre Jülich</institution><addr-line><named-content content-type="city">Jülich</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Nägele</surname><given-names>Felix Leonard</given-names></name><role specific-use="author">Author</role><aff><institution>University Medical Center Hamburg-Eppendorf</institution><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Mayer</surname><given-names>Carola</given-names></name><role specific-use="author">Author</role><aff><institution>University Medical Center Hamburg-Eppendorf</institution><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Schell</surname><given-names>Maximilian</given-names></name><role specific-use="author">Author</role><aff><institution>University Medical Center Hamburg-Eppendorf</institution><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Rimmele</surname><given-names>David Leander</given-names></name><role specific-use="author">Author</role><aff><institution>University Medical Center Hamburg-Eppendorf</institution><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Zyriax</surname><given-names>Birgit-Christiane</given-names></name><role specific-use="author">Author</role><aff><institution>University Medical Center Hamburg-Eppendorf</institution><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Zeller</surname><given-names>Tanja</given-names></name><role specific-use="author">Author</role><aff><institution>University Medical Center Hamburg-Eppendorf</institution><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Kühn</surname><given-names>Simone</given-names></name><role specific-use="author">Author</role><aff><institution>University Medical Center Hamburg-Eppendorf</institution><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Gallinat</surname><given-names>Jürgen</given-names></name><role specific-use="author">Author</role><aff><institution>University Clinic Hamburg-Eppendorf</institution><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Fiehler</surname><given-names>Jens</given-names></name><role specific-use="author">Author</role><aff><institution>University Medical Center Hamburg-Eppendorf</institution><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Twerenbold</surname><given-names>Raphael</given-names></name><role specific-use="author">Author</role><aff><institution>University Medical Center Hamburg-Eppendorf</institution><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Omidvarnia</surname><given-names>Amir</given-names></name><role specific-use="author">Author</role><aff><institution>Institute of Neuroscience and Medicine, Brain &amp; Behaviour (INM-7), Research Centre Jülich</institution><addr-line><named-content content-type="city">Jülich</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Patil</surname><given-names>Kaustubh R</given-names></name><role specific-use="author">Author</role><aff><institution>Research Centre Jülich</institution><addr-line><named-content content-type="city">Jülich</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Eickhoff</surname><given-names>Simon B</given-names></name><role specific-use="author">Author</role><aff><institution>Institute of Neuroscience and Medicine, Brain &amp; Behaviour (INM-7), Research Centre Jülich</institution><addr-line><named-content content-type="city">Julich</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Thomalla</surname><given-names>Goetz</given-names></name><role specific-use="author">Author</role><aff><institution>University Medical Center Hamburg-Eppendorf</institution><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Cheng</surname><given-names>Bastian</given-names></name><role specific-use="author">Author</role><aff><institution>University Medical Center Hamburg-Eppendorf</institution><addr-line><named-content content-type="city">Hamburg</named-content></addr-line><country>Germany</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer 1</bold></p><p>Comment 1.1: “Did the UKB or HCHS datasets have information on accurate markers of insulin resistance, such as HbA1c or HOMA-IR (if fasting glucose was not available)? Looking at that data would allow us to determine the contribution of insulin resistance to the observed cortical phenotype.”</p></disp-quote><p>Reply 1.1: We appreciate the insightful suggestion from the reviewer. In response, we incorporated the HbA1c into our analysis, enhancing its sensitivity to potential effects of insulin resistance. Subsequently, our analysis was reperformed, integrating HbA1c alongside non-fasting blood glucose in the PLS. This addition did not alter our main results, i.e., that of the PLS, virtual histology, and network contextualization analysis. Notably, as a result of the inclusion of HbA1c, the second latent variable now accounted for a greater shared variance (22.13%), with HbA1c showing the highest loading among MetS component variables. The manuscript has been thoroughly revised to incorporate these results.</p><disp-quote content-type="editor-comment"><p>Comments 1.2: “(Results, p.13, 291-292) &quot;A correlation matrix relating all considered MetS component measures is displayed in supplementary figure S12. Please clarify in this figure labels whether this was non-fasting glucose. If this is non-fasting glucose, it is not a MetS-related risk factor. The reader might be misled into thinking that fasting-glucose has a weak correlation, while its contribution (and the effect of insulin resistance) was not studied here.”</p><p>“Table S8 and Table S9: Is the glucose metric here measured following fasting? If not, this should not be listed as a metabolic syndrome criterion. Or it should be specified that it isn't fasted glucose, otherwise, it sounds misleading.”</p></disp-quote><p>Reply 1.2: We thank the reviewer for bringing this ambiguity to our attention. The initial analysis included only non-fasting plasma glucose in the PLS, as fasting plasma glucose data was unavailable for UKB and HCHS participants. Following your suggestion in reply 1.1, we have now incorporated HbA1c, a more indicative marker of insulin resistance. We retained non-fasting blood glucose in our analysis, recognizing its relevance as a diagnostic variable for type 2 diabetes mellitus, although it is less informative than fasting plasma glucose, HbA1c, or HOMA-IR. This decision is substantiated by the significant correlation found between non-fasting plasma glucose and HbA1c in our sample (r=.49).</p><p>To enhance clarity, we have revised the methods section to explicitly mention that the study investigates non-fasting blood glucose. The revised sentence reads: “Here, we related regional cortical thickness and subcortical volumes to clinical measurements of MetS components, i.e., obesity (waist circumference, hip circumference, waist-hip ratio, body mass index), arterial hypertension (systolic blood pressure, diastolic blood pressure), dyslipidemia (high density lipoprotein, low density lipoprotein, total cholesterol, triglycerides) and insulin resistance (HbA1c, non-fasting blood glucose).”</p><p>Additionally, we have updated the caption of supplementary figure S13 (formerly supplementary figure S12) to clearly indicate the investigation of non-fasting plasma glucose. The table detailing diagnostic MetS criteria (supplementary table S2) has also been amended to clarify the absence of fasting plasma glucose data in our study and to indicate that only data on antidiabetic therapy and diagnosis of type 2 diabetes mellitus were used as criteria for insulin resistance in the case-control analysis.</p><disp-quote content-type="editor-comment"><p>Comment 1.3: “I do not understand how the authors can claim there is a deterministic relationship there if all the results are only correlational or comparative. Can the differences in functional connectivity and white matter fiber tracts observed not be caused by the changes in cortices they relate to? How can the authors be sure the network organisation is shaping the cortical effects and not the opposite (the cortical changes influence the network organisation)? This should be further discussed or explained.”</p></disp-quote><p>Reply 1.3: We agree with the reviewer's comment on the non-causative nature of our data and have accordingly revised the discussion section to reflect a more cautious interpretation of our findings. We have carefully reframed our language to avoid any implications of causality, ensuring the narrative aligns with the correlational nature of our data. Nevertheless, we believe that exploring causal interpretations can offer valuable clinical insights. Therefore, while moderating our language, we have maintained certain speculative discussions regarding potential causative pathomechanistic pathways.</p><disp-quote content-type="editor-comment"><p>Comment 1.4: “The hippocampus is also an area where changes have consistently been observed. Why did the authors limit their analysis to the cortex.”</p></disp-quote><p>Reply 1.4: We appreciate this reviewer comment. In response, we have added volumes of Melbourne Subcortical Atlas parcels (including the hippocampus) to the analysis. Corresponding results are now shown in figure 2. The subcortical bootstrap ratios indicated that higher MetS severity was related to lower volumes across all investigated subcortical structures.</p><disp-quote content-type="editor-comment"><p>Comment 1.5: “Which field ID of the UK biobank are the measures referring to? If possible, please specify the Field ID for each of the UKB metrics used in the study.”</p></disp-quote><p>Reply 1.5: We thank the reviewer for the recommendation. The Field IDs used in our study are now listed in supplementary figure S1.</p><disp-quote content-type="editor-comment"><p>Comment 1.6: “Several Figures were wrongly annotated, making it hard to follow the text.”</p></disp-quote><p>Reply 1.6: Thank you for bringing the annotation issues to our awareness. We have thoroughly edited all annotations which should now correctly reference the figure content.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer 2</bold></p><p>Comment 2.1: “Do the authors have the chance to see how the pattern relates to changes in cognitive function in the UKBB and possibly HCHS? This could help to provide some evidence about the directionality of the effect.”Reply 2.1: Thank you for your suggestion. We acknowledge the potential value of investigating graymatter morphometric data alongside longitudinal information on cognitive function. Although we concur with the significance of this approach, we are constrained by the ongoing processing of the UKB's imaging follow-up data and the pending release of the HCHS follow-up data. Consequently, our current analysis cannot incorporate this aspect for now. We plan to explore the relationship between MetS, cognition and brain morphology using longitudinal data as soon as it becomes available.</p><p>Comment 2.2: “Also, you could project new data onto the component and establish a link with cognition in a third sample which would be even more convincing. I can offer LIFE-Adult study for this aim.”</p></disp-quote><p>Reply 2.2: We are grateful for your recommendation to enhance our study's robustness by including a third sample to establish a cognitive link. While we recognize the merit of such a sensitivity analysis, we believe that our current dataset, derived from two large, independent cohorts, is sufficiently comprehensive for the scope of our current analysis. However, we are open to considering this approach in future studies and appreciate your offer of the LIFE-Adult study. We would welcome further conversation with you regarding future joint projects.</p><disp-quote content-type="editor-comment"><p>Comment 2.3: “The sentences (p.17, ll.435 ff) seem to repeat: &quot;Interestingly, we also observed a positive relationship between cortical thickness and MetS in the superior frontal, parietal and occipital lobe. Interpretation of this result is, however, less intuitive. We also noted a positive MetS-cortical thickness association in superior frontal, parietal and occipital lobes, a less intuitive finding that has been previously reported [60,61].”</p></disp-quote><p>Reply 2.3: Thank you for making us aware of this duplication. We have deleted the first part of the section. It now reads “We also noted a positive MetS-cortical thickness association in superior frontal, parietal and occipital lobes, a less intuitive finding that has been previously reported.”</p><disp-quote content-type="editor-comment"><p>Comment 2.4: “I would highly appreciate empirical evidence for the claim in ll. 442 &quot;In support of this hypothesis, the determined cortical thickness abnormality pattern is consistent with the atrophy pattern found in vascular mild cognitive impairment and vascular dementia&quot; Considering the previous reports about the co-localization of obesity-associated atrophy and AD neurodegeneration (Morys et al. 2023, DOI: 10.3233/JAD-220535), that most dementias are mixed and that MetS probably increases dementia risk through both AD and vascular mechanisms, I feel such &quot;binary&quot; claims on VaD/AD-related atrophy patterns should be backed up empirically.”</p></disp-quote><p>Reply 2.4: Thank you for highlighting the need for clarity in differentiating between vascular and Alzheimer's dementia. We recognize the intricate overlap in dementia pathologies. Acknowledging the prevalence of mixed dementia and the influence of MetS on both AD and vascular mechanisms, we realize our original statement might have implied a specificity to vascular dementia, which was not intended.</p><p>To address your concern, we have revised our statement to avoid an exclusive focus on vascular pathology, ensuring a more balanced representation of dementia types. Additionally, we have included Morys et al. 2023 as a reference. The section now reads: “In support of this hypothesis, the determined brain morphological abnormality pattern is consistent with the atrophy pattern found in vascular mild cognitive impairment, vascular dementia and Alzheimer’s dementia.”</p><disp-quote content-type="editor-comment"><p>Comment 2.5: “I wonder how specific the cell-type results are to this covariance pattern. Maybe patterns of CT (independent of MetS) show similar associations with one or more of the reported celltypes? Would it be possible to additionally show the association of the first three components of general cortical thickness variation with the cell type densities?”</p></disp-quote><p>Reply 2.5: Thank you for your query regarding the specificity of the cell-type results to the observed covariance pattern. To address this, we have conducted a virtual histology analysis of the first three latent variables of the main analysis PLS. The findings of this extended analysis have been detailed in the supplementary Figure S21. The imaging covariance profile of latent variable 2 was significantly associated with the density of excitatory neurons of subtype 3. The imaging covariance profile linked to latent variable 3 showed no significant association of cell type densities. Possibly, latent variable 3 represents only a noise component as it explained only 2.12% of shared variance. We hope this addition provides a clearer understanding of the specificity of our main results.</p><disp-quote content-type="editor-comment"><p>Comment 2.6: “I agree that this multivariate approach can contribute to a more holistic understanding, yet I would like to see the discussion expanded on how to move on from here. Should we target the MetS more comprehensively or would it be best to focus on obesity (being the strongest contributor and risk factor for other &quot;downstream&quot; conditions such as T2DM)? A holistic approach is somewhat at odds with the in-depth investigation of specific mechanisms.”</p></disp-quote><p>Reply 2.6: We value your suggestion to elaborate on the implications of our findings. Our study indicates that obesity may have the most pronounced impact on brain morphology among MetS components, suggesting it as a key contributor to the clinical-anatomical covariance pattern observed in our analysis. This highlights obesity as a primary target for future research and preventive strategies. However, we believe that our results warrant further validation, ideally through longitudinal studies, before drawing definitive clinical conclusions.</p><p>Additionally, our study endorses a comprehensive approach to MetS, highlighting the importance of considering the syndrome as a whole to gain broader insights. We want to clarify, however, that such an approach is meant to complement, rather than replace, the study of individual cardiometabolic risk factors. The broad perspective our study adopts is facilitated by its epidemiological nature, which may not be as applicable in experimental settings that are vital for deriving mechanistic disease insights.</p><p>To reflect these points, we have expanded the discussion in our manuscript to include a more detailed consideration of these implications and future research directions.</p><disp-quote content-type="editor-comment"><p>Comment 2.7: “Please report the number of missing variables.”</p></disp-quote><p>Reply 2.7: Thank you for your request to report the number of missing variables. We would like to direct your attention to table 1, where we have listed the number of available values for each variable in parentheses. To determine the number of missing variables, one can subtract these numbers from the total sample size.</p><disp-quote content-type="editor-comment"><p>Comment 2.8: “Was the pattern similar in pre-clinical (pre-diabetes, pre-hypertension) vs. clinical conditions?“</p></disp-quote><p>Reply 2.8: Thank you for your interest in the applicability of our findings across different MetS severity levels. Our analysis employs a continuous framework to encompass the entire range of vascular and cardiometabolic risks, including those only mildly affected by MetS. The linear relationship we observed between MetS severity and gray matter morphology patterns, as illustrated in Figure 2d, supports the interpretation that our findings apply to the entire spectrum of MetS severities.</p><disp-quote content-type="editor-comment"><p>Comment 2.9: “How did you deal with medication (anti-hypertensive, anti-diabetic, statins..)?”</p></disp-quote><p>Reply 2.9: Information on medication was considered for defining MetS for the case-control sensitivity analysis but was not included in the PLS. Detailed information can be found in table 1.</p><disp-quote content-type="editor-comment"><p>Comment 2.10: “It would be really interesting to determine the genetic variations associated with the latent component. Have you considered doing a GWAS on this, potentially in the CHARGE consortium or with UKBB as discovery and HCHS as replication sample?”</p></disp-quote><p>Reply 2.10: Thank you for your valuable suggestion regarding the implementation of a GWAS. We agree that incorporating a GWAS would provide significant insights, but we also recognize that it extends beyond the scope of our current analysis. However, we are actively planning a follow-up analysis. This subsequent analysis will encompass a comprehensive examination of both genetic variation and imaging findings in the context of MetS.</p><disp-quote content-type="editor-comment"><p>Comment 2.11: “Please provide more information on which data fields from UKBB were used exactly (e.g. in github repository).”</p></disp-quote><p>Reply 2.11: We appreciate your recommendation. The details regarding the Field IDs used in our study have been included as supplementary table S1.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer 3</bold></p><p>Comments 3.1: “After a thorough review of the methods and results sections, I found no direct or strong evidence supporting the authors' claim that the identified latent variables were related to more severe MetS to worse cognitive performance. While a sub-group comparison was conducted, it didnot adequately account for confounding factors such as educational level.”</p><p>“Page 18-19 lines 431-446: the fifth paragraph in the discussion section. - As previously mentioned in the &quot;Weaknesses&quot; section, this study did not conduct a direct association analysis between MetS and cognitive levels without considering subgroup comparisons. Hence, I recommend the content of this paragraph warrants careful reconsideration.”</p></disp-quote><p>Reply 3.1: We acknowledge the reviewer's constructive feedback regarding our analysis of cognitive data. We have performed a mediation analysis relating the subject-specific clinical PLS score of latent variable 1 representing MetS severity and cognitive test performances and testing for mediating effects of the imaging PLS score capturing the MetS-related brain morphological abnormalities. The imaging score was found to statistically mediate the relationship between the clinical PLS score and executive function and processing speed, memory, and reasoning test performance. These findings highlight brain structural differences as a relevant pathomechanistic correlate in the relationship of MetS and cognition. Corresponding information can now be found in figure 3, methods section 2.6.2, result section 3.3 and discussion section 4.2.</p><p>Moreover, we would like to apologize for any confusion caused by previous unclear presentation. Our study further incorporates association analyses between MetS, brain structure, and cognition using MetS components, regional brain morphological measures, and cognitive performance data in a PLS to investigate whether cognitive measures contribute to the latent variable. These analyses were separately performed on the UK Biobank and HCHS datasets, due to their distinct cognitive assessments. We adjusted for age, sex, and education in the subgroup analyses by removing their effects from the input variables. These relationships are detailed in supplementary figures S16b and S17b, with loadings close to zero for age, sex, and education, confirming effective deconfounding.</p><p>In sum, we greatly appreciate the suggestion to conduct a mediation analysis, which has substantially enhanced the strength and relevance of our analysis.</p><disp-quote content-type="editor-comment"><p>Comment 3.2: “I would suggest the authors provide a more comprehensive description of the metrics used to assess each MetS component, such as obesity (incorporating parameters like waist circumference, hip circumference, waist-hip ratio, and body mass index) and arterial hypertension (detailing metrics like systolic and diastolic blood pressure), etc.”</p></disp-quote><p>Reply 3.2: Thank you for your suggestion regarding a more detailed description of the metrics for assessing each component of MetS. We would like to point out that the specific metrics used, including those for obesity (such as waist circumference, hip circumference, waist-hip ratio, and body mass index) and arterial hypertension (including systolic and diastolic blood pressure), are comprehensively detailed in table 1 of our manuscript. We hope this table provides the clarity and specificity you are seeking regarding the MetS assessment metrics in our study.</p><disp-quote content-type="editor-comment"><p>Comment 3.3: “I recommend the inclusion of an additional, detailed flowchart to further illustrate the procedure of virtual histology analysis. This would enhance the clarity of the methodological approach and assist readers in better comprehending the analysis method.”</p></disp-quote><p>Reply 3.3: Thank you for your suggestion. Recognizing the challenges in visually representing many of our analysis steps, we have instead supplemented our manuscript with additional references. These references provide a clearer understanding of our virtual histology approach, particularly focusing on the processing of regional microarray expression data.</p><p>The corresponding sentence reads: “Further details on the processing steps covered by ABAnnotate can be found elsewhere (<ext-link ext-link-type="uri" xlink:href="https://osf.io/gcxun">https://osf.io/gcxun</ext-link>) [42]”</p><disp-quote content-type="editor-comment"><p>Comment 3.4: “Why were both brain hemispheres used instead of solely utilizing the left hemisphere as the atlas, especially considering that the Allen Human Brain Atlas (AHBA) only includes gene data for the right hemisphere for two subjects?”</p></disp-quote><p>Reply 3.4: Thank you for your query regarding our decision to use both brain hemispheres instead of solely the left hemisphere, especially considering the Allen Human Brain Atlas (AHBA) predominantly featuring gene data from the left hemisphere. Given the AHBA's limited spatial coverage of expression data in the right hemisphere, our approach involved mirroring the existing tissue samples across the left-right hemisphere boundary using the abagen toolbox,1 a practice supported by findings that suggest minimal lateralization of microarray expression.2,3 Further details are provided in previous work employing ABAnnotate.4 These studies are now referenced in our methods section.</p><disp-quote content-type="editor-comment"><p>Comment 3.5: “The second latent variable was not further discussed. If this result is deemed significant, it warrants a more detailed discussion.”</p></disp-quote><p>Reply 3.5: Thank you for the suggestion. We have added a paragraph to the discussion that discusses the second latent variable in greater detail. It reads: “The second latent variable accounted for 22.33% of shared variance and linked higher insulin resistance and lower dyslipidemia to lower thickness and volume in lateral frontal, posterior temporal, parietal and occipital regions. The distinct covariance profile of this latent variable, compared to the first, likely indicates a separate pathomechanistic connection between MetS components and brain morphology. Given that HbA1c and blood glucose were the most significant contributors to this variable, insulin resistance might drive the observed clinicalanatomical relationship.”</p><disp-quote content-type="editor-comment"><p>Comment 3.6: “I suggest appending positive MetS effects after &quot;..., insular, cingulate and temporal cortices;&quot; for two reasons: (a). The &quot;positive MetS effects&quot; might represent crucial findings that should not be omitted. (b). Including both negative and positive effects ensures that subsequent references to &quot;this pattern&quot; are more precise.”</p></disp-quote><p>Reply 3.6: We concur with the notion that the positive MetS effects should be highlighted as well. We modified the first discussion paragraph now mentioning them.</p><disp-quote content-type="editor-comment"><p>Comment 3.7: “I would appreciate further clarification on this sentence and the use of the term &quot;uniform&quot; in this context. Does this suggest that despite the heterogeneity in the physiological and pathological characteristics of the various MetS components (e.g., obesity, hypertension), their impacts on cortical thickness manifest similarly? How is it that these diverse components lead to &quot;uniform&quot; effects on cortical thickness? Does this observation align with or deviate from previous findings in the literature?”</p></disp-quote><p>Reply 3.7: Thank you for highlighting the ambiguity in our previous explanation. We agree that the complexity of the relationship between MetS components and brain morphology requires clearer articulation. To address this, we have revised the relevant sentence for better clarity. It now reads: „This finding indicates a relatively uniform connection between MetS and brain morphology, implying that the associative effects of various MetS components on brain structure are comparatively similar, despite the distinct pathomechanisms each component entails.“</p><disp-quote content-type="editor-comment"><p>Comment 3.8: “Figure 1 does not have the labels &quot;(c)&quot; and &quot;(d)&quot;. ”</p></disp-quote><p>Reply 3.8: Thank you. We have modified figure 1 and made sure that the caption correctly references its content.</p><disp-quote content-type="editor-comment"><p>Comment 3.10: “Incorrect figure/table citation:</p><list list-type="bullet"><list-item><p>Page 18 line 418: &quot;(figure 2b and 1c)&quot; à (figure 2b and 2c).</p></list-item></list><list list-type="bullet"><list-item><p>Page 18 line 419: &quot;(supplementary figures S8 and S12-13)&quot; à (supplementary figures S11 and S1516).</p></list-item></list><list list-type="bullet"><list-item><p>In the supplementary material, &quot;Text S5 - Case-control analysis&quot; section contains several figure or table citation errors. Please take a moment to review and correct them.”</p></list-item></list></disp-quote><p>Reply 3.10: Thank you for bringing this to our attention. We have corrected the figure and table citation errors.</p><disp-quote content-type="editor-comment"><p>Comment 3.11: “Page 8 line 184: The more commonly used term is &quot;insulin resistance&quot; rather than &quot;insuline resistance.”</p></disp-quote><p>Reply 3.11: We now use “insulin resistance” throughout the manuscript.</p><disp-quote content-type="editor-comment"><p>Comment 3.12: “Nevertheless, variations in gene sets may introduce a degree of heterogeneity in the results (Seidlitz, et al., 2020; Martins et al., 2021). Consequently, further validation or exploratory analyses utilizing different gene sets can yield more compelling results and conclusions.”</p></disp-quote><p>Reply 3.12: Thank you for your insightful comment regarding the potential heterogeneity introduced by variations in gene sets. We agree that exploring different gene sets could indeed enhance the robustness and generalizability of our findings. However, we think conducting a comprehensive methodological analysis of the available cell-type specific gene sets is a substantial effort and warrants its own investigation to thoroughly implement it and assess its implications. We also like to highlight that we are adhering to previous practices in our analysis setup.4,5</p><p>References</p><p>(1) Markello RD, Arnatkeviciute A, Poline JB, Fulcher BD, Fornito A, Misic B. Standardizing workflows in imaging transcriptomics with the abagen toolbox. Jbabdi S, Makin TR, Jbabdi S, Burt J, Hawrylycz MJ, eds. eLife. 2021;10:e72129. doi:10.7554/eLife.72129</p><p>(2) Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature. 2012;489(7416):391-399. doi:10.1038/nature11405</p><p>(3) Hawrylycz M, Miller JA, Menon V, et al. Canonical genetic signatures of the adult human brain. Nat Neurosci. 2015;18(12):1832-1844. doi:10.1038/nn.4171</p><p>(4) Lotter LD, Saberi A, Hansen JY, et al. Human cortex development is shaped by molecular and cellular brain systems. Published online May 5, 2023:2023.05.05.539537. doi:10.1101/2023.05.05.539537</p><p>(5) Lotter LD, Kohl SH, Gerloff C, et al. Revealing the neurobiology underlying interpersonal neural synchronization with multimodal data fusion. Neuroscience &amp; Biobehavioral Reviews.2023;146:105042. doi:10.1016/j.neubiorev.2023.105042</p></body></sub-article></article>